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Abstract 
Tooth development is complex and dependent on epithelial-mesenchymal interactions 
involving key molecular signalling pathways. Preliminary data indicate that the 
pleiotropic growth factor adrenomedullin (ADM) is expressed during tooth 
development. Furthermore, in osteoblasts, cells which share structural and functional 
similarities to odontoblasts, ADM increases proliferation in vitro and can promote 
mineralised bone volume and strength in vivo. 
 Immunohistochemical analysis of ADM demonstrated expression during key 
stages in tooth development in particular in cells responsible for signalling 
odontoblast differentiation and subsequently in secretory odontoblasts. Similarities 
with the temporo-spatial expression profile of TGF-β1 were also observed. In vitro 
analysis using the developmentally derived dental cell lines, MDPC-23 and OD-21, 
demonstrated ADM stimulated a biphasic response in dental cell numbers with peak 
stimulation at 10
-11
M and that it stimulated mineral deposition at levels comparable to 
that of the known mineralising agent dexamethasone. Analysis of tooth tissue volume 
and key mandibular measurements in Swiss mice systemically treated with ADM 
using techniques including micro-Computer Tomography did not identify significant 
differences in craniofacial mineralised tissue structures compared to sham treated 
controls.  
 The data presented here along with the known pleiotropic properties of ADM 
indicate it may be an important regulator of tooth development particularly in the 
processes of cell proliferation, differentiation and mineralisation. However, in adult 
animals systemic ADM supplementation appears to have limited affect on mandibular 
bone and dentine synthesis. 
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1. Introduction 
1.1 Project Aims 
The development of a tooth is complex and dependent on epithelial-mesenchymal 
interactions and involves key cellular and molecular signalling processes and 
pathways. It is important to gain a clearer understanding of the factors involved in 
tooth development as this can not only aid our understanding of the developmental 
process but can help to increase our knowledge of developmental defects and also 
help in the understanding of how growth factors could be used in the repair of teeth, 
as the reparative processes of odontoblast induction and dentine secretion are thought 
to closely mimic those of tooth development (Smith and Lesot, 2001). 
Recently, preliminary data has indicated the presence of the pleiptropic growth 
factor adrenomedullin (ADM) in the developing tooth bud (Monuenga et al, 1997), 
however, only limited expression characterization at early stages of development were 
performed. Notably, ADM has demonstrated similar temporo-spatial patterns of 
expression during embryogenesis as TGF-β1, a growth factor known to play a key 
role in tooth development. Furthermore, in osteoblasts, cells which share many 
structural and functional similarities to odontoblasts, data demonstrates that ADM 
increases proliferation in vitro (Cornish et al, 1997; Cornish et al, 2002) and can 
promote mineralised bone volume and strength in vivo (Cornish et al, 1997; Cornish 
et al, 2001). 
The aims of this project were: 
i) to characterise the expression of ADM, in comparison to TGF-β1, during 
key stages of rodent tooth development using immunohistochemical analysis  
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ii) to study ADM‟s effect on developmentally derived dental cell numbers and 
extracellular secretion indicative of mineralisation in vitro which may indicate 
its potential role(s) in tooth development and, 
iii) to analyse the effects of ADM, using μCT technology, in adult mice to 
determine its effects on dental and craniofacial mineralised tissue in vivo.  
The data generated should provide valuable insight into the role of ADM in the dental 
and craniofacial mineralised tissues both developmentally and post-natally and may 
indicate its potential application for dental regenerative therapy. 
 
1.2 Teeth in Oral Function during Health and Disease 
Teeth have many functions. The primary and most commonly associated being that of 
mastication. In many animals, teeth also play a major role in attack and defence whilst 
in humans, teeth also aid speech (Ten Cate, 1998). During oral and dental disease, 
e.g., periodontal diseases and caries, oral function may be compromised. 
Traditionally, oral function has been restored by simple surgical procedures to the 
dentition and periodontium, often using inert dental materials to replace lost tissue 
(Schröder, 1985; Murray and Garcia-Godoy, 2004). Currently, there is much interest 
in biological approaches to restore function by tissue regeneration and a deep 
understanding of the cellular and molecular processes involved in oral and dental 
tissue behaviour is required for effective clinical translation of such approaches 
(Smith 2003; Nakashima, 2005). The following sections of this Introduction aim to 
provide a background to the understanding of cell behaviour in teeth as a basis for 
future clinical exploitation of various bioactive molecules for dental regeneration. 
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1.3 Tooth Structure 
There are three structurally distinct components that constitute a tooth which include 
the enamel, dentine and pulp (Figure 1.1). The enamel is the acellular layer that 
covers the exposed surface of the tooth (Figure 1.1) and is formed by ameloblasts 
during development that subsequently apoptose when the tooth erupts into the oral 
cavity (Kondo et al, 2001). Enamel is the most mineralised tissue and hardest 
substance found in the body. Although biologically “dead”, this layer is permeable, 
allowing ion exchange between the enamel and the oral cavity, in particular those ions 
present in saliva which aid remineralisation. Enamel is highly susceptible to 
demineralisation by bacterial acids, and once lost to wear or caries it cannot be 
replaced by cellular activity due to the absence of its formative cells (Ten Cate, 1998). 
Dentine is an avascular, hard, connective tissue, which makes up the majority 
of the tooth (Figure 1.1). It consists of a complex compound of type I collagenous 
fibres and an apatite mineral phase, providing rigidity and strength, while the tubular 
nature of dentine provides the flexibility required to support the enamel, especially 
during mastication (Ten Cate, 1998; Kinney et al, 1999). Dentine is synthesized and 
maintained by odontoblasts, which secrete structurally distinct forms of dentine 
depending on their maturity. Between the odontoblasts and mineralised dentine is an 
unmineralised newly secreted predentine layer, 10–30µm wide, consisting of type I 
collagen and proteoglycans (Linde & Goldberg, 1993; Torneck, 1994). The principal 
component of dentine is the primary dentine, which is relatively rapidly synthesised 
up to root formation at which point secondary dentine is subsequently laid down at a 
much slower rate. Dentine is tubular in structure due to the mode by which it is 
deposited and the tubules contain the odontoblast processes, collagen fibrils, 
peritubular dentine and a complex mixture of proteins (Thomas, 1979; Linde & 
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Goldberg 1993; Torneck 1994). In the crown of the tooth the tubules extend from the 
dentine-enamel junction to the odontoblast layer, giving rise to the permeability of the 
dentine (Torneck 1994). Inside these tubules, the peritubular dentine can become 
hypermineralised and ultimately occlude the tubules thereby reducing permeability 
(Torneck 1994). At the outermost region of the primary dentine, just beneath the 
enamel, a narrow zone termed mantle dentine exists. This has a different composition 
to primary dentine, generally being less mineralised, and is produced by the newly 
differentiated odontoblasts (Linde & Goldberg, 1993; Torneck, 1994). Once the tooth 
is fully formed, i.e. after root formation, the odontoblasts continue to deposit 
secondary dentine at a significantly slower rate resulting in a reduction of the pulp 
chamber. Secondary dentine resembles primary dentine in structure but is less regular 
although the tubules are generally continuous (Linde & Goldberg, 1993; Torneck, 
1994). Tertiary dentine is formed in response to trauma, such as dental caries, by 
odontoblasts or newly derived odontoblast-like cells beneath the site of injury to 
protect the underlying soft tissue of the pulp (for further description of this see 
Section 1.5) (Lesot et al, 1994; D‟Souza et al, 1995). Unlike primary dentine, the 
morphology of the tertiary dentine varies greatly and it is often irregular, with 
permeability reduced as a result of a reduction of tubular structure and/or continuity 
(Tziafas et al, 2000). 
The pulp, at the core of the tooth, comprises of soft connective tissue (Figure 
1.1). Its primary functions are to form, repair and nourish the dentine. The majority of 
the dental pulp is made up of a heterogeneous cell population of fibroblasts 
(Tsukamoto et al, 1992) which, amongst other activities, secrete an extracellular 
matrix (ECM) composed primarily of type I and III collagenous fibrils responsible for 
maintaining its structural integrity (Goldberg and Smith, 2004; Killough et al, 2009). 
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Also within the pulp are undifferentiated mesenchymal cells known as dental pulp 
stem cells (DPSC) (Gronthos et al, 2000) that have a similar gene expression profile 
to bone marrow stem/stromal cells (BMSC) (Shi et al, 2001) and are thought to reside 
in the perivascular niche region of the pulp (Shi and Gronthos, 2003). DPSCs have the 
potential to differentiate down several cell lineages including adipocytes (Gronthos et 
al, 2002), neural-like cells (Gronthos et al, 2002), osteoblasts (Otaki et al, 2007) and 
notably, odontoblasts (Gronthos et al, 2002). Recent studies have also demonstrated 
that in response to dental tissue injury perivascular DPSCs exhibit increased 
proliferation, can migrate to the site of tissue damage and can secrete reparative 
dentine ECM (About et al, 2000; Téclès et al, 2004). Notably, residing within the 
dental pulp immuno-responsive cells are also present, these include dendrocytes, 
macrophages, lymphocytes and mast cells, which mediate the inflammatory reaction 
in response to cellular or tissue insults arising due to dental trauma or disease, e.g. 
dental caries (Jontell et al, 1998; Goldberg and Smith, 2004). Also present within the 
pulp is a complex network of capillaries and sensory nervous tissue (plexus of 
Raschkow), which provide nutritive and sensory support to the dentine-pulp complex  
(Goldberg and Smith, 2004). 
To enable the tooth to perform its primary functions and to retain its position 
within the jaws, it is attached to the alveolar bone by two specialised supporting 
tissues, namely the periodontal ligament (PDL) and cementum (Figure 1.1). The PDL 
is a specialised connective tissue consisting of collagen fibre bundles synthesised by 
dental follicle-derived fibroblasts. These collagen fibres form a gel-like matrix, 
embedding themselves into the cementum and alveolar bone enabling the tooth to 
adapt to the forces applied during mastication. The PDL contains several cell lineages 
that are capable of (re)generating and maintaining the ligament itself as well as the 
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cementum and the alveolar bone adjacent to it. Cells resident in this tissue include 
fibroblasts, capable of collagen secretion, (McCulloch et al, 1989), cementoblasts and 
cementoclasts capable of remodelling the cementum (McCulloch et al, 1989; Seo et 
al, 2004), osteoblasts and osteoclasts (Basdra and Komposch, 1997) which maintain 
the alveolar bone. In addition, within the PDL are a population of progenitor/stem 
cells that have the potential to differentiate into all of these specific cell types to 
enable regeneration of the PDL fibres, alveolar bone and cementum following disease 
or trauma (Seo et al, 2004). 
Cementum is the hard, mineralised connective tissue, which is attached to the 
root dentine (Ten Cate, 1998). There are three distinct types of cementum, acellular 
afibrillar cementum, acellular extrinsic fibre cementum and cellular intrinsic 
cementum (Saygin et al, 2000; Grzesik and Narayanan, 2002). Acellular afibrillar 
cementum is present at the cemento-enamel junction and is made up of a mineralised 
matrix lacking in collagenous fibres and embedded cells (Sagyin et al, 2000; Grzesik 
and Narayanan, 2002). Acellular extrinsic fibre cementum is the primary cementum 
involved in attachment to the tooth and consists of dense collagenous fibres, primarily 
type I collagen, perpendicularly implanted into the dentine matrix (Sagyin et al, 2000; 
Grzesik and Narayanan, 2002). The cellular intrinsic cementum plays a reparative role 
and therefore contains cementocyte cells embedded in mineralised matrix and 
collagenous fibrils (Sagyin et al, 2000; Grzesik and Narayanan, 2002). 
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1.4 Craniofacial development 
 
1.4.1 Development of the mandible 
Mammalian development is a multifaceted process involving an intricate network of 
cell-cell signalling and is dependent on numerous epithelial-mesenchymal 
interactions. Craniofacial development is especially complex due to the diverse nature 
of the tissues involved (Thesleff et al, 1995). 
Development of the craniofacial tissues is initiated
 
as soon as the antero-posterior 
axis of an embryo is established and corresponds with the acquisition of two cell 
populations,
 
the neural crest and the ectodermal placodes (Basch
 
et al, 2004; McCabe 
et al, 2004). The neural crest comprises a pluripotent cell population derived from the 
neural plate during early stages of embryogenesis and in addition to giving rise to 
craniofacial structures, it also gives rise to the peripheral nervous system and 
connective tissues associated with the facial muscles (Noden, 1988; Couly et al, 1992; 
Kontges and Lumsden, 1996; Osumi-Yamashita et al, 1997). 
Following initiation of craniofacial development, neural crest cells disperse from 
the dorsal surface of the neural tube and undergo epithelial-mesenchymal 
transformation, where the epithelial cells dissociate from the tissue they originate 
from and become mesenchymal in nature, migrating ventro-laterally as they populate 
the craniofacial region. These cells then interact with, and are instructed by, the 
pharyngeal endoderm, ectoderm, and mesoderm before giving rise to the fronto-nasal 
process and the discrete swellings that distinguish each branchial arch (Chai and 
Maxson, 2006). It is the ventral
 
region of the first branchial arch that eventually gives 
rise to both maxillary
 
and mandibular processes (Cerny et al, 2004; Lee et
 
al, 2004). 
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The mandibular processes are bilaterally symmetrical structures located below the 
future oral cavity and composed of mesenchymal tissue derived from neural crest 
cells, enclosed by an epithelial cell layer of ectodermal and endodermal origin. 
Mandibular bone formation commences with
 
the condensation of the mesenchymal 
cells (Hall and Miyake, 2000;
 
Helms and Schneider, 2003; Eames et al, 2004) which 
then
 
differentiate into osteoblasts and form bone through
 
the intramembranous 
deposition and calcification of mineralized matrix
 
(Tyler and Hall, 1977). After their 
initial formation, these processes undergo considerable outgrowth along 3 axes, fusing 
in the midline region to give rise to the triangular-shaped lower jaw (Mina, 2001). 
This fusion is a result of epithelial cell migration and the merging of the mesenchymal 
cells from the neighbouring processes (Shuler et al, 1992; Shuler, 1995; Chai et al, 
1997; McGonnell et al, 1998). 
The processes involved are dependent on epithelial-mesenchymal interactions. 
This was demonstrated by tissue recombination studies suggesting that signals derived 
from mandibular epithelium regulate growth of the underlying mesenchyme (Wedden, 
1987; Richman and Tickle, 1989; Hall and Coffin-Collins, 1990; Mina et al, 1994). 
Similar to that seen during tooth development (see Section 1.4.2), these interactions 
are known to involve key growth factors, such as members of the Transforming 
Growth Factor-β superfamily, such as Bone Morphogenic Proteins (BMP), Fibroblast 
Growth Factors (FGFs), Wnt and Hedgehog (Hh) families, as demonstrated either by 
their temporo-spatial expression patterns (Chai et al, 1994; Chai et al, 1997; Trumpp 
et al, 1999; Ito et al, 2002; Liu et al, 2005) or in rodent genetic knockout studies 
(Chiang et al, 1996; Sanford et al, 1997; Nomura and Li, 1998; Liu
 
et al, 2005). Key 
transcription factors involved in this process include Msxl and Msx2, and members of 
the Dlx family and Pitx2 families, once again similar studies as used for growth 
 10 
factors have shown their involvement in mandibular epithelium development 
(Davidson, 1995; Maas and Bei, 1997; Davideau et al, 1999; Kraus and Lufkin, 1999; 
Meijlink et al, 1999; Lin et al, 1999; Satokata et al, 2000). 
 
1.4.2 Development of the Tooth 
 
1.4.2.1 Initiation of Tooth Development 
Tooth development is a reciprocal series of epithelial-mesenchymal 
interactions with both the epithelium and mesenchyme each being dominant at 
different stages throughout tooth development (Thesleff et al, 1995). Initiation of 
tooth development has been demonstrated to begin in the dental epithelium, with the 
molecules expressed interacting with the dental mesenchyme in such a way that there 
is a shift in the odontogenic potential, resulting in the mesenchymal cells being 
responsible for tooth development. In mouse embryos this shift occurs at 
approximately embryonic day 12.5 (E12.5), as shown in experiments by Mina and 
Kollar (1987) and Lumsden (1988). In these studies, only dental epithelium extracted 
before E12.5 initiated tooth formation when recombined with neural-crest-derived, 
second branchial arch mesenchyme. Conversely, only dental mesenchyme extracted 
after E12.5 carried odontogenic potential when recombined with second arch 
epithelium (Mina and Kollar, 1987; Lumsden, 1988). 
At a molecular level, initiation and odontogenic potential are regulated by 
protein signalling molecules, in particular by members of several growth factor 
families (Smith and Lesot, 2001). These molecules act by inducing intracellular 
pathways in the target tissue to activate transcription factors and increase gene and 
protein expression, which subsequently affect cellular phenotype. Prominent growth 
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factors demonstrably involved in tooth development are similar to those involved in 
the development of the mandible (Section 1.4.1) and include members of the 
Transforming Growth Factor-β superfamily, such as Bone Morphogenic Proteins 
(BMPs), Fibroblast Growth Factors (FGFs), Wnt and Hegdehog (Hh) families 
(Hardcastle et al, 1998; Jernvall et al, 2000; Sarkar et al, 2000; Thesleff et al, 2002). 
Whilst transcription factors that are induced by these growth factors and have been 
shown to be instrumental in tooth development include Msx1, Msx2, Dlx2, Pax9, 
Pitx1 and 2, and Barx1 (Dassule and McMahon, 1998; Grigoriou et al, 1998; Tucker 
et al, 1998; Peters et al, 1999; St Amand et al, 2000). 
Members of the TGF-β superfamily play key roles in organogenesis 
throughout the developing embryo. The best characterised member being TGF- β1, 
which is discussed in further detail in Section 1.8. Another prominent subfamily of 
the TGF-β superfamily are BMPs, and several of these are expressed during tooth 
development, although BMP4 in particular has been demonstrated to play a central 
role in this process (Thesleff et al, 2002). BMP4 is expressed in the dental epithelium 
prior to E12.5, and in the mesenchyme after E12.5, coinciding with the shift in 
odontogenic potential in mice (Vainio et al, 1993; Tureckova et al, 1995). BMP4 is 
known to regulate several dental development processes, including the restriction of 
transcription factor expression (e.g. Pax9, Pitx2 and Barx1) to sites of tooth initiation 
(Tucker et al, 1998; Peters et al, 1999; St Amand et al, 2000). BMP4 also induces 
expression of other transcription factors in the mesenchyme, including Msx1, Msx2, 
Dlx2 and Lef1 (Dassule and McMahon, 1998). However, the precise role of BMP4 
during tooth development has yet to be fully elucidated as mice deficient in BMP4 fail 
to survive before tooth formation is initiated (Winnier et al, 1995). 
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Several FGF family members exhibit a similar temporo-spatial expression 
pattern to that observed for BMPs during tooth formation and their functions range 
from tooth initiation to cusp formation regulation (Jernvall et al, 2000). Notably, 
FGF8 is expressed at significant levels in the dental epithelium prior to and during 
tooth development and is known to play a role in the induction of many transcription 
factors, including Pax9, Pitx1 and 2, Barx1, Lhx6 and Lhx7 (Grigoriou et al, 1998; 
Tucker et al, 1998; Peters et al, 1999; St Amand et al, 2000). 
Among the Hh family of growth factors in mammals only Sonic Hedgehog 
(Shh) is expressed in teeth (Johnson and Tabin, 1995). During tooth initiation Shh is 
thought to regulate the epithelial thickening and invagination required during bud 
formation, by stimulating proliferation in the epithelial cells (Cobourne et al, 2001). 
Studies have shown that Shh is required for early tooth germ development as blocking 
of Shh using neutralising antibodies at E10.5 resulted in tooth development arrest at 
the lamina stage (Cobourne et al, 2002). Double mutants of the Shh downstream 
signalling molecules Gli2 and Gli3 also resulted in the arrest of tooth development 
prior to bud stage (Hardcastle et al, 1998). 
The Wnt gene family encode a large group of signalling proteins involved in 
the proliferation and differentiation of several organs and cell types (Cadigan & 
Nusse, 1997). One of the predominant Wnt genes involved in tooth development is 
Wnt7b which is expressed in the oral epithelium and is thought to interact with Shh in 
determining tooth pattern formation (Sarkar et al, 2000). 
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1.4.2.2 Bud, Cap and Bell Stages during Tooth Development 
During development, the tooth goes through three morphological stages, which are 
named according to their histological appearance. These stages are used for 
descriptive purposes and represent a continuum of change with the end of one stage 
often overlapping with the beginning of the next (Ten Cate, 1998; Tucker and Sharpe, 
2004) and therefore making it difficult to distinguish morphologically the distinct 
stages. 
The first stage of tooth development is that of the bud stage. This begins with 
the thickening of the oral epithelium in what becomes known as the dental lamina. 
This „thickening‟ begins to invaginate into the underlying neural crest-derived 
mesenchyme as the epithelial cells proliferate (Figure 1.2), whilst showing little or no 
change in shape or function (Ten Cate, 1998). As the epithelial cells transcend into the 
ectomesenchyme, the ectomesenchymal cells become condensed, surrounding the 
epithelial “bud” (Tucker and Sharpe, 2004). 
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During the second stage of development, the cap stage (Figure 1.3), the 
density of ectomesenchymal cells beneath the epithelial bud increases significantly as 
cells fail to separate due to the pressure of the migrating “bud”. These mesenchymal 
cells become known as the dental papilla, which forms the pulp and dentine forming 
odontoblasts of the mature tooth (Tucker and Sharpe, 2004). This ability of dental 
papilla cells to differentiate into dentine forming odontoblasts has recently been 
elegantly demonstrated by Kikuchi et al, 2004, where dental papilla cells incubated in 
a three-dimensional model, encompassed by an artificial extracellular matrix, 
differentiated into tubular process forming columnar odontoblast-like cells. Atop the 
condensed, mesenchyme-derived dental papilla, the epithelial ingrowth continues to 
proliferate, surrounding the dental papilla to resemble a cap on the papilla‟s “head”. 
This epithelial ingrowth becomes known as the dental organ (Figure 1.3), which, 
amongst other things, will provide the ameloblast cells which form the tooth enamel 
(Sasagawa and Ishiyama, 2005). 
Surrounding the dental papilla and tip of the dental organ is a condensed lining 
of ectomesenchyme known as the dental follicle. Once the tooth is fully formed the 
cells of the dental follicle express key chemotactic agents which cause an influx of 
mononuclear cells, these cells fuse to become osteoclasts, which resorb the overlying 
alveolar bone to provide an eruptive pathway for the tooth (Marks et al, 1983; Wise et 
al, 1985). Once this process is finalised, the dental follicle gives rise to the 
periodontal ligament and cementum (Morsczeck et al, 2005).  
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The final morphological stage of tooth development is known as the bell stage 
(Figure 1.4). It is during this stage that the cells of the dental organ begin to undergo 
histodifferentiation. The central area of the dental organ differentiates into a 
population of large, star shaped cells with large extracellular regions known as the 
stellate reticulum (Sasaki, 1990), and the cells in contact with the dental papilla 
differentiate into inner dental epithelium cells following a highly controlled signalling 
cascade originating from the basement membrane. These cells in turn differentiate 
into ameloblasts, the cells responsible for the formation of enamel, following the 
growth factor signals received from a layer of cells separating them from the stellate 
reticulum known as the stratum intermedium (Ten Cate, 1998; Sasagawa and 
Ishiyama, 2005). It is also during this stage that the tooth “bell” disassociates from the 
oral epithelium and the future crown shape becomes apparent (histologically 
resembling a bell shape), due to the ingrowth of the inner dental epithelial cells into 
the dental organ. 
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1.4.2.3 Odontogenesis 
Following the formation of the future crown shape, the next stage of tooth 
development results in the generation of the tooth‟s hard tissues, dentine and enamel 
(Figure 1.5). This is initiated as the cells of the inner dental epithelium cease to 
proliferate at the future cusp tip of the tooth. As the cells stop proliferating they begin 
to differentiate into tall, columnar cells with their nuclei positioned at the dental organ 
end of the cell and are now ameloblasts, the cells responsible for enamel formation. 
As they are differentiating, they release a series of signalling molecules to the cells of 
the dental papilla, which subsequently differentiate into odontoblasts, which 
synthesise and secrete dentine. 
As the odontoblasts differentiate they initially produce unmineralised type I 
collagen and proteoglycans (Linde & Goldberg, 1993; Torneck, 1994), which is 
deposited between the odontoblast and the ameloblast cell layers, forming a type of 
pre-dentine with a ground substance present by the basal lamina. This process is 
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followed by the secretion of mantle dentine, which mineralises within matrix vesicles 
formed from buds that develop from the membrane of the odontoblast processes 
(Stratmann et al, 1995). Mantle dentine is less mineralised than primary dentine and 
resides at the periphery of the dentine, at the dentino-enamel junction. As dentine 
deposition continues, the odontoblasts secrete dentine whilst migrating towards the 
centre of the papilla, as they migrate they create cytoplasmic, odontoblast processes 
around which primary dentine is secreted. These remain embedded within the dentine 
giving rise to the tubular nature of the dentine matrix. Inside these dentine tubules 
peritubular dentine is formed, as has been demonstrated through ultrastructural, 
electron microscope studies of human molars (Thomas, 1979; Linde & Goldberg, 
1993; Torneck, 1994). 
As the first dentine is being secreted (mantle dentinogenesis), the fully 
differentiated ameloblasts begin secreting their own partially mineralised organic 
matrix against the newly formed dentin. This rapidly mineralises to form enamel, and 
as the enamel begins to form the ameloblasts begin to migrate away from the dental 
papilla, depositing increasing amounts of enamel. 
Once the tooth is fully formed the odontoblasts once again undergo a series of 
morphological changes that are associated with a pronounced down-regulation in 
dentine production. In this state the odontoblasts produce relatively low amounts of 
dentine whilst staying viable throughout the tooth‟s life (Linde & Goldberg, 1993; 
Torneck, 1994; Ten Cate, 1998). 
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1.4.2.4 Molecular Regulation of Odontoblast Differentiation 
Odontoblast differentiation is a complex process controlled by cells of the inner dental 
epithelium, through a series of cell-cell signalling events. Therefore, despite the 
majority of dental papilla cells having the potential to differentiate, only those cells in 
contact with the basement membrane at its interface with the inner dental epithelium 
become odontoblasts (Ruch, 1998). 
The exact molecular interactions involved in odontoblast differentiation are, as 
yet, not completely understood. Research has however demonstrated that several 
growth factors, including members of the TGF-β, IGF and FGF families, have been 
implicated in signalling this process. Many of these molecules are demonstrably 
expressed in the cells of the inner dental epithelium, the odontoblasts, or both, at the 
time of differentiation (Cam et al, 1992; Bégue-Kirn et al, 1994; Helder et al, 1998; 
Russo et al, 1998). In addition, in vitro studies have demonstrated the involvement of 
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TGF-β1, TGF-β3, BMP2 and IGF-1 in odontoblast differentiation (Bégue-Kirn et al, 
1992; Bégue-Kirn et al, 1994; Sloan and Smith, 1999; Ruch and Lesot, 2000). 
The precise role of these growth factors and their signalling inter-relationship 
is still undetermined due to their simultaneous expression, their functional 
redundancy, and due to relevant genetic knock-out animal models arresting during, or 
prior to, tooth development (Bégue-Kirn et al, 1994; Helder et al, 1998). 
 
1.5 Dental Tissue Disease - Caries 
Dental caries affects 60-90% of school children and the majority of adults in 
industrialised countries, whilst it is increasingly prevalent in developing countries. It 
is now estimated that approximately 5 billion people of all ages worldwide suffer 
from some form of caries which not only causes pain but also inevitably a reduction 
in quality of life due to impairment of function (Rohr Inglehart and Bagramian, 2002; 
Petersen, 2003). Caries treatment in children alone is currently beyond the resources 
of some developing countries (Petersen, 2003; Yee and Sheiham, 2002). 
Pathologically dental caries is characterized by the progressive destruction of 
dental hard tissues due to bacterial infection. Currently clinical treatment for restoring 
the tooth utilises materials that share few of the natural characteristics of a tooth, often 
resulting in a high proportion of restorations failing mechanically (Murray and 
Garcia-Godoy, 2004). In severe cases of dental caries, when the pulp is exposed, 
direct pulp capping utilising a protective agent, such as calcium hydroxide, is often 
applied which can induce natural dental repair process (Schröder, 1985), thought to be 
a result of the solubilisation of growth factors such as TGF-β1 from the dentine 
matrix (Smith and Smith, 1998). It is therefore desirable for future dental treatments 
to develop a modality that promotes the natural reparative processes. Current opinions 
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suggest that such an approach would likely involve the use of growth factors to 
stimulate specific cellular responses in the dentine-pulp complex, similar to those seen 
during tooth development and repair, that would result in a directed enhancement of 
the natural healing process and somewhat restore tooth structure, rather than the 
simplistic mechanical treatments currently utilised. Thereby preserving pulpal tissue 
function, providing a long-term clinical solution and reducing the number of 
restorations failing (Smith 2003; Nakashima, 2005). 
 
1.6 Molecular and Cellular Components of Dental Tissue Regeneration 
Currently there are two characterised mechanisms of natural tooth regeneration that 
depend upon the intensity of injury sustained. These dental tissue regeneration 
mechanisms are termed reactionary and reparative dentinogenesis (Figure 1.6). Both 
mechanisms result in the formation and secretion of tertiary dentine matrix, which 
varies in structure from primary dentine and is often irregular with a reduction of 
tubular dentine (Tziafas et al, 2000). Tertiary dentine provides a barrier between the 
injury and the underlying dental tissue (Lesot et al, 1993; Smith et al, 1995). 
During mild injury to the tooth, the undamaged odontoblasts are stimulated by 
molecular signals, understood to involve a cocktail of growth factors sequestered into 
the dentine matrix during dental tissue development. Following demineralisation by 
bacterial acids and other metabolites during caries these molecules are released, which 
subsequently result in an up-regulation in formation and secretion of dentine (Smith et 
al, 1995; Smith, 2003). Signals sequestered in the dentine matrix which are thought to 
play a role in the up-regulation of dentine secretion include IGF-1 (Bégue-Kirn et al, 
1994), TGF-β1 and TGF-β3 (Sloan and Smith, 1999), and BMP7 (Sloan et al, 2000), 
all of which are capable of up-regulating dentine secretion in vivo. Notably, many of 
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these molecules involved in this mechanism are also important in dental tissue 
development (see Section 1.4). In addition, reactionary dentinogenesis has also been 
stimulated in vivo following implantation of dentine fragments into prepared, exposed 
cavities providing further evidence that the molecules sequestered within dentine 
during development are key to modulating post-natal repair mechanisms (Smith et al, 
1994). 
Reparative dentinogenesis occurs when the injury to the tooth is more intense, 
often exposing the pulpal tissue, causing death of the primary odontoblast layer. In 
this case a new generation of odontoblast-like cells are signalled to differentiate from 
pulp progenitor/stem cells, a process involving cell recruitment, cell differentiation 
and an up-regulation of dentin synthesis (Lesot et al, 1993; Smith et al, 1995). 
Induction of odontoblast-like cell differentiation from progenitor cells involves 
several growth factors, once again those sequestered and released from the dentine 
matrix following demineralisation, including TGF-β isoforms, BMPs and IGFs 
(Finkleman et al, 1990; Bégue-Kirn et al, 1994; Cassidy et al, 1997; Butler, 1998; 
Sloan and Smith, 1999; Roberts-Clark and Smith, 2000; Smith, 2003).  
Despite the differing odontoblast phenotype and dentine structure, the process 
of stem cell recruitment, odontoblast differentiation and the induction of dentine 
secretion from the new generation odontoblasts that occurs during reparative 
dentinogenesis are thought to closely mimic those of tooth development (Smith and 
Lesot, 2001) with the release of signalling molecules from the demineralised dentine 
imitating the signalling events of the inner dental epithelium. Whilst there are a 
number of molecules known to be common to both processes further work is required 
to elucidate their individual roles, as a number of the growth factors involved have 
similar functions, often overlapping with each other and each interacting with each 
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other in a complex manner.  As well as the release of this bio-active cocktail from the 
dentine there is likely a co-ordinate release of growth factors by pulpal and 
inflammatory cells that could also aid the reparative response (Sloan et al, 2000).  
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1.7 Adrenomedullin (ADM) and its Potential Role in Dental Tissues 
In a recent study analysing the genes differentially regulated in carious 
compared to healthy pulpal tissue, the ADM transcript was identified as being 
significantly up-regulated (McLachlan et al, 2002). In addition studies have now also 
demonstrated that ADM can be released from human dentine, at levels comparable or 
potentially higher than those of TGF-β1, by dental cavity etchants and acids similar to 
those from cariogenic bacteria (Tomson et al, 2007; L. Graham - PhD Thesis). This 
data indicates that ADM is likely expressed during tooth development by odontoblasts 
and deposited into the dentine matrix, this is somewhat supported by data presented 
by Montuenga et al (1997), who published a paper studying ADM‟s expression 
pattern during embryogenesis which included an image of a developing tooth 
expressing ADM. It‟s release from the dentine matrix during tooth injury may 
therefore promote repair processes potentially in synergy with other dentine matrix 
signalling molecules.  
ADM is a pleiotropic molecule known to be up-regulated in several diseased 
states (Bunton et al, 2004) such as congestive heart failure (Kobayashi et al, 1996), 
sepsis (Hirati et al, 1996), myocardial infarction (Asakawa et al, 2001) and renal 
impairment (Ishihara et al, 1999), where it potentially may function in several distinct 
ways. Notably ADM been demonstrated to act as a regulator of i) inflammation, 
including inducing ocular inflammation through increasing inflammation cell number 
in rabbits (Clementi et al, 2000) and reducing glomerular inflammation by reducing 
monocyte chemoattractant protein-1 (MCP-1) expression and subsequently 
glomerular monocyte infiltration (Plank et al, 2005) (for full review of ADM‟s role in 
inflammation see Elsasser and Kahl, 2002), ii) apoptosis, where ADM can act as both 
antiapoptotic and proapoptotic, promoting cell survival in vascular endothelial cells 
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(Kato et al, 1997) and astrocytes, an effect reversed by the addition of an ADM 
antagonist, (Xia et al, 2004), while inducing apoptosis in glomerular mesengial cells 
(Parameswaran et al, 1999) (for review see Filippatos et al, 2001), iii) cell migration, 
where Xia et al, (2004) demonstrated that ADM dose dependently enhanced astrocyte 
migration in modified Boyden chambers and iv) angiogenesis and vasodilation, 
enhancing capillary-like tube formation and blood vessel formation, an effect reversed 
by the addition of an ADM antagonist (Ribatti et al, 2003) and increasing arteriole 
diameter and lowering blood pressure in streptozotocin induced rats (Kaneko et al, 
2006) (for review see Ribatti et al, 2007). In addition, it can function as an inducer of 
osteoblastic activity, increasing osteoblast cell number in vitro and increasing indexes 
of bone formation and mineralized bone area of mouse calvaria in vivo (Cornish et al, 
1997). Furthermore, both immunohistochemical and in situ hybridisation studies have 
demonstrated a co-localisation of ADM and TGF-β1 protein and mRNA during 
embryogenesis, including the giant trophoblastic cells of the early placenta and later 
in the developing cardiovascular, neural, lung, kidney, intestinal and skeletal-forming 
tissues (Montuenga et al, 1998).  
ADM‟s up-regulation in carious teeth (McLachlan et al, 2002) could 
conceivably relate to its role(s) in inflammatory regulation, vasodilation and 
angiogenesis or cell survival promotion. However, data demonstrating that it is 
expressed during tooth development (Montuenga et al, 1997) combined with its 
ability to stimulate bone formation (Cornish et al, 1997) also suggests that ADM 
could be an important regulator of dental tissue development and regeneration.  
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1.7.1 ADM and ADM Receptors. 
ADM is a 52 amino acid, pleiotropic peptide, initially isolated from human brain 
phechromocytoma (Kitamura et al, 1993). It is part of the calcitonin gene-related 
peptide (CGRP) family and is known to be expressed in various adult and developing 
tissues including heart, lung, kidney and brain (Washimine et al, 1996; Cameron & 
Fleming, 1998; Montuenga et al, 1997; Montuenga et al, 1998). 
ADM acts through two ADM-specific receptors (AM-1 and AM-2) which are 
comprised of a dimer of calcitonin receptor-like receptor (CRLR) and receptor 
activity modifying proteins 2 and 3 (RAMP-2 and RAMP-3, respectively) (McLatchie 
et al, 1998; Aiyar et al, 2001; Muff et al, 2001; Oliver et al, 2001), although no 
pharmacological difference with respect to ligand preference or signalling pathways 
stimulated has been identified between the two (Hay et al, 2003). ADM also exhibits 
affinity for the CRLR and RAMP1 complex however binding to this receptor is 
significantly weaker and this receptor is generally regarded as a CGRP receptor 
(Buhlmann et al, 1999). 
CRLR is a member of the family-B G-protein coupled receptors (GPCRs) 
which contain seven transmembrane domains and share approximately 50% 
homology to the calcitonin receptor. CRLR was first cloned in 1993 by Chang et al, 
and was initially considered an orphan receptor until McLatchie et al (1998) 
discovered that, in the presence of RAMPs, the CRLRs were transported to the cell 
surface and became active receptors for the CGRP family.  
Studies have suggested that binding of the ADM ligand to its receptors 
appears reliant on the cyclic structure formed by ADM‟s disulfide bridge and the C-
terminal residue (Eguchi et al, 1994). This observation potentially explains how the 
ADM antagonist, ADM22-52 (Eguchi et al, 1994; Hay et al, 2003) functions, as this 
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molecule retains the C-terminal residue allowing it to partially bind the receptor 
without leading to its activation, hence acting as a low affinity competitive inhibitor 
(Eguchi et al, 1994; Hay et al, 2003). Once ADM has bound to its receptor it can 
reportedly stimulate two signalling pathways involving either cAMP and/or Ca
2+
, in 
order to induce its cellular physiological affects (Shimekake et al, 1995; Xu and 
Krukoff, 2005). 
 
1.7.2 ADM in Development. 
Mammalian development and organogenesis is a complex process involving a series 
of instructive and permissive cell-cell interactions (Wessells, 1977) and whilst some 
signalling pathways are well characterized, for example chick embryo limb bud 
pathways (Johnson and Tabin, 1997), the majority of mammalian regulatory pathways 
are still unknown. 
Adrenomedullin is thought to play an important role in mammalian 
development (for review see Garayoa et al, 2002). ADM signalling has been indicated 
in a number of embryonic tissue during rat and mouse development. It‟s expression is 
limited to small regions of the embryo at the early stages of embryogenesis such as 
the giant trophoblastic cells of the ectoplacental cone, during early placenta 
development (Montuenga et al, 1997; Yotsumotu et al, 1998). This is thought to be 
important in fetoplacental vasculogenesis and for providing nutrition and oxygen from 
maternal blood during early postimplantation (Yotsumotu et al, 1998). During the 
latter stages of development and organogenesis, it is expressed in the majority of 
tissues and organs. It‟s expression is first detected in the developing heart, which 
remains the most immunoreactive organ for ADM expression throughout 
development, notably in the walls of the atrial and ventricular walls and in the 
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differentiating smooth muscle cells of the large arteries (Montuenga et al, 1997; 
Montuenga et al, 1998). Other organs demonstrating ADM expression during 
development include the nervous system, where ADM expression has been suggested 
to appear parallel to sensory neuron maturation, the skeletal-forming tissues, with 
osteoblasts of the developing bone continuously expressing ADM and maturing 
cartilage becoming increasingly immunoreactive for ADM. Interestingly, regions in 
which epithelial-mesenchymal interactions occur such as the lung, kidney, tooth and 
intestines also demonstrate ADM expression at key developmental time points, 
particularly the meschyme surrounding developing brochi in the lungs, the epithelium 
of the metanephric duct and the metanephric collecting tubules of the kidney, what 
appears to be the odontoblasts of the developing tooth and in the mesenchymal cells 
that will form the gut muscle layer during early intestine development and later in the 
differentiated simple columnar intestinal eithelium (Montuenga et al, 1997; 
Montuenga et al, 1998).  
The exact mechanism(s) of action(s) of ADM during development has yet to 
be entirely elucidated, partially due to ADM knockout mice being embryonically 
lethal (Ando and Fujita, 2003). However, ADM‟s activity is thought to regulate 
embryogenesis by controlling cell proliferation, differentiation and migration. 
Supporting data is provided from ADM‟s expression patterns (Montuenga et al, 1997; 
Montuenga et al, 1998), it‟s known mitogenic affect on many embryonic and neonatal 
derived cell lines, including those derived from rat osteoblasts (Cornish et al, 1997), 
rat cardiac fibroblasts (Tsuruda et al, 1999) and other embryonic-derived fibroblasts 
(Isumi et al, 1998; Coppock et al, 1999), ADM‟s expression in embryonic tissues and 
organs apparently coinciding with the onset of the differentiation process, for example 
in bone, the cells of the nervous tissue and areas of placental vasculogenesis 
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(Montuenga et al, 1997) and with a number of chemotactic cell processes present in 
the embryo, for example neural crest-derived cell migration (Montuenga et al, 1997) 
and it‟s ability to enhance cell migration in vivo (Xia et al, 2004). 
Notably ADM‟s spatio-temporal expression pattern is somewhat similar to 
that of other growth factors known to be important in mammalian development. For 
example in the developing kidney ADM appears to share very specific spatial and 
temporal expression patterns with insulin growth factors (IGFs), platelet – derived 
growth factor (PDGF) and members of the TGF-β family (Hammerman, 1995; 
Montuenga et al, 1997). The embryonic expression of members of the latter of these 
growth factor families was directly comparable to that of ADM. In particular it was 
reported that TGF-β1 and ADM exhibited an overlapping expression pattern as both 
were concurrently present in several developmental tissues within the same cell types, 
indicating a potential inter-relationship between the two (Montuenga et al, 1998). 
Recently it has been shown that TGF-β1 and ADM can act to suppress the expression 
of each other, with ADM also acting through the intracellular signal transducer 
Smad6 (Huang et al, 2005). While, studies using TGF-β1 null mutant mice 
demonstrate a reduction in embryonic ADM expression (Bodegas et al, 2004), also 
indicating that a positive feedback mechanism may exist between the two molecules.  
Overall, ADM‟s potential to induce proliferation, differentiation and migration 
in developmental cell-lines, coupled with its apparent abundant expression in areas 
involving key epithelial-mesenchymal interactions occurring during development 
suggest that ADM‟s role in tooth development warrants further investigation. 
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1.8 Transforming Growth Factor-Beta 1 (TGF-β1) 
TGF-β1 was initially isolated from human platelet cells (Assoian et al, 1983) and is a 
multifunctional member of the TGF-β-superfamily of cytokines. TGF-β1 plays 
important roles in regulating cell proliferation, inducing proliferation in the human 
osteoblast cell lines hMS(OB) and hOB (Kassem et al, 2000), while inhibiting 
proliferation in primary rabbit epithelial cells and rat heart endothelial cells, possibly 
through altering the cells‟ response to other growth factors (Takehara et al, 1987; 
Rotello et al, 1991), it‟s been demonstrated to both inhibit and induce the 
differentiation of osteoblasts and periodontal cells in vitro (Erlebacher et al, 1998; 
Chien et al, 1999; Spinella-Jaegle et al, 2001), it increases fibroblast and glioma cell 
migration in vitro (Cordeiro et al, 2000; Platten et al, 2000), can induce apoptosis in 
lymphocytes and podocytes (Lomo et al, 1995; Schiffer et al, 2001), inhibit apoptosis 
in myofibroblasts (Zhang and Phan, 1999) and induces the secretion of extracellular 
matrix in fibroblasts (Ihn, 2002). It has also demonstrated both pro-and anti-
inflammatory properties (Brandes et al, 1991; Echeverry et al, 2009) and is released 
during tissue injury by inflammatory cells exposed to bacteria (Wahl et al, 1993). 
During disease TGF-β1 is key to modulating the immune response and is well 
characterized in this context for example in rheumatoid arthritis and periodontal 
disease (Wahl et al, 1993; Skaleric et al; 1997).  
TGF-β1 exerts its cellular activity via binding its receptors, TGF-βRI and 
TGF-βRII, which are members of a transmembrane serine/threonine kinase receptor 
family. There is also a TGF-βRIII betaglycan receptor which does not contain an 
intracellular signalling domain but is thought to be important in retaining TGF-β1 on 
the cell surface for presentation to TGF-βRI and TGF-βRII (Massagué, 1992; Lin and 
Lodish, 1993; Lopez-Casillas et al, 1993; Massagué, 1996). TGF-β1 binds to TGF-
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βRII, which dimerises with TGF-βRI resulting in the phosphorylation of a group of 
intracellular messengers called Smads (Massagué et al, 2000; He et al, 2001; Xu et al, 
2003). 
 In embryogenesis, members of the TGF-β superfamily, including TGF-β1, are 
expressed in specific temporo-spatial patterns and are important in regulating the 
formation of various
 
craniofacial structures (Chai et al., 1994; Kaartinen et al., 1995;
 
Proetzel et al., 1995; Sanford et al., 1997). Attempts to develop TGF-β1 knock-out 
mice to study its role during embryonic development have invariably failed due to 
embryonic growth arrest. TGF-β1 null mutant mice have resulted in defective organ 
and vascular development resulting in pre-natal
 
lethality indicating the pivotal role
 
TGF-β1 plays in regulating cell differentiation and cellular modulation during early 
embryogenesis (Dickson et al., 1995). 
 In mineralised tissues, TGF-β1 plays a key role in proliferation, differentiation 
and mineralisation processes. In bone, it has been proven to increase rat calvarial and 
human osteoblast proliferation (Bonewald et al, 1994), whilst also potentially being a 
key mediator of bone resorption and deposition (Chen and Bates, 1993). In tooth 
development TGF-β1 is essential for maintaining the homeostasis of the dentine-pulp 
complex (D‟Souza et al., 1998). In the developing tooth, expression of TGF-β1 has 
been detected within the cells of the inner dental epithelium. Once histodifferentiation 
begins expression switches to pre-odontoblasts where it continues to be expressed 
throughout dentine secretion (Vaahtokari et al, 1991; Begue-Kirn et al, 1994), 
expression then decreases once the odontoblasts reach maturity and down-regulate 
their dentine secretory activity (Begue-Kirn et al, 1994). Furthermore, in vitro and in 
vivo studies have demonstrated TGF-β1 has the ability to initiate odontoblast 
differentiation and stimulate the synthesis of extracellular matrix (Sloan and Smith; 
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1999; Sloan et al, 2000; Unda et al, 2001). TGF-β1 is also present in the cocktail of 
bioactive molecules released from dentine (Cassidy et al, 1997), which have 
demonstrable ability to induce odontoblast differentiation and mineralisation (Smith 
et al, 1995; Smith and Lesot, 2001; Liu et al, 2007). 
 The expression of TGF-β1 during tooth development along with ADM 
therefore warrant further characterisation. Their reported sharing of similar temporo-
spatial expression patterns during embryogenesis (Montuenga et al, 1998) along with 
their ability to modulate each others activity (Huang et al, 2005) is suggestive of a 
possible synergistic or antagonistic relationship during tooth development. 
 
1.9 Role of Glucocorticoids in Mineralisation 
Dexamethasone is arguably the best-characterized synthetic member of the 
glucocorticoid family of steroid hormones. Therapeutically it is commonly used in a 
wide range of treatments including the reduction of meningitis associated 
inflammation (van de Beek et al, 2007), controlling side effects associated with 
chemotherapy (Ioannidis et al, 2000) and is also used in obstetrics to promote foetal 
lung development in premature babies (Bloom et al, 2001).  
In vitro, dexamethasone also has well characterised ability to induce mineralisation 
processes (Cheng et al, 1996; Hildebrandt et al, 2009) and can promote the 
differentiation of MC3T3 cells, bone marrow stromal cells, umbilical blood 
mesenchymal stem cells and dental papilla-derived cells into osteoblasts (Quarles et 
al, 1992; Cheng et al, 1994; Kosmacheva et al, 2008; Park et al, 2009). 
Dexamethasone is thought to elicit it‟s mineralising and differentiating effects through 
the expression of key matrix proteins Bone Sialoprotein (BSP), Osteocalcin (OCN) 
and Osteopontin (OPN) (Cheng et al, 1996; Mikami et al, 2007), regulated through 
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the transcription factor Runx2 (Mikami et al, 2007). Notably when dexamethasone is 
used in concordance with TGF-β1 it promotes the differentiation of umbilical blood 
mesenchymal stem cells into chondrocytes (Kosmacheva et al, 2008).  
In relation to dental effects, interestingly, long term treatment with glucocorticoids 
have been implicated in the narrowing of the pulpal chamber in humans and rats, 
thought to be a result of increased stimulation of the secretion of a new layer of 
dentine (Näsström et al, 1985; Näsström, 1996; Symons et al, 2000). Paradoxically, 
glucocorticiods have also demonstrated an ability to induce rapid bone loss and are 
thought to increase the risk of osteoporosis (Canalis, 2005), a result of decreased 
calcium levels caused by reduced absorption in the small intestines (Weiler et al, 
1995). 
Dexamethasone is a known regulator of ADM expression as well as the ADM-
related receptors, CRLR, RAMP-2 and RAMP-3. Such regulation has been 
demonstrated in several different cell types including myocytes, smooth muscle cells, 
retinal pigment epithelial cells and osteoblasts (Nishimori et al, 1997; Hattori et al, 
1999; Frayon et al, 2000; Udono-Fujimori et al, 2004 and Uzan et al, 2004). Notably, 
ADM and the ADM receptor, calcitonin gene related peptide (CRLR) have now been 
identified as containing a glucocorticoid receptor element in their regulatory 
sequences (Nikitenko et al, 2003; Zudaire et al, 2005) suggesting a potential for a 
component of dexamethasone‟s cellular effects to be mediated via regulation of ADM 
signalling mechanisms. Hence the regulation of ADM and associated cellular, 
biochemical, molecular and mineralisation responses due to dexamethasone in dental 
cells and tissues warrants further investigation. 
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1.10 In vivo, ex vivo and in vitro approaches used for studying mineralised tissue 
biology 
 
1.10.1 In vivo experimental models 
In vivo research approaches are generally the preferred method of biological study as 
they allow determination of the relevant systemic impact of the experimentations. 
However, such studies can be incredibly complex and are constrained by ethical 
considerations in humans. Therefore this work in general utilises animals, primarily 
rats and mice, as alternative relevant model systems. This also carries specific ethical 
issues and experiments involving animals are subject to individual scrutinisation by 
the home office and can only be used if the expected benefit outweighs the adverse 
effects and if there is no alternative research technique. The breeding and supply of 
animals for scientific use is also regulated by the home office, with the Animals 
(Scientific Procedure) Act 1986 (Home office website). Such analyses however also 
present limitations in particular due to inter-species differences in genetic make-up.  
 One of the most common methods of in vivo study involves the use of gene 
knockout mice which utilises genetically engineered mice in which one or more genes 
are inactivated, this is a reliable experimental model of in vivo study as it allows 
researchers to study the exact systemic role of each knock-out gene. Technologically, 
they are generated by the introduction of a DNA vector into embryonic stem cells 
harvested from early stage mouse embryos. Subsequently homologous recombination 
events are used to inactivate the target gene(s) and the embryonic stem cells generated 
are cultured for several days before being injected into blastocyst mouse embryos 
prior to implantation in a surrogate female mouse for further development. The 
implanted embryos contain both engineered and normal embryonic stem cells, 
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resulting in heterozygous knockouts, which are subsequently crossbred to produce 
homozygous mutant animals (Melton, 1994; Bedell et al, 1997). 
 Limitations which associate with this technology predominantly include early 
embryonic lethality which affects approximately 15 percent of gene knockouts made 
and which make it impossible to study the effects of the mutations in the adult animal 
or even at late stages of embryonic development. This problem can however be 
overcome by the use of conditional mutants whereby genes can be inactivated at later 
stages of development. The resulting phenotype using this approach, however, is not 
necessarily representative of the full effect of gene deletion. Other limitations of this 
technology include differing roles of genes during development and adulthood, 
making the study of gene knockouts in adults troublesome if the gene is important in 
developmental processes, and varying effects in different species, meaning the role a 
gene might play in the development of a mouse may not correspond to it‟s role in 
humans. Despite these limitations, knockout mice are still a key tool for determining 
gene function in vivo (Hardouin & Nagy, 2000). 
 In mineralised tissue development, knockout mice have been used to study the 
role of several growth and transcription factors, including members of the TGF-β 
family (D‟Souza and Litz, 1995; Letterio and Roberts, 1996; Atti et al, 2002), BMPs 
(Bandyopadhyay et al, 2006; Retting et al, 2009), FGFs (Naganawa et al, 2008), Msx-
1 and -2 (Satokata et al, 2000; Han et al, 2007) and Pitx2 (Lin et al, 1999). Notably 
Adrenomedullin knockout mice were found to be embryonic lethal, however ADM
+/-
 
heterozygous mice were viable and fertile (Ando and Fujita, 2003). Unfortunately, 
subsequent studies have focused on ADM‟s effect on vascular tissues (Ando and 
Fujita, 2003) and as such no information is reported on the development of 
mineralising tissues in ADM
+/-
 mice. 
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 Other experimental models utilised to study the in vivo effects of growth 
factors on mineralising tissues include injection supplementation and, in dental 
tissues, the introduction of cavities to study tooth regeneration (Goldberg et al, 2001; 
Zhang et al, 2006; Simon et al, 2008), discussed in the next paragraph. Injection 
supplementation involves dosing the animal with the molecule via a series of local or 
systemic injections over a designated time period. An example of this approach used 
for mineralised tissue research is that described by Cornish et al (1997; 2001). In their 
initial study (Cornish et al, 1997), adult mice were subjected to local injections of 
ADM directly over the calvaria for a five-day period. Subsequent analysis revealed 
that indices of bone formation and mineralised bone area within the calvaria were 
increased. In the second study Cornish et al, (2001) administered subcutaneous 
injections of ADM into the loose skin at the nape of the neck over a four-week period. 
This approach enabled the study of the systemic effect of ADM on bone growth and 
identified an increase in the indices of osteoblast activity, osteoid perimeter, 
osteoblast perimeter, cortical width, trabecular bone volume and bone strength 
(Cornish et al, 2001). A limiting factor in the use of systemic injections as a means to 
study growth factors in vivo is their stability within the vascular system, which will 
vary depending on liver metabolism of the individual animals. Notably degradation of 
the growth factor will therefore significantly reduce the amount present in the target 
tissue. 
 A method used to study tooth regeneration in vivo involves the introduction of 
type V cavities into animal teeth. Type V cavities are defined as being of either i) 
moderate size and positioned in close proximity to gingival tissue, therefore in a 
position that is difficult to access and treat, or ii) severe carious lesions that results in 
a reduction in tooth structure (Mount and Hume, 1998). Significant research utilising 
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this experimental method involves the application of substances for pulp capping to 
the exposed cavities, such as calcium hydroxide and mineral trioxide aggregate 
(Zhang et al, 2006; Simon et al, 2008), dentine matrix proteins (Goldberg et al, 2001) 
and growth factor soaked beads (Goldberg et al, 2001). This approach provides a 
valuable method for studying tissue responses in physiological conditions however 
the use of relevant controls requires important consideration.  
 Methods for studying the effects of these in vivo experimental approaches 
include histological investigation, analysis of protein/mRNA expression, Fourier 
transform infrared spectroscopy (FTIR) and more recently micro-computed 
tomography analysis.  
Histological investigations include any study of the tissues or cells as a whole. 
In mineralised tissues this generally involves the analysis of trabecular bone volume, 
dentine bridge formation and increases in osteoblast and odontoblast morphology 
(Cornish et al, 1997; Cornish et al, 2001; Simon et al, 2008; Six et al, 2000; Zhang et 
al, 2006).  
Analysis of protein/mRNA expression is a fundamental tool in in vivo studies 
as it allows the researchers to determine what tissues/cells the protein of interest is 
expressed in, at what time point and by comparing them to control specimens they can 
determine whether the protein of interest in up- or down-regulated. Some histological 
methods that are employed to determine protein/mRNA expression include in situ 
hybridization and immunohistochemistry. 
In situ hybridization is a method that utilises radio-, fluorescent- or 
digoxigenin-labelled cDNA or RNA probes to hybridize to complementary DNA or 
mRNA within tissues of interest (Schaeren-Wiemers and Gerfin-Moser, 1993; Jin and 
Lloyd, 1997). The use of flourescent cDNA probes is generally used to determine the 
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integrity of chromosones in medical diagnostics, for example the detection of trisomy 
in chromosome 21 (Pinkel et al, 1988). The hybridization of mRNA allows for the 
localisation of gene expression within the tissue of interest and has been utilised in 
mineralised tissue research to localise the expression of DMP-1 in the chondrocytes, 
cementoblasts, osteoblasts, ameloblasts and odontoblasts of embryonic and post-natal 
mice (Feng et al, 2003) and to localise the expression of osteopontin and bone 
sialoprotein to the osteoblasts, chondrocytes and cementoblasts of embryonic mice, 
the expression of osteonectin to the osteoblasts, chondrocytes and odonotblasts of 
embryonic mice and osteocalcin to the osteoblasts and odontoblasts of developing 
mice (Sommer et al, 1996). 
Immunohistochemical approaches enable determination of the expression and 
localisation of specific proteins within the cells and tissues of interest. Briefly, this 
method uses a biotinylated primary antibody specific to the antigen of the protein of 
interest. This is then bound by a secondary enzyme-labelled antibody, which reacts 
with 3,3'-diaminobenzidine (DAB) to produce brown staining which can be visualised 
by light microscope, an alternative to this method is conjugating the secondary 
antibody to a fluorescent agent, or flourophore, which allows visualisation using a 
fluorescent or confocal microscope (Ramos-Vara, 2005). This approach has been used 
to determine the expression pattern of ADM during embryogenesis where it was 
found to be expressed in the heart, lungs, kidney, skeletal forming tissues, neural 
system and developing teeth of embryonic mice (Montuenga et al, 1997; Montuenga 
et al, 1998). 
 Fourier transform infrared spectroscopy (FTIR) is an analytical technique that 
is used to measure the absorption of infrared radiation that is passed through an 
organic sample. Each sample will produce a unique wavelength, characteristic of its 
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molecular structure, allowing the identification and quantification of organic 
materials. In mineralised tissue research this technique is often used to quantify the 
presence of mineralised tissue, this is usually analysed through the measurement of 
apatite phosphates which produce a wavelength of approximately 900-1200cm
-1
 (Rey 
et al, 1991). An example of the application of this techniques was described for the 
analysis of variations in the quantity and quality of cortical and trabecular bone, by 
measuring mineral:matrix ratios (Paschalis et al, 1997). 
Micro-computed tomography (μCT) can also be used to analyse mineralised 
tissue deposition in vivo, with a number of companies producing scanners of high 
quality including GE Healthcare (USA), Skyscan (Belgium) and Nanotom (US). μCT 
utilises X-ray technology to create 2-dimensional (2D) cross sectional images of 3-
dimensional (3D) objects. μCT works in the same way as X-ray tomography systems 
(CAT scans) currently used in medicine, however the term „micro‟ is used to indicate 
the pixel size of the 2D cross sectional images, i.e. pixels are in the μm range, 
enabling higher resolution images to be captured [e.g. <1µm using the high resolution 
Skyscan 1172 (Skyscan, Belgium)] (Holdsworth and Thornton, 2002). Due to the high 
resolution images current µCT scanners are capable of generating they are often used 
to create reconstructions of relatively small objects [e.g. maximum sample size of 
68mm in Skyscan 1172 (Skyscan, Belgium)] (Holdsworth and Thornton, 2002).  
μCT analysis has been used in a variety of research areas for both quantitative 
and qualitative determinations. Examples include in palaeontology, where μCT 
provides a wealth of qualitiative taxonomical data on fossils, especially those 
preserved in amber (Dierick et al, 2007), geology, where both qualitative and 
quantitative analyses have been studied, including quantitative analysis of the porosity 
of rocks (Cnudde et al, 2006), the study of composite materials, including quantitative 
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measurement of polymer fibre length and qualitative analysis of fibre distribution 
(Shen et al, 2004) and food studies where quantitative analysis includes measurement 
of apple porosity (Mendoza et al, 2007). More frequent application has been in the 
biomedical science areas of bone and tooth biology (Andreoni et al, 1997). In bone 
biology uses have ranged from quantitatively measuring trabecular bone thickness to 
qualitatively determining differences in the architecture of mandibular bone (Saha and 
Wehrli, 2004; Mulder et al, 2006). For dental research, applications have included 
structural evaluation of root canal treatments and restorative procedure success, while 
quantitative analyses have included determination of cavity size and measuring pulpal 
chamber volume (Bergmans et al, 2001; Oi et al, 2004, Amano et al, 2006; Magne, 
2006). An example 2D image along with digitised analysis of a mouse mandible 
obtained from the present study, using a Skyscan 1172, is shown in Figure 1.7 to 
demonstrate the high resolution analysis which can be performed using this 
technology. 
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1.10.2 Ex vivo experimental models 
Ex vivo studies refer to experimental approaches that involve analysis of living cells 
or tissues taken from an organism and cultured in a laboratory. These studies provide 
a bridge between in vitro and in vivo studies as the cells or tissues used are generally 
more representative of the in vivo situation whilst being analysed under well-
controlled laboratory conditions. Ex vivo differs from in vitro in that ex vivo involve 
cells/tissues extracted from organisms and experiments occur outside the organism 
with minimum alterations to natural conditions and are limited to a time period, 
usually no more than 24 hours, these are invariably multicellular and 3D in 
arrangement. While in vitro generally refers to experiments on cells in a controlled 
environment, which rarely mimic the natural environments, such as petri dishes. 
 Commonly used ex vivo models for mineralised tissue research include organ 
culture approaches, whereby slices of bone, usually the calvaria or tibia (Mueller and 
Richards, 2004; Mohammed et al, 2008), and teeth, primarily incisor (Sloan et al, 
1998), are removed and maintained in growth media. This technique allows for direct 
stimulation of mineralised tissues with growth factors of interest in an environment 
that preserves much of the architecture and cellular diversity present in vivo, yet offers 
greater physiological relevance than cell cultures (see below section 1.10.3). Such an 
approach is especially important in tooth biology where it has been demonstrated that 
odontoblasts require contact with the dentine matrix in order to retain their phenotypic 
morphology and secretory activity (Munksgaard et al, 1978; Heywood and Appleton, 
1984). Organ culture approaches can be used for many purposes, including the 
determination of expression patterns of key mineralising mediators through 
immunohistochemical study (Mueller and Richards, 2004) and the effect of local 
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administration of growth factor soaked agarose beads on extracellular matrix secretion 
(Smith and Sloan, 1999; Sloan et al, 2000). 
 
1.10.3 In vitro experimental models 
Due to the complexity involved in studying mineralised tissues in vivo, in vitro model 
systems have also been developed which include the use of primary cell cultures and 
cell lines. Whilst providing a relatively easy method of studying cell activity they 
have limitations which include alterations to cell phenotype that result from removal 
from their natural environment and therefore subsequent interpretation of data needs 
to be placed in context (Tjäderhane et al, 1998). 
 In mineralised tissue research a number of immortalised cell lines have been 
developed and are frequently used. There are an extensive number of cell generated 
for study of mineralisation tissue behaviour in vitro, a small sample of cells derived 
from bone lineages include the osteoblast-derived cell lines MC3T3-E1 cells 
(Kodama et al, 1981), adult human osteoblast (hOB) cells (Keeting et al, 1992), 
human fetal osteoblast (hFOB) cells (Harris et al, 1995) and osteosarcoma derived 
cell lines used as osteoblast-like cells such as SAOS-2 cells (Fogh and Trempe, 1975) 
and MG-63 cells (Heremans et al, 1978); while dentally derived cell lines include the 
odontoblast-like MDPC-23 cells (Hanks et al, 1998) and pulp-like OD-21 cells 
(Hanks et al, 1998) used in this study and a number of other odontoblast-like cells, 
including the immortalised MO6-G3 cell line (George et al, 1996). Murine skin 
fibroblast-derived 3T3 cells (Todaro and Green, 1963) are also often used as a control 
in this study as they frequently used in a range of diverse studies. More detailed 
application of some of these cell lines will be discussed below 
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 MC3T3 cells are inherently pre-odontoblast cells derived from newborn 
mouse calvaria (Kodama et al, 1981), their name is derived from the tissue they are 
isolated from, mouse calvaria (MC) and their general growth pattern of tripling in 
number every three days (3T3) (Kodama et al, 1981). They are characterised by high 
alkaline phosphatase activity, their ability to respond to parathyroid hormone (PTH) 
and inducible collagen secretion (Kumegawa et al, 1994). Since this cell line was 
initially established, numerous sub-types have been isolated, some with an osteoblast-
like ability to induce mineralisation while others remained inherently non-
mineralising cells (Leis et al, 1997; Wang et al, 1999). MC3T3 cells are therefore still 
primarily used as a pre-osteoblast cell line with recent studies demonstrating their 
ability to mineralise following stimulation using low-intensity ultrasound (Unsworth 
et al, 2007) and the ability of dexamethasone and growth and transcription factors to 
initiate their differentiation into osteoblast-like cells (Quarles et al, 1992; Bergeron et 
al, 2007; Sun et al, 2008). 
 The hOB cell line was isolated from a 68 year old female and immortalised 
following transfection with the SV40 large and small T antigens (Keeting et al, 1992). 
These cells closely represent a mature osteoblast phenotype and are characterised by 
their expression of procollagen-αI, osteopontin, TGF-β1, and interleukin-1β (IL-1β). 
Notably they have the ability to secrete a mineralised matrix following exposure to β-
glycerophosphate (Keeting et al, 1992). hFOB cells were isolated from a spontaneous 
miscarriage and immortalised in a similar manner to hOB cells (Harris et al, 1995). 
hFOB cells are also characterised by their high alkaline phosphatase activity and 
prevalent expression of osteopontin, osteonectin, bone sialoprotein (BSP) and type I 
collagen (Harris et al, 1995). Studies using these cell lines have examined the effect 
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of growth factors on osteoblast differentiation and mineralisation (Eichner et al, 2002; 
Zhang et al, 2003). 
Originally isolated from the osteosarcoma tumour of an 11 year old girl (Fogh 
and Trempe, 1975), SAOS-2 cells are well characterised in their osteoblast-like 
characteristics (Rodan et al, 1987; McQuillan et al, 1995). Indeed, these cells have 
demonstrated high alkaline phosphatase activity (Murray et al, 1987) and when 
compared to primary osteoblast cultures, a study of the expression profile of fifty 
eight cytokines, growth factors and their receptors showed high similarities between 
the two, although they do lack the expression of IL-1β and IL-6 (Bilbe et al, 1996). 
These cells are often used in mineralised research, demonstrating the release of 
mineralisation forming matrix vesicles (Fedde, 1992), specifically from their 
microvilli (Thouverey et al, 2009), they have been used to study the role of 
interleukins in glucocorticoid-induced osteoporosis (Dovio et al, 2003) and have been 
used to study the efficacy of a number of plate coatings for potential use in 
implantation, showing increased cell integration and mineralisation on biosilica 
coated plates and RGD/bisphosphonate coated titanium compared to non-coated 
materials (Schröder et al, 2005; Beuvelot et al, 2009). However, it should be noted 
that there are doubts over their phenotypic stability when cultured over long periods 
(Hausser and Brenner, 2005). 
MG-63 cells were first isolated from the osteosarcoma tumour of a 14 year old 
male (Heremans et al, 1978). Unlike the osteosarcoma derived SAOS-2 cell line, their 
alkaline phosphatase activity is not representative of primary osteoblast cultures 
(Clover and Gowen, 1994). However, a study into the expression profile of fifty eight 
cytokines, growth factors and their receptors, compared to primary osteoblast 
cultures, found them to be largely representative of said primary cells, although some 
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indiscretions were present, such as MG-63 expressing PDGF-β and a number of 
cytokine receptors, including TNF IR and IIR and IGF IIR, while primary osteoblast 
cells do not (Bilbe et al, 1996). MG-63 cells have been utilised in a number of 
mineralised research studies including the potential role of interleukins on 
glucocorticoid-induced osteopoosis (Dovio et al, 2003), the effect of glucose on MG-
63 cell mineralisation, providing knowledge into diabetic osteoporosis (Wang et al, 
2009) and have been used to study the efficacy of bone tissue regeneration scaffolds, 
determining that 3D microporous/macroporous magnesium-calcium phosphate 
scaffolds produce a higher level of attachment, proliferation and alkaline phosphatase 
activity in MG-63 cells than both macroporous and calcium phosphate cement 
scaffolds (Wei et al, 2010) 
The MDCP-23 cell line represents cloned odontoblast-like cells derived from 
dental papilla cells from embryonic day 18 – 19 (E18-19) mouse mandibular molars 
(Hanks et al, 1998). These cells share characteristics with odontoblasts in vivo, 
including high alkaline phosphatase activity, similar morphology with multiple 
processes, and they are known to express several dental-specific molecular markers, 
including dentin sialoprotein (DSP) and dentin phosphoprotein (DPP) (Hanks et al, 
1998; Sun et al, 1998). MDPC-23 cells have often been used in experiments in vitro 
as representative odontoblast models. Recently they have been used for studies on the 
biocompatibility of pulpal capping agents (Mantellini et al, 2005) and also as models 
for the analysis of the effects of growth factors, such as TGF-β1, on odontoblasts (He 
et al, 2004; He et al, 2005). MDPC-23 cells do however exhibit limitations, including 
their lack of ability to express Dental matrix protein-1 (DMP-1), which is known to be 
produced by odontoblasts in vivo (Hanks et al, 1998). Furthermore, a characteristic of 
odontoblast cells in vivo is their cell cycle arrest. Therefore an odontoblast cell line 
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that is constantly undergoing cellular proliferation is inherently un-odontoblast-like in 
behaviour.  
MO6-G3 cells are an immortalised odontoblast-like cell line (George et al, 
1996) that is well characterised in it‟s role in dentinogenesis research (MacDougall et 
al, 2001). It has been used to demonstrate the effect of growth factors on odontoblast 
cell lines, showing that TGF-β1 is capable of downregulating DMP-1 and DSPP 
expression (Unterbrink et al, 2002). While recently, an ultrastructural analysis and 
immunocytochemical determination of dentine sialoprotein, alkaline phosphatase, 
type I collagen and actin filaments in MO6-G3 cells demonstrated that, over a period 
of 42 days, these cells retain their odontoblast phenotype and the characteristic 
morphodifferentiation pattern of polarized odontoblasts (Mesgouez et al, 2006). 
OD-21 cells are a developmentally derived, pulp-like cell line, often used as 
an in vitro model for undifferentiated pulp cells (Hanks et al, 1998). These cells are 
also frequently used in similar experiments as the MDPC-23 cells, for example as a 
model for the analysis of the effects of pulpal capping agents (Mantellini et al, 2005) 
and the effect of bacterial invasion during caries (Botero et al, 2003). Due to the 
abundance of cell types within the dental pulp, experimental results often vary 
between primary pulp derived cultures, depending on which lineages are isolated 
Goldberg and Smith, 2004), therefore the application of a well characterized cell line 
is often preferred. 
The 3T3 cell line is a fibroblast-like culture established from the tissue of an 
albino Swiss mouse (mus musculus) embryo (Todaro and Green, 1963). Mouse 3T3 
cells are frequently used in research as both a fibroblast-like cell line and as a 
developmental cell line. Notably several studies have analysed the effects of ADM on 
these cells, with findings demonstrating that ADM induces proliferation and regulates 
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cytokine release (Isumi et al, 1998). It has also been shown that 3T3 cells express 
both ADM and its related receptors (Withers et al, 1996; McLatchie et al, 1998). 
In addition to the use of immortalised cell lines in mineralised tissue studies, 
primary cell lines are also commonly used. Primary cell cultures for mineralised 
tissue research often involve the isolation of dental pulp or bone marrow cells. The 
isolation of dental pulp cells is generally considered problematic due to their 
heterogeneity (Huang et al, 2006). The approach used involves the removal of the 
pulpal tissue from healthy teeth then cells are isolated using either out-growth by 
adherence to tissue culture plastic from explant tissue (Park et al, 2004) or using an 
enzyme digestion approach (Gronthos et al, 2000), whereby minced pulp tissue is 
digested with collagenase type I and dispase and passed through a cell strainer before 
seeding on tissue culture plastic. Interestingly, it has been demonstrated that each 
method produces phenotypically variable cell lines (Huang et al, 2006). Studies 
utilising primary dental pulp cells have demonstrated the ability of such cells to 
differentiate into odontoblast-like cells and produce mineralised matrix in vitro 
(Tsukamoto et al, 1992; About et al, 2000) Notably, primary cells when seeded onto 
human dentine surfaces secreted a reparative-like dentine (Batouli et al, 2003). 
  
1.10.4 In vitro mineralisation analyses 
Determination of mineralisation in vitro generally utilises the measurement of 
markers of mineralisation. These rely upon chemicals or antibodies binding to 
substrates that are indicative of mineralisation, whether they are proteins involved in 
the process of mineralisation or the components of mineralised deposits. Some 
methods that utilise these techniques include high alkaline phosphatase activity, 
alizarin red staining or von Kossa staining.  
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High alkaline phosphatase activity is one of the most commonly used markers 
for assaying mineralisation. It is an enzyme that is localized on the plasma membrane 
of cells and on the membrane of matrix vesicles from which mineralised deposits are 
secreted (Golub and Boesze-Battaglia, 2004). It is thought to act by increasing 
calcium phosphate levels, which facilitates the mineralisation process (Golub and 
Boesze-Battaglia, 2004). The presence of alkaline phosphatase in tissues can be 
determined using a biochemical assay or by histochemical staining (Sartoris, 1996).  
 Alizarin red staining utilizes direct binding to calcium ions present in the cells 
and is subsequently characterised by the presence of an orange-red stain (Figure 1.8). 
This approach allows the evaluation of calcium distribution and inspection of 
mineralised nodule formation by microscopic analysis (Putchler et al, 1969). Staining 
for alizarin red also allows for relative quantification of mineral deposits through dye 
extraction and spectrophotometric analysis (Gregory et al, 2004). 
 
Figure 1.8: Positive alizarin red staining for the presence of calcium ions in a murine 
periodontal ligament cell line culture. Adapted from Saito et al, (2002). 
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The von Kossa staining method is also used to detect the presence of calcium 
deposits. This approach utilizes metal substitution of calcium deposits, whereby silver 
ions, usually in the form of silver nitrate, bind to the phosphate and carbonate groups 
of calcium deposits subsequently producing black staining (Figure 1.9). Despite 
limitations associated with this method, such as false-positive staining (Putchler and 
Meloan, 1978), studies have demonstrated a good correlation between positive von 
Kossa staining and calcium in the extracellular matrix of osteoblast cultures 
determined using electron microscopy (Kassem et al, 1998). More recently a study 
compared the efficacy of von Kossa staining to electron microscopy, X-ray diffraction 
and Fourier transform infrared spectroscopy (FTIR) (Bonewald et al, 2003). Whilst 
von Kossa staining was not as accurate as the other methods tested, it provided 
adequate data and was the simplest and cheapest method used. Its relative ease and 
inexpense therefore indicate why this approach is one of the most commonly used 
methods used for assaying mineralisation in vitro (Hakki et al, 2009; Park et al, 
2009). 
Figure 1.9: A-C: Von Kossa staining of adipocyte stem cells following osteogenic 
differentiation. Black staining denotes presence of calcium. (Downloaded from 
http://www.ijps.org/viewimage.asp?img=ijps_2008_41_1_8_41104_3.jpg) 
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2.0 Materials and Methods 
 
2.1 Histology 
 
2.1.1 Tissue specimens 
Male Wistar rats between the ages of embryonic day (E) 16 – 20 were obtained from 
Charles River Laboratories, UK. They were sacrificed by cervical dislocation in the 
Pharmacy Department, Aston University, UK. Rats were decapitated using a sterile 
scalpel and the heads were de-skinned and bisected longitudinally prior to histological 
processing.  
 
2.1.2 Fixing and demineralisation 
Rat heads were fixed for 24 – 48 hours, depending upon age and size, in 10% (w/w) 
neutral buffered formalin (Surgipath Europe Ltd). Samples were demineralised in 
10% formic acid (VWR) for at least 48 hours, with the end point measured using a 
chemical decalcification end-point test as described below. 
 
2.1.3 Test for decalcification end-point 
Five ml of used decalcifying fluid were removed, and placed in a test-tube containing 
litmus paper (BDH Ltd, UK). 29% concentrated ammonia (Sigma, UK) was 
subsequently added dropwise with constant agitation until the litmus paper indicated 
the solution to be alkaline. 0.5ml of this solution was then added to 5ml of saturated 
5% ammonium oxalate (VWR), and agitated. If, after 30 minutes, a precipitate was 
formed, this indicated that calcium was still present and therefore the decalcification 
process was continued for a further 24 hours and the end-point test repeated. 
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However, if the fluid was clear after 30 minutes, the decalcification was determined to 
be complete and samples remained in decalcification fluid for a further 24 hours 
before further processing (see below).  
 
2.1.4 Tissue processing and embedding 
Following fixation and decalcification, samples were processed for histological 
analysis. Samples were submersed in 70% Industrial Methylated Spirits (IMS 99) 
(Genta Medical, UK) overnight, prior to being washed twice in 95% IMS 99 for 60 
minutes each. Specimens were then washed four times in 100% IMS 99 for 90 
minutes each and remained in 100% IMS 99 overnight. Subsequently, samples were 
washed twice for 90 minutes in xylene (Genta Medical, UK), followed by a further 
120 minute wash in xylene. Samples were then transferred to a 68ºC oven where they 
were imbibed with hot wax (Sakura Finetek Europe, NL) for 90 minutes. After 90 
minutes, the hot wax was replaced with fresh wax and incubated for a further 90 
minutes. Samples were incubated in a fresh batch of hot wax overnight.  Following 
processing, samples were mounted into a mould with the inner surface orientated 
downwards prior to embedding in paraffin wax (Sakura Finetek Europe, NL). 
 
2.1.5 Tissue sectioning 
For each category of specimen age, a mandible was histologically analysed from each 
of 6 rats to provide a representative sample. Tissue sections of 5µm thick were cut 
from all samples using a rotary microtone (Leica DM 2135). Sections containing 
dental tissue were transferred to water at room temperature and then to warm water 
(50°C) before mounting on a SuperFrost® Plus slide (VWR International, DE) and 
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then dried in a 56°C oven for 120 minutes, then overnight at 37°C (Stuart scientific, 
UK). 
 
2.1.6 Tissue staining 
Sections for histology were stained with Haematoxylin and Eosin using an automated 
tissue stainer (Shandon Linistain, GLX). In the tissue stainer, sections were passed 
through xylene (Genta Medical, UK), a series of graded alcohols (Genta Medical, 
UK) and then water; before being stained with Gills (III) haematoxylin (Surgipath 
Europe Ltd). Sections were washed in distilled water, then in Scott‟s tap water 
(Surgipath Europe Ltd) to “blue”, before being placed in 0.3% acetic acid (VWR) and 
counterstained in 0.125% buffered eosin (Surgipath Europe Ltd). Following staining, 
sections were washed in water, dehydrated through a series of graded alcohols (Genta 
Medical, UK) and finally cleared in xylene (Genta Medical, UK). Once stained, 
sections were mounted using a coverslip (Surgipath Europe Ltd) and Xam (a xylene 
based mountant) (BDH, UK) before being viewed by light microscopy (Leitz, UK)  
(see Section 2.1.8). 
 
2.1.7 Immunohistochemistry (IHC) 
Sections were de-waxed in xylene (Genta Medical, UK), re-hydrated through a series 
of graded alcohols (Genta Medical, UK) and then hydrated in phosphate buffered 
saline (PBS, pH 7.6) (Sigma, UK). Sections were digested in freshly made 0.1% 
Trypsin (150mg in 150ml PBS, Difco, UK) for 13 minutes with gentle agitation for 
antigen exposure. Trypsin was removed by rinsing in water for 5 minutes before 
sections were immersed in 3% hydrogen peroxide buffer (H2O2) (Sigma, UK) for 15 
minutes to block endogenous peroxidase activity. Sections were washed in PBS and 
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then overlaid with diluted goat serum (1:5, Sigma, UK) in order to block non-specific 
protein binding. After 30 minutes, excess goat serum was removed and the 
appropriately diluted antibody, either ADM positive [1/3500 anti-ADM (Bachem, 
UK)], ADM blocking control [1/3500 anti-ADM (Bachem, UK) pre-incubated for 24 
hours with 20x Molecular Weight ADM (Bachem, UK)], TGF-β1 Positive [1/300 
anti-TGF-β1 (Santa Cruz Biotechnology, USA)], TGF-β1 blocking control [1/300 
Anti-TGF-β1 (Santa Cruz Biotechnology, USA) + 20x Molecular Weight TGF-β1 
peptide (Santa Cruz Biotechnology, USA)], pre-bleed rabbit control (1/3500 pre-bleed 
rabbit serum (Sigma, UK)), negative control (PBS/BSA (Sigma, UK) only) (see 
Table 2.1 for more details) was applied for 120 minutes, before being washed in PBS. 
Sections were then treated with 1:50 Multilink (Biogenex, USA) for 60 minutes 
(made up 60 minutes before use), washed in PBS and overlaid with Multi-label 
(Biogenex, USA) for a further 60 minutes; these contain a biotinylated secondary 
antibody, which binds to the primary antibody, and the enzyme streptavidin 
horseradish peroxidase which reacts with the diaminobenzidene (DAB) (Sigma, UK) 
to produce a brown staining wherever primary and secondary antibodies are attached. 
Sections were then washed again in PBS before being overlaid with the freshly 
prepared DAB (Sigma, UK) substrate reagent (10mg in 20ml PBS, filtered with 25ml 
H202 added) for 5 minutes, prior to rinsing in water. Sections were then overlaid with 
copper sulphate (0.5% w/v in NaCu, BDH, UK) to enhance the brown reaction 
product, rinsed in water, counterstained with Mayer‟s haematoxylin (VWR) for 50 
seconds and „blued‟ in water. Once stained, sections were dehydrated in graded 
alcohols (Genta Medical, UK), cleared in xylene (Genta Medical, UK) and then 
mounted using a coverslip (Surgipath Europe Ltd) and Xam (DBH, UK) as previously 
described. 
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Treatment Antibody concentrations 
ADM Positive 1μl Anti-adrenomedullin (Bachem, UK) in 3499 PBS/BSA 
(Sigma, UK) 
ADM Blocking 
Control 
1μl Anti-adrenomedullin (Bachem, UK) in 3499 PBS/BSA 
(Sigma, UK) + 20x Molecular weight ADM (Bachem, UK) 
TGF-β1 Positive 1μl Anti-TGF- β1 (Santa Cruz Biotechnology, USA) in 299μl 
PBS/BSA (Sigma, UK) 
TGF-β1 
Blocking control 
1μl Anti-TGF- β1 (Santa Cruz Biotechnology, USA) in 299μl 
PBS/BSA (Sigma, UK) + 20x mol. weight TGF-β1 peptide 
(Santa Cruz Biotechnology, USA) 
Negative control 1000μl PBS/BSA (Sigma, UK) 
Pre-bleed rabbit 
control 
1μl Pre-bleed rabbit serum in 3499μl PBS/BSA (Sigma, UK) 
 
Table 2.1 Antibody specifications used for immunohistochemistry. All antibodies 
were diluted in PBS/BSA (Sigma, UK) 12 hours prior to performing the procedure. 
ADM = adrenomedullin, TGF-β1 = transforming growth factor – beta1. 
 
2.1.8 Image analysis 
Slides were viewed under a Dialux 22 light microscope (Leitz, UK), with images 
captured using a Coolpix 950 digital camera (Nikon, UK). All captured images had 
their blank, background images, taken at the same magnification as the original 
image, removed using the calculator plus plug-in with Image J software (downloaded 
from http://rsbweb.nih.gov/ij/) to give clearer images. Measurements of developing 
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teeth were made from images of scale bars obtained at the same magnification as 
H&E sections, using ImageJ software.  
 
2.2 Cell culture 
 
2.2.1 Cell lines 
Cell culture experiments were performed using three developmentally derived murine 
cell lines. These were 3T3 fibroblasts (Todaro and Green, 1963), MDPC-23 
odontoblast-like cells (Hanks et al, 1998) and OD-21 undifferentiated pulp cells 
(Hanks et al, 1998). Mouse 3T3 fibroblasts were cultured in 75cm
2
 flasks (Appleton 
Woods, UK) in Dulbecco‟s Modified Eagle Media (DMEM) (Labtech International, 
UK) containing 10% foetal calf serum (FCS, Labtech International, UK), 2.5 HEPES 
(pH 7.4, filter sterilised, Labtech International, UK) and 1% Penicillin-Streptomycin 
(combined stock solution; Sigma, UK). Mouse OD-21 pulp-like cells and MDPC-23 
odontoblast-like cells were cultured in 25cm
2
 flasks (Appleton Woods, UK) in 
DMEM growth media (Labtech International, UK), containing 10% FCS (Labtech 
International, UK) 1mM L-glutamine (Sigma, UK) and 1% Penicillin-Streptomycin 
(combined stock containing 10,000 units penicillin and 10mgs streptomycin per ml; 
Sigma, UK). All cell lines were cultured in a MCO 175 CO2 Incubator (Sanyo) with 
5% CO2, at 37°C. 
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2.2.2 Cell culture procedures for analysis of ADM, dexamethasone and dentine 
matrix protein extracts exposure 
Confluent cell cultures were released from culture surfaces using 0.25% trypsin with 
0.38g/l EDTA (Sigma, UK) and cells transferred to a 15ml tube (NUNC™, Denmark) 
for centrifugation at 1000rpm for 5mins, to pellet the cells. Cells were re-suspended in 
growth medium and seeded into 24-well, flat bottomed, sterile, micro-well plates 
(NUNC™, Denmark) at a density of 5 x 104 cells/well. After 24 hours incubation, 
media was removed and replaced with fresh media containing a range of 
concentrations of ADM (Pheonix Laboratories, US) (10
-7
, 10
-9
, 10
-11
, 10
-13
 or 10
-15
 
M), dexamethasone (Sigma, UK) (10
-7
, 10
-8
, 10
-9
, 10
-10
 or 10
-11
 M) or EDTA extracted 
Dentine Matrix Proteins (DMPs) (0.00001, 0.001, 0.1, 10, 1000ng/ml) for 24 hours. 
DMPs were provided as a kind gift (Mrs G. Smith, Oral Biology, University of 
Birmingham) and were extracted as previously described (Graham et al, 2006). Cell 
counts were performed by releasing cells from wells using 0.5ml 0.25% trypsin with 
0.38g/l EDTA (Sigma, UK) and transferring to a 2ml tube (Appleton Woods, UK) 
containing 0.5ml growth media. Tubes were gently vortexed (Vortex Genie-2 
(Scientific Industries, UK)) before 10µl of the suspension was removed, mixed with 
2µl trypan blue (Sigma, UK) and placed onto a standard Neubaeur haemocytometer. 
Viable cell numbers were counted over the entire haemocytometer grid following 
observation using a variable relief contrast (VAREL) microscope (Zeiss Axiovert 25). 
Briefly, cells stained with trypan blue were regarded as non-viable, as the dye is taken 
up due to damaged cell membranes, therefore non-stained cells were counted over the 
large square grid area. The number of viable cells counted was subsequently 
multiplied by 10,000 to give cell number per ml of original dilution. Cell viability 
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data not presented due to insignificance of non-viable cell number (non viable cells < 
1%). 
 For antagonist studies, cells were pre-treated with a range of concentrations of 
ADM22-52 (10
-14
M,
 
10
-12
M,
 
10
-10
M,
 
10
-8
M
 
and 10
-6
M) (Bachem, UK) for 20 minutes 
prior to the addition of ADM as described previously. 
 
2.3 Analysis of cell culture mineralisation 
 
2.3.1 Cell culture  
Cell lines, as described previously (see section 2.2.1), were seeded into 35mm Petri 
dishes (NUNC™, Denmark) at a density of 7.15 x 104 cells/cm2. Following 24 hours 
culture, media were removed and replaced with either a medium containing 50mg/ml 
Ascorbic Acid (A.A) (Sigma, UK) and 10mM β-glycerophosphate (β-G) (Sigma, 
UK), medium containing 50mg/ml Ascorbic Acid (A.A) (Sigma, UK), 10mM β-
glycerophosphate (β-G) (Sigma, UK) plus range of concentrations of ADM (Pheonix 
Laboratories, US) (10
-7
, 10
-9
, 10
-11
, 10
-13
 or 10
-15
 M), standard mineralising medium 
[50mg/ml A.A (Sigma, UK), 10mM β-G (Sigma, UK) and 10-8M Dexamethasone 
(Sigma, UK)] or standard mineralising medium including a range of concentrations of 
ADM (Pheonix Laboratories, US) (10
-7
, 10
-9
, 10
-11
, 10
-13
 or 10
-15
 M). Ascorbic acid is 
known to increase alkaline phosphatase (ALP) levels and β-glycerophosphate is a 
substrate of ALP. Standard culture growth medium was also used as a control for each 
sample. Cultures were incubated for periods of 3, 7, 11, 14 and 21 days, with media 
changed every third day. Following the designated incubation time, cultures were von 
Kossa stained to detect mineral deposition (Section 2.3.2). 
 
 58 
2.3.2 Von Kossa staining 
Medium was removed from culture dishes and replaced with 10% formalin (Surgipath 
Europe Ltd) in PBS (Sigma, UK) for 30 minutes to fix the cells. Once fixed, the 
solution was removed and cells were washed in distilled water three times. Cells were 
stained with freshly made 5% silver nitrate solution (BDH Ltd, UK) for 30 minutes. 
Residual silver nitrate was subsequently removed by washing in distilled water. 
Staining was developed using fresh 5% sodium carbonate (BDH Ltd, UK) in 25% 
formalin (Surgipath Europe Ltd) for 3 minutes, washed with distilled water and 
finally fixed in 5% sodium thiosulphate (BDH Ltd, UK) for two minutes. Cells were 
then washed and covered in distilled water for viewing and digital analysis as 
described below (see section 2.4.2). 
 
2.3.3 Digital analysis of von Kossa stained cultures 
Images of the von Kossa stained cultures were captured following illumination on a 
light box (Hancocks, UK). Regions surrounding the culture dish were blacked out 
using a standard opaque card re-usable template. All images were captured from a 
distance of 20cm on a Coolpix 950 digital camera (Nikon, UK) using standard 
settings.  
Images were analysed using ImageJ software (downloaded from 
http://rsbweb.nih.gov/ij/) following the image of the plate being isolated from the 
remainder of the image. Using ImageJ software captured images were adjusted to 
binary mode resulting in all stained sections appearing black and the non-stained 
regions white. The total binary area was measured using the analyse particles function 
on ImageJ, thereby providing a percentage value for the total area of mineral 
deposition as a function of plate area. 
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2.4 Gene expression analysis 
 
2.4.1 Exposure of cell cultures to ADM for gene expression analysis 
Cell lines were seeded into T25 flasks (Appleton Woods, UK) at a density of 2 x 10
4
 
cells/cm
2
. When cultures reached ~90% confluency, media was replaced with growth 
medium containing a range of concentrations of ADM (Pheonix Laboratories, US) 
(10
-7
, 10
-9
, 10
-11
, 10
-13
 or 10
-15
 M). Cultures were incubated for 24 hours under 
treatment to allow growth of a confluent monolayer of cells, following which RNA 
extraction was performed (see Section 2.4.2). Cell cultures grown in the absence of 
ADM were used as controls. 
 
2.4.2 RNA isolation and extraction 
All RNA isolations were performed with a SV Total RNA Isolation System using the 
procedure as recommended by the manufacturer (Promega, UK). Cell samples were 
directly collected from culture dishes in 175μl SV RNA lysis buffer (containing -
mercaptoethanol) (Promega, UK) and subsequently mixed by inversion in 1.5ml 
microcentrifuge tubes (Eppendorf, UK). Samples (and buffers) were then incubated at 
70°C for 3 minutes. Following heating, samples were centrifuged for 10 minutes at 
10,000 rpm (Centrifuge 5415D, Eppendorf) to pellet cell debris and the cleared lysate 
was transferred to a fresh Eppendorf tube, where 200μl 95% ethanol (Genta Medical, 
UK) was added and mixed by pipetting. The mixture was transferred to a spin basket 
assembly, centrifuged for 1 minute to capture the RNA on the spin basket membrane 
and the eluate discarded. 600μl SV RNA wash solution (Promega, UK) was added to 
the spin basket assembly, which was then centrifuged for 1 minute. Whilst 
centrifuging, a DNase incubation mix was prepared containing 40μl Yellow Core 
 60 
Buffer (Promega, UK), 5μl 0.09m MnCl2 (Promega, UK) and 5μl DNase I (Promega, 
UK). After centrifugation, the eluate was discarded and the DNase incubation mix 
was placed directly on the spin basket membrane and incubated at room temperature 
for 15 minutes. This procedure was used to degrade any DNA contaminants that 
might be present, ensuring that pure RNA was isolated. The reaction was 
subsequently stopped by the addition of 200μl DNase Stop Solution (Promega, UK) 
and centrifugation at 100000 rpm for one minute. The eluate was discarded, and two 
further washes with SV RNA wash solution (Promega, UK) were performed before 
the spin basket was transferred to a collection tube. 30μl nuclease-free water 
(Promega, UK) was added to the membrane and centrifuged at 100000 rpm for one 
minute to collect the RNA prior to storage at -80°C (-86°C Ultralow Freezer, Nuaire).  
 
2.4.3 Reverse transcription 
Reverse transcription was performed using an Omniscript Reverse Transcriptase kit 
(Qiagen, UK), following the protocol supplied in the handbook. This reaction was 
performed on ice, unless otherwise stated. 
Previously obtained RNA was thawed on ice and 1-2 g were added to 2μl 
10mM Oligo DT primer (Ambion, UK), this mix was then made up to a total volume 
of 14μl using molecular grade water (Merck, UK) in a 0.2ml PCR tube (Appleton 
Woods, UK). The mix was incubated for 10 minutes at 80°C to minimise RNA 
secondary structures, such as hairpins, before being chilled on ice for 5 minutes. 
Whilst still on ice, 2μl RT buffer (Qiagen, UK), 2μl dNTP mix (Qiagen, UK), 0.3μl 
RNase inhibitor (Promega, UK) and 1μl Reverse Transcriptase enzyme (Qiagen, UK) 
were added. Following the addition of these components, the solution was incubated 
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at 37°C for 60 minutes, and then for a further 5 minutes at 93°C to remove enzyme 
activity, before storage at -20°C. 
 
2.4.4 Purification of cDNA 
To clean the cDNA and remove unincorporated nucleotides and other chemical 
contaminants, the cDNA solutions from the RT procedure described previously 
(Section 2.4.3) were transferred to YM-30 microcons (Millipore, UK), diluted to 
500μl with molecular grade water (Merck, UK) and centrifuged for 7 minutes at 
10,000 rpm (Centrifuge 5415D, Eppendorf). This process was repeated and 
centrifuged until approximately 30μl cDNA mix was remaining. The cDNA mix was 
collected in an Eppendorf tube by inverting the microcon and centrifuging at 1000rpm 
(Centrifuge 5415D, Eppendorf) for 3 minutes. 
 
2.4.5 Quantification of RNA and cDNA 
Following RNA extraction and reverse transcription, it was necessary to quantify the 
RNA and DNA concentrations and determine the purity of the RNA sample. This was 
performed using a Biophotometer (Eppendorf, UK). 1μl of the samples were diluted 
with 69μl molecular grade water (Merck, UK) in an Uvette (Eppendorf, UK) and the 
absorbance of the samples were read at 260nm (A260). An absorbance value of 1 
denotes 40μg/μl of RNA and cDNA. 
The spectrophotometer was also used to determine RNA purity and degree of 
protein contamination. The purity was measured from a ratio of readings at 260nm 
and 280nm, with pure RNA giving a reading of 1.8 – 2.1. RNA quality was also 
confirmed by agarose gel electrophoresis (see section 2.4.7). 
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2.4.6 Polymerase chain reaction (PCR) 
PCR was performed using reagents from the REDTaq™ ReadyMix™ PCR Reaction 
Mix with MgCl2 (Sigma, UK). PCRs were prepared on ice to prevent degradation or 
premature annealing of primers. Individual PCR tubes (0.2ml volumes) (Appleton 
Woods, UK) contained a solution comprising of 100ng cDNA, 30μm forward and 
reverse primers (Invitrogen, UK) (see Table 2.2 for primer details) and 12μl 
REDTaq™ ReadyMix™ (Sigma, UK) containing 20mM Tris-HCl (pH 8.3), 100mM 
KCl, 3mM MgCl2, 0.002% gelatine, 0.4mM dNTP mix, stabilizers and 0.06 unit/μl 
Taq DNA Polymerase. This solution was then made up to a total volume of 25μl using 
PCR grade water (Sigma, UK). 
The PCR tubes containing reaction solutions were transferred to a thermal 
cycler (Mastercycler Gradient, Eppendorf, UK) at the correct starting temperature 
(94
◦
C, lid at 105
◦
C) and thermocycled for the required number of cycles depending 
upon the primer conditions required (for a full list of conditions see Table 2.2) 
 
A typical PCR programme used was as follows: 
  Temperature. Time.  Process. 
 1. 94◦C   5 minutes Denaturation 
 2. 94◦C   30 seconds Denaturation 
 3. *   30 seconds Annealing 
 4. 72◦C   20 seconds Elongation 
 5.  72◦C   10 minutes Elongation 
Steps 2-4 are repeated for the required number of cycles 
* = Annealing temperature varied depending on primers used (see Table 2.2) 
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Gene Symbol Primer sequences (5’→3’) 
Annealing 
temp. (°C) 
Cycle no. 
GAPDH F - cccatcaccatcttccaggagc 
R- ccagtgagcttcccgttcagc 
60.5 19 
ADM F- atataggtgcgggtgacagc 
R- acctttggctggacaacaag 
60 33 
CRLR F- tcttcgctgacagtgttcgt 
R- ccaggaggctggtttatca 
60 43 
RAMP-2 F- cattacagcgacctgcgaaa 
R- acaggtctgtgggaaggatg 
55 32 
PCNA F- ttggaatcccagaacaggag 
R- cgatcttgggacccaaataa 
60.5 25 
TGF-β1 F- ctgtccaaactaaggctcga 
R- cgtcaaaagacagccactca 
60 28 
BMP-2 F- tggaagtggcccatttagag 
R- catgccttagggatttgga 
60 27 
Coll-1α F- aaaagggtcatcgtggcttc 
R- actctgcgctctttgatatt 
60 23 
 
Table 2.2: Primers and PCR conditions used for gene expression analysis. GAPDH = 
glyceraldehydes-3-phosphate-dehydrogenase, ADM = adrenomedullin, CRLR = 
calcitonin receptor like receptor, RAMP-2 = receptor activity modifying protein-2, 
PCNA = proliferating cell nuclear antigen, TGF-β1 = transforming growth factor – 
beta1, BMP-2 = bone morphogenic protein – 2, Coll-1α = collagen - 1α. 
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To enable comparison of relative gene expression levels between samples, the 
routinely used glyceraldehydes-3-phosphate-dehydrogenase (GAPDH) expression 
was used to normalise the samples as this housekeeping gene is reportedly expressed 
at  relatively equal levels in a significant number of cells lines and under similar 
growth conditions (Silver et al, 2006). Following agarose gel electrophoresis (see 
section 2.4.7.) GAPDH densitometric intensity of amplified products was determined 
using AIDA software (Fuji, UK) and cDNA amounts were modified until 
densitometric values were within 10% of each other (see section 2.4.8). 
 
2.4.7 Agarose gel electrophoresis 
Non-denaturing agarose gels were prepared by adding agarose powder (Helena 
Biosciences, UK) to 1X TAE buffer [10X Tris acetate EDTA buffer, pH ~8.3, (Helena 
Biosciences UK,) diluted to 1X with distilled water]. The weight of agarose and 
volume of TAE buffer used depended on the percentage of agarose required in the gel 
to enable high resolution of sample separation. RNA samples were analysed using 1% 
agarose gels, whilst PCR products required 1.5 – 2.0% agarose gels. 
Agarose was completely dissolved in TAE buffer by heating the mixture in a 
microwave (Samsung, TDS) on full power for a suitable time period. The mixture was 
allowed to cool, but not solidify before either 0.5 ug/mL ethidium bromide [EtBr  
(Sigma, UK)] or 1X SYBR Gold nucleic acid gel stain (Molecular probes, UK) was 
added to enable visualisation of samples under ultra-violet light. The solution was 
poured into an appropriate sized gel tray and a comb added to form sample-loading 
wells prior to gel solidification at room-temperature. 
Following gel solidification, well forming combs were removed and the gel 
placed into an electrophoresis tank and covered with 1X TAE buffer. 7 l of PCR 
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products were directly loaded per well. 100 ng of RNA, DNA or cDNA was mixed 
with 2 μL 6X bromophenol blue buffer (VWR, UK) and loaded into the formed wells; 
3 μL of an appropriate RNA (Promega, UK) or DNA (Bioline, UK) size ladder was 
also loaded into appropriate sample wells. Gel electrophoresis was subsequently 
performed for 20-40 min at 80 to 120 volts until sample separation was achieved. The 
size of PCR products could subsequently be determined by comparing the position of 
the separated sample band to the known size bands of the electrophoresed DNA 
ladder.  
 
2.4.8 Image analysis 
Following electrophoresis, gel images were captured using the Electrophoresis 
Documentation Analysis System [EDAS (Kodak, USA)] whilst exposing the gel to a 
ultra-violet light source (Vilber Lourmat, UK) to enable sample visualisation. 
Captured RT-PCR gel images were subsequently imported into AIDA image analysis 
software (FUJI, UK) and semi quantitative densitometric analysis performed. To 
obtain a semi quantitative value of the volume density of amplified products, a 
rectangular area of equal size was outlined around PCR products for each sample 
using AIDA software, and the local background (an area 0.1mm
2
 surrounding the 
rectangle) subsequently subtracted. Prior to comparison of gene expression levels 
between samples, obtained volume density values for each sample were normalised to 
their respective GAPDH housekeeping gene, volume density control values. 
Normalisation was achieved by dividing the obtained sample volume density values 
for each assay by their respective GAPDH volume density values. Normalised 
expression levels for each sample were then expressed as either a percentage or as 
relative expression levels of the highest normalised volume density obtained.  
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2.5 Systemic administration of ADM  
The following work was performed by Professor Cornish and members of the Bone 
Research Group, based at the University of Aukland, New Zealand and previously 
used in a published study to determine the effect of systemic administration of ADM 
on tibia bone length and strength (Cornish et al, 2001). The murine specimens (whole 
animals) were provided as a kind gift from Professor Cornish as part of a Universitas 
21 funded collaborative project (http://www.u21.bham.ac.uk/). 
Briefly, two groups of male adult Swiss mice aged between 40 and 50 days 
and weighing 25-32g were used. Each group were given daily subcutaneous injections 
into the nape of the neck for 5 days/week over a period of 4 weeks. The test group 
received injections contained 8.1µg ADM in 50µl of water, whilst the control group 
received sham injections of 50µl saline solution alone. Each group was provided with 
the same chow diet and allowed to feed ad libitum. Following the experimental test 
period of 4 weeks, the mice were terminated by cervical dislocation prior to 
mineralised tissue analysis (see Cornish et al 2001 for further details on experimental 
procedure). 
 
2.6 Micro-Computed Tomography (MicroCT) analysis of dental and craniofacial 
structures from experimental animals from sham and ADM exposed mice  
 
2.6.1 MicroCT scanning and specimen reconstruction 
Mice heads were removed from bodies and boiled for one hour to detach any adherent 
soft tissue from the bony structures. Heads were frozen for transport to the department 
of Chemical Engineering, University of Birmingham. Subsequently, at location, heads 
were defrosted and securely placed into plastic bijou tubes (Appleton Woods, UK). 
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Bijous were securely fixed onto the rotating analysis platform inside the Skyscan 
1172 (Skyscan, Belgium) (Figure 2.1). The scanning parameters for this study were 
set at 100kV source voltage and 98μA source current. Samples were stationed 202mm 
from x–ray source and 95mm from the detector, giving a pixel size of 18.8μm. 
Subsequently, samples were rotated, enabling 600 X-ray images to be captured, one 
every 0.6°, to enable the building of a 3D X-ray reconstruction image of the 
specimen. This process is shown diagrammatically in Figure 2.2. 
 
 
Figure 2.1: Skyscan 1172 (Skyscan, Belgium) 
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Figure 2.2: Diagrammatic representation of the scanning process used by the Skyscan 
1172 (Skyscan, Belgium).  
 
The images obtained from the scanning process were electronically transferred for the 
computer assisted reconstruction process (Figure 2.3). This analysis was performed 
using the CTrecon software (Skyscan, Belgium), which uses the 3D model to create 
2D bitmap cross-sectional images of the hard tissue along the horizontal plane (as 
shown in Figure 6.2). Each scan provided approximately 920 2D slices, each 
measuring 1024x1024 pixels with a pixel size of 18.9μm. 
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Figure 2.3: Reconstruction process underway using CTrecon software (Skyscan, 
Belgium) 
 
2.6.2 Volumetric measurements 
2D bitmap images obtained from reconstruction stage (Section 2.6.1) were analysed 
using CT analysis software (CTan) (Skyscan, Belgium). Using CTan it was possible 
to create volumes of interest (VOIs) by manually isolating the tooth area on each 
cross sectional image, approximately 120 per molar, 215 per incisor and 750 per 
mandible. The software then provides a stack of images, measures each isolated area 
from the sections selected and enables determination of the total hard tissue volume 
(see Figure 6.3). Prior to the study each sham and ADM exposed animal was 
assigned a random number by a person unrelated to this study. When measurements 
were taken, the author was only aware of samples by their assigned number, therefore 
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removing any possibility of bias. This process was performed on each sample tooth 
and for the whole mandibles from sham and ADM exposed animals. 
 
2.7 Digital analysis of heads from ADM treated mice  
Ten mandibles from both test and control animals were removed. Digital images were 
taken against a background of standard graph paper from a fixed height of 10cm 
directly above using a Coolpix 950 digital camera (Nikon, UK) and accompanied by a 
standard ruler to provide scale. Key lengths were measured along the mandible, as 
proposed by Atchley et al 1984, who previously used this approach to study the effect 
of the muscular dysgenesis gene on mouse mandible development. Image analysis for 
craniofacial measurements was performed using ImageJ software (downloaded from 
http://rsweb.nih.gov/ij/). Prior to the study each sham and ADM exposed animal was 
assigned a random number by a person unrelated to this study. When measurements 
were taken the author was only aware of samples by their assigned number, therefore 
removing any possibility of bias. 
 
2.8 Statistical analysis 
The significance of the data presented was evaluated using one-way ANOVA and 
Dunnett‟s test to determine whether treated samples were significantly different from 
control samples. Data are presented as mean ± standard error of the mean (s.e.m). A 
5% significance level was maintained throughout.  
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3. Results chapter 1 
 
3.1 Expression of ADM and TGF-β1 in the developing tooth: An 
immunohistochemical study 
Many growth factors are known to be important in regulating tooth development and 
associated dentinogenesis, with members of the TGF-β, BMP, IGF and FGF families 
implicated due to their expression patterns during tooth development (Vaahtokari et 
al, 1991; Cam et al, 1992; Bégue-Kirn et al, 1994; Helder et al, 1998; Russo et al, 
1998), while in vitro studies have demonstrated the involvement of these growth 
factors in odontoblast differentiation (Bégue-Kirn et al, 1992; Bégue-Kirn et al, 1994; 
Sloan and Smith, 1999; Ruch and Lesot, 2000). However, further molecular 
characterisation in this area is still required as the precise role of these growth factors 
and their inter-relationship is still undetermined due to their simultaneous expression 
and due to relevant genetic knock-out animal models arresting during, or prior to, 
tooth development (Bégue-Kirn et al, 1994; Helder et al, 1998) (See Section 1.4.2 for 
further details).  
Previously published preliminary work has now indicated that ADM is 
expressed in the odontoblasts of the developing tooth at the approximate time of 
dentinogenesis onset, indicating that ADM may be important in regulating these 
processes (Montuenga et al, 1997). The role of the growth factor, TGF-β1, is well 
established in regulating odontoblast differentiation and dentine secretion during tooth 
development (Begue-Kirn et al, 1992; Begue-Kirn et al, 1994; Smith et al, 1995; 
Sloan and Smith, 1999; Unda et al, 2001; Xu et al, 2003; Klopcic et al, 2007; Oka et 
al, 2007; Sassá Benedete et al, 2008) and now there is data that shows that ADM is 
co-expressed with TGF-β1 during general mammalian embryogenesis (Montuenga et 
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al, 1998). In addition, a regulatory interrelationship between ADM and TGF-β1 has 
been described, with studies showing that TGF-β1 and ADM can act to suppress the 
expression of each other, while studies using TGF-β1 null mutant mice demonstrate a 
reduction in embryonic ADM expression (Bodegas et al, 2004; Huang et al, 2005). 
The following study was therefore undertaken to characterize the temporo-spatial 
expression of ADM and TGF-β1 during rat tooth development. This data may help 
clarify ADM's potential role during dental tissue development and may indicate 
whether a regulatory inter-relationship between these two molecules likely exists 
during tooth development. 
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3.2 Histological study of tooth development in rats 
Throughout this study it was often difficult to obtain exact times of conception for the 
rodents used. To initiate conception, male and female animals were placed together at 
the end of a working day and the following morning vaginal plugs were used to assess 
early signs of pregnancy. As conception time is taken from this timepoint, there 
remains a 14 hour period in which conception could have occurred this potentially 
contributes to slight inaccuracies with regards developmental age for the animals used 
in this study. Therefore to better assess the developmental age at which the rats used 
in this work underwent each stage of tooth development, a preliminary study was 
undertaken. During this study, sections of tooth germs of rat foetuses from embryonic 
day 16 (E16), embryonic day 18 (E18) and embryonic day 20 (E20) were stained with 
Haematoxylin and Eosin (H&E) (see Section 2.1). These images were then compared 
to the key stages of tooth development previously reported (Ten Cate, 1998). 
Furthermore, measurements of organ width, height and distance from oral epithelium 
were taken of the developing molars, using ImageJ software (see Section 2.1.8), as 
there appears to be no such information currently available. These measurements may 
act as useful guidelines for determining developmental stages in future study. 
 
At the embryonic age of E16 it appeared that the 1
st
 molars of the rats were in 
the bud stage of development (Figure 3.1A & B). When viewed under high 
magnification (x500) the cells of the dental mesenchyme, dental epithelium and oral 
epithelium were clearly visible (Figure 3.1B). Also visible was the apparent 
condensing of the ectomesenchyme around the dental membrane, caused by the 
epithelial „ingrowth‟ (As described in Section 1.4.2.2). This histological event is a 
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key stage in the transition from bud to cap stage. As the molar is still in the bud stage 
it was only possible to measure the width of the tooth bud, which was 2.76mm. 
The incisor tooth at E16 appeared to be in the cap stage of development 
(Figure 3.1C), as it can be seen that the developing tooth remains attached to the oral 
epithelium by the dental lamina, whilst at the higher magnification the dental papilla, 
inner and outer dental epithelium and the stellate reticulum are all visible. The only 
feature not visible, that is synonymous with the cap stage, is the enamel knot. 
However, as none of the cells appear to have begun histodifferentiation indicative of a 
tooth being in the bell stage, such as odontoblast and ameloblasts differentiation, and 
as the developing tooth is attached to the oral epithelium, it is reasonable to presume 
that this represents the cap stage of development (Ten Cate, 1998). The enamel knot is 
a relatively transient structural feature and thus, the fact it is not visible is perhaps 
unsurprising as its presence is very dependent on the exact time of observation. 
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Histological evidence indicates that the developing incisor of a rat at E18 
appeared to be on the boundary of cap and bell stage (Figures 3.2A, B & C provide 
representative images). At this stage, the developing tooth appears to be dissociated 
from the oral epithelium indicating entry into the bell stage (Ten Cate, 1998). 
Inspection of the image also provides morphological evidence indicative of a 
developing incisor (Figure 3.2). However, as yet there appears to be little of the 
histodifferentiation which is indicative of a developing tooth in the bell stage. It is 
often difficult to state with certainty which developmental stage a tooth is at due to 
stages overlapping, as appears the case here at embryonic age E18 (Figure 3.2). 
 The developing molar at E18 also appears to have dissociated from the oral 
epithelium, however, other apparent features indicate this section as being derived 
from the cap stage of development. The tooth has yet to gain the crown shape 
associated with a molar in bell stage and there appears to be no histodifferentiation 
indicative of bell stage occurring. Clearly visible are the dental papilla, inner dental 
epithelium, stellate reticulum and outer dental epithelium (Figures 3.2D - H) as 
would be expected for a tooth at the cap stage of development (Ten Cate, 1998). 
  In Figure 3.2F it is also possible to observe the onset of the 2
nd
 molar 
development. It is interesting to note that the dental epithelia of the 1
st
 and 2
nd
 molars 
appear to be attached. It also appears that the 2
nd
 molar is currently developmentally 
between bud and cap stages as the developing organ has yet to take on the „cap‟ 
appearance. At this stage, the width of the developing molar has now more than 
doubled as compared to the E16 derived tissue and now measures 6.98mm. The 
height of the developing tooth bud was 3.33mm and the distance from the oral 
epithelium was 1.08mm.  
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Once the rat reaches E20, the developing incisor appears to be in the bell stage of 
development (Ten Cate, 1998). The tooth is clearly forming its‟ predetermined shape, 
notably it has fully dissociated from the oral epithelium and the cells have begun to 
undergo histodifferentiation. Figure 3.3C clearly shows that the cells of the inner 
dental epithelium and stratum intermedium have differentiated into odontoblasts and 
ameloblasts, with the odontoblasts beginning to deposit dentine. The differentiation of 
these cells begins at the cusp of the developing crown, which signals to the 
neighbouring cells initiating a cascade of differentiation throughout the inner dental 
epithelium and stratum intermedium; as such not all cells of the inner dental 
epithelium and stratum intermedium have begun to differentiate (Figure 3.3B).  
 The 1
st
 molar of the rat at E20 appears to be developmentally between the cap 
and bell stages. The developing organ has yet to undergo the histodifferentiation one 
would expect for a tooth in the bell stage, such as the differentiation of odontoblasts 
and ameloblasts, however, it had taken on the future crown shape of a molar. There 
also appears to be a mixture of structures from both cap and bell stage present, with 
the inner dental epithelium, outer dental epithelium and stellate reticulum indicative 
of cap stage visible and the stratum intermedium which is indicative of bell stage also 
visible. This suggests a general continuum from one stage to another (Figure 3.3F). 
 The size of the developing molar has changed minimally from the E18 time-
point, with the width increasing by 0.21mm to 7.17mm and the height increasing by 
0.16mm to 3.49mm. The distance from the oral epithelium has also increased between 
E18 and E20 from 1.08mm to 2.65mm. 
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3.3 Immunohistochemical analyses of ADM and TGF-β1 in the developing tooth 
organ of male Wistar rats 
Following the histological determination of the developmental ages at which male 
Wistar rats exhibit certain tooth developmental stages (Section 3.2), an 
immunohistochemical study was performed to determine in which histological 
locations and at what developmental ages ADM was detectable in the developing 
teeth. Previously published data is limited to a single image of ADM positive staining 
in a developing mouse tooth (Montuenga et al, 1997), therefore all 
immunohistochemical data obtained from the developing teeth of embryonic male 
Wistar rats in this study is novel and will increase our knowledge. 
Initially adult male Wistar rat heart sections were used as a positive 
immunohistochemical staining control, as ADM is reportedly prevalently expressed in 
the heart (Jougasaki et al, 1995). Subsequently, 5µm sections of teeth from rats aged 
at embryonic day 16 (E16), embryonic day 18 (E18) and embryonic day 20 (E20) 
were obtained and stained for the presence of ADM (Section 2.1).  
Furthermore, sections from male Wistar rats aged E20 were stained for the 
presence of TGF-β1 to determine if concurrent expression with ADM exists in the 
developing tooth, as has previously been described during embryogenesis in other 
tissues (Montuenga et al, 1998). 
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Notably, ADM expression was confirmed to be prevalent throughout the heart 
tissue (Figure 3.4A), predominantly the smooth muscle cells, as previously described 
in literature (Jougasaki et al, 1995; Montuenga et al, 1997). The pre-incubation of an 
ADM peptide with the ADM antibody overnight (ADM blocking control) resulted in 
a reduction in staining for ADM (Figure 3.4B) indicating that the staining seen in 
Figure 3.4A was due to specific ADM antigen binding and confirming that the ADM 
antibody functions as expected. The absence of an ADM antibody (-ve control) 
resulted in no detectable staining (Figure 3.4C). Figure 3.4D provides an image of 
H&E staining of the heart tissue section. 
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At embryonic age E16, when the incisor was identified as being in the bud 
stage, a high intensity of staining was visible in the majority of oral epithelial cells 
throughout the developing jaw, whilst in the majority of mesenchymal cells there 
appeared to be a lower intensity of positively stained cells for the presence of ADM 
(Figure 3.5A). A higher magnification view (Figure 3.5B) demonstrated that in the 
developing incisor, positive staining for ADM appears to be present in the cells of 
both the internal and external dental epithelium.  
In the pre-bleed control specimens (Figures 3.5C & D), there was no apparent 
positive staining for ADM in any of the cells of the developing jaw or tooth. 
Furthermore, there was no positive staining in the negative control (no ADM 
antibody) specimens (Figures 5.3E & F). 
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 At E18 when the developing incisor was in transition from cap to bell stage 
(Figure 3.6), positive staining for the presence of ADM was visible in the cells of the 
internal dental epithelium, whilst there appears to be some pericellular positive 
staining indicating the presence of ADM in the cells of the dental papilla, stellate 
reticulum and outer dental epithelium, which could indicate paracrine signalling 
(Figures 3.6 A & B). The pre-incubation of an ADM peptide with the ADM antibody 
resulted in no detectable positive staining for the presence of ADM in any of the cells 
of the developing incisor (Figure 3.6 C). Similar results were observed with pre-bleed 
rabbit serum and the negative control samples, with no positive staining for ADM 
apparent (Figures 3.6 D, E & F). 
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 At E20, when the incisor was demonstrably in the bell stage, positive staining 
for ADM was observed in the odontoblasts and ameloblasts, predominantly in the 
processes where extracellular secretion occurs (Figure 3.7 A), suggesting that ADM 
may be involved in this process. The cells of the dental papilla appear to have some 
positive staining albeit at a lower intensity compared to the odontoblasts and 
ameloblasts, while in the stellate reticulum it appears that there was no 
immunoreactivity detected for ADM (Figure 3.7 A). In the ADM blocking control 
(Figure 3.7 B), there was no observable positive staining for ADM in any of the cells 
of the developing incisor. 
 Following staining of embryonic age E20 incisors using a TGF-β1 antibody 
(Figure 3.7 C) positive staining was observed in the processes of the odontoblasts and 
ameloblasts, similar to that observed following staining for ADM (Figure 3.7 A), 
increasing our knowledge from previously published data showing co-expression of 
these two growth factors during embryogenesis. The inclusion of a TGF-β1 peptide 
pre-incubation step blocked detectable immunoreactivity for TGF-β1 (Figure 3.7 D). 
 Sections stained with pre-bleed rabbit serum and the negative control 
produced no observable positive staining in any cells of the developing incisor 
(Figure 3.7 E & F). 
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4. Results Chapter 2 
 
4.1 Effect of ADM, Dexamethasone and DMPs on dental cell behaviour 
Whilst published data (Montuenga et al, 1997), along with the histological studies 
reported in the previous chapter, implicate ADM in tooth development, its‟ 
mechanism of action in these cells is yet to be determined. Notably ADM has been 
shown to stimulate proliferation in several cell types, including Swiss 3T3 fibroblasts, 
skin and oral keratinocytes, thymocytes and osteoblasts (Martinez et al, 1997; Kapas 
et al, 1997; Isumi et al, 1998; Cornish et al, 2002; Hamada et al, 2002; Belloni et al, 
2003). Conversely, in cardiac fibroblasts, hepatic stellate and rat mesangial cells, 
ADM suppresses cell growth (Jiang et al, 2004; Wang et al, 2005; Chini et al, 1995). 
The purpose of the following studies, therefore, was to determine whether ADM 
affected cell numbers in dental cells. The cell lines used were MDPC-23 cells and 
OD-21 cells, which are murine odontoblast-like and dental pulp-like cells isolated 
from foetal tissues, respectively (Hanks et al, 1998). The murine 3T3 skin fibroblast 
cell line was used as control, as ADM has been previously shown to induce 
proliferation in these cells (Isumi et al, 1998).  
Initially, to determine whether these cell lines were likely to respond to ADM, 
gene expression analyses for the ADM receptors, along with the proliferation marker 
PCNA, were performed. ADM is known to signal through two ADM-specific 
receptors, namely AM-1 and AM-2, and these are made up of a dimer of calcitonin 
receptor-like receptor (CRLR) and either receptor activity modifying protein-2 or -3 
(RAMP-2 and RAMP-3, respectively) (McLatchie et al, 1998; Aiyar et al, 2001; Muff 
et al, 2001; Oliver et al, 2001).  
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The effects of ADM on cell number were also compared to that of EDTA 
extracted dentine matrix proteins (DMPs) and dexamethasone. Notably, particular 
concentrations of DMPs have been shown to increase dental cell numbers (Graham, 
2004) and these preparations are known to contain ADM, which is released along 
with other growth factors during dentine dissolution (Graham, 2004; Tomson et al, 
2007). Dexamethasone is well characterized in vitro with regards to its mineralising 
induction action (Cheng et al, 1996; Hildebrandt et al, 2009) and is known to induce 
the differentiation of bone marrow stromal cells into osteoblasts (Cheng et al, 1994). 
Dexamethasone is thought to elicit it‟s mineralising and differentiating effects through 
the expression of key matrix proteins Bone Sialoprotein (BSP), Osteocalcin (OCN) 
and Osteopontin (OPN) (Cheng et al, 1996; Mikami et al, 2007), regulated through 
the transcription factor Runx2 (Mikami et al, 2007). It has also been shown to regulate 
expression of ADM and/or its receptors in several cell lines, including myocytes, 
smooth muscle cells, retinal pigment epithelial cells and osteoblasts (Nishimori et al, 
1997; Hattori et al, 1999; Frayon et al, 2000; Udono-Fujimori et al, 2004 and Uzan et 
al, 2004). Markedly a glucocorticoid receptor element has been identified in the 
regulatory sequences of ADM and the ADM receptor, calcitonin receptor like receptor 
(CRLR) (Nikitenko et al, 2003; Zudaire et al, 2005). These results indicate the 
potential for a component of dexamethasone‟s cellular effects to be mediated via 
regulation of an ADM autocrine signalling mechanism. 
 To confirm that the responses observed were due to ADM specific 
interactions, an antagonist for ADM was also included in the experimental design. 
ADM22-52 is known to act as a competitive antagonist for both the AM-1 and AM-2 
receptors (Hay et al, 2004). ADM22-52 is a partial fragment of the full ADM growth 
factor and is able to partially bind to the receptors as it retains the C-terminal residue, 
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however, it does not contain the disulfide bridge which would allow it to elicit a 
response, hence acting as a low affinity competitive antagonist (Eguchi et al, 1994; 
Hay et al, 2003). Initially, ADM22-52 activity was analysed alone to determine whether 
it elicited agonistic effects and subsequently in the presence of ADM to determine if it 
modulated ADM activity. 
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4.2 Effect of ADM cellular exposure on ADM receptor and PCNA gene 
expression 
In this study, MDPC-23, OD-21 and 3T3 cells were exposed to a range of 
concentrations of ADM for 24 hours. Cells were subsequently lysed and the RNA 
extracted. RT-PCR was performed to determine the effect of ADM exposure on the 
gene expression of CRLR, RAMP-2 and PCNA (see Sections 2.2.4 and 2.5). ADM is 
part of the calcitonin superfamily of regulatory peptides (Kitamura et al, 1993) and 
exerts its effect upon cells directly through interactions with CRLR/RAMP-2 (AM-1) 
or CRLR/RAMP-3 (AM-2) receptor complexes (McLatchie et al, 1998). ADM‟s 
effects upon CRLR and RAMP-2 gene expression were therefore examined to 
determine whether these receptor components were present in the target cell lines and 
whether ADM has a role in regulating their expression. PCNA is expressed in the 
nuclei of cells during DNA synthesis (Leonardi et al, 1992) and therefore transcript 
levels were also investigated as a surrogate marker for cell proliferation.  
 
4.2.1 Analysis of CRLR, RAMP-2 and PCNA transcript levels in MDPC-23, OD-
21 and 3T3 cells 
Figure 4.1A provides representative gel images of GAPDH, CRLR, RAMP-2 and 
PCNA gene expression in MDPC-23 cells following 24 hour exposure to a range of 
concentrations of ADM. Figure 4.1B presents the mean band intensities obtained from 
these studies. The data indicate that CRLR gene expression appeared relatively 
unaltered following treatment with ADM. Expression levels decreased only minimally 
following treatment with 10
-15
M, 10
-13
M, 10
-11
M and 10
-9
M, while 10
-7
M ADM had 
no observable effect on CRLR transcript levels. RAMP-2 expression appeared to 
minimally decrease following cell exposure to the ADM concentrations used.  
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PCNA gene expression marginally increased following exposure to all concentrations 
of ADM used, with potentially the greatest change observed at 10
-11
M ADM.  
The effect upon OD-21 cell gene expression levels of CRLR, RAMP-2 and PCNA 
following exposure to ADM is presented in Figures 4.1C and D with representative 
gel images and associated densitometric analysis provided.  In OD-21 cells, the levels 
of CRLR mRNA appeared to show a dose dependent trend in reduction following 
exposure to ADM. ADM concentrations of 10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and 10
-7
M 
decreased densitometrically derived values by 18%, 22%, 34%, 9% and 14%, 
respectively, compared to the untreated control. RAMP-2 levels also appeared to 
decrease in OD-21 cells following exposure to the lower three concentrations of ADM 
(10
-15
M, 10
-13
M and 10
-11
M by 6, 4 and 11% densitometric reduction compared to 
control, respectively). Changes in PCNA expression in OD-21 cells exhibited a 
similar pattern to that observed for MDPC-23 cells. ADM appeared to marginally 
elevate expression as 10
-15
M, 10
-13
M, 10
-11
M and 10
-9
M increased the densitometric 
values by 14%, 15%, 26% and 9%, respectively.  
ADM‟s effect on gene expression in 3T3 cells is presented in Figures 4.1E and 
F. In this cell line exposure to each concentration of ADM resulted in a marginal 
reduction in CRLR gene expression. A maximum reduction, as derived from 
densitometric values, of 10% was observed in CRLR expression following treatment 
with 10
-7
M ADM. Other reductions observed in transcript levels were relatively 
minor. RAMP-2 gene expression generally appeared unaltered following ADM 
exposure, although 10
-7
M ADM induced a RAMP-2 densitometric reduction of ~28%. 
PCNA expression appeared to marginally increase in 3T3 cells with a dose-dependant 
trend following ADM exposure. At the highest concentration used, 10
-7
M ADM, a 
densitometric increase of 15% was calculated compared to the control cultures. 
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4.3 Effect of ADM on MDPC-23, OD-21 and 3T3 cell number 
Following the identification of an ADM receptor component in the target cell lines 
and the increases in PCNA expression observed as a result of ADM exposure 
(Section 4.2), the effect of ADM upon MDPC-23, OD-21 and 3T3 cell number was 
assessed. Viable cell numbers (see Section 2.2.2) following 48 hour exposure to a 
range of concentrations of ADM were determined and compared to control 
unstimulated cultures. Statistical significance was measured using one-way ANOVA 
test (P<0.05) (see Section 2.9). Cell viability data not presented as non-viable cell 
number was not affected by exposure to ADM (non viable cells < 1% for all 
concentrations studied). 
 Results presented in Figure 4.2A indicate the ratio of the average MDPC-23 
cell number following treatment with a range of concentrations of ADM, in relation to 
the control. Data indicate ADM has a biphasic response on cell number in these cells. 
The relatively low concentrations of ADM, 10
-13
M and 10
-11
M, induced a statistically 
significant increase in cell number of 24% and 34%, respectively, compared to 
control. Whilst 10
-9
M and 10
-7
M ADM both increased cell numbers by ~8%, these 
changes, however, were not statistically significant. 
 Interestingly a similar biphasic response to ADM exposure, as seen with the 
MDPC-23 cells, was observed in OD-21 cells (Figure 4.2B). Whilst ADM 
concentrations of 10
-15
M, 10
-9
M and 10
-7
M all produced increases in viable cell 
numbers (7%, 9% and 8%, respectively), these were not found to be statistically 
significant. However 10
-13
M and 10
-11
M ADM, both elicited a statistically significant 
increase in cell number compared to the control, with both stimulating increases in 
cell numbers by ~32% as compared to the control. 
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The cell number profile of 3T3 cells in response to increasing concentrations 
of ADM is shown in Figure 4.2C. The relatively low concentrations of ADM, 10
-15
M 
and 10
-13
M, did not elicit a statistically significant change in 3T3 cell number 
compared to the control. Conversely 10
-11
M, 10
-9
M and 10
-7
M ADM all statistically 
significantly increased 3T3 cell numbers by 24%, 24% and 50%, respectively. 
Notably the growth response profile observed for the 3T3 cultures was markedly 
different from that observed for the MDPC-23 and OD-21 cells (Figures 4.1A & B). 
This result, however, is comparable to that reported by Isumi et al, (1998), who also 
analysed the effect of ADM on Swiss 3T3 fibroblasts cell growth. 
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4.4 Analysis of the ADM22-52 antagonist on MDPC-23, OD-21 and 3T3 cell 
number 
To determine if the ADM antagonist, ADM22-52, affected numbers of the cell lines, 
cell counts were performed following treatment with a range of concentrations of 
ADM22-52. Concentrations analysed were selected from studies, which previously used 
the ADM antagonist (Hay et al, 2003). Viable cell numbers were compared to those 
of the control unexposed samples (see Section 2.2.2). Cell viability data not presented 
as non-viable cell number was not affected by exposure to ADM22-52 (non viable cells 
< 1% for all concentrations studied). 
 Data indicated that that ADM22-52 had minimal effect on MDPC-23, OD-21 
and 3T3 cell numbers at the concentrations used (Figure 4.3). Cell numbers varied 
minimally for all cell lines under the range of concentrations used, however, no 
changes were found to be statistically significant.  
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4.5 Antagonistic effect of ADM22-52 on ADM’s ability to increase cell number 
To determine whether the effect of ADM exposure on cell numbers in the cell lines 
studied in Section 4.3 was likely due to ADM specific receptor interactions, analyses 
were performed which included 20 minute pre-treatment of cells with a range of 
concentrations of the ADM antagonist, ADM22-52 (10
-12
M, 10
-10
M, 10
-8
M and 10
-6
M), 
prior to stimulation with ADM at concentrations of 10
-11
M, 10
-11
M and 10
-7
M. These 
ADM concentrations analysed were those previously identified as being optimal to 
increase cell number in the MDPC-23, OD-21 and 3T3 cells, respectively (Figure 
4.2). The ADM22-52 concentrations chosen for this study were the same as those in 
previously published reports (Hay et al, 2004). As previously described, viable cell 
numbers were determined and compared to those of the control (see Section 2.2.2). 
Statistical significance was determined using one-way ANOVA tests (P<0.05) (see 
Section 2.9). Cell viability data not presented as non-viable cell number was not 
affected by exposure to ADM22-52 or ADM (non viable cells < 1% for all 
concentrations studied). 
 
4.5.1 Antagonistic effect of ADM22-52 on the proliferative effect of ADM in 
MDPC-23, OD-21 and 3T3 cells 
Data demonstrating the ability of ADM22-52 to act antagonistically to ADM in MDPC-
23 cells are provided in Figure 4.4A. In this study 10
-11
M ADM alone statistically 
significantly increased cell numbers by 37% above those of the control. However, as 
the concentrations of the ADM22-52 antagonist used increased, the cell numbers at 48 
hours of growth decreased. Notably 10
-8
M ADM22-52 statistically significantly reduced 
the cell numbers from 37% with 10
-11
M ADM alone down to 17% in the presence of 
the antagonist, as compared to control cultures. When the concentration of ADM22-52 
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was increased to10
-6
M, cell numbers decreased by 47% compared to 10
-11
M ADM 
exposure alone. This reduction in cell number was statistically significant. 
Data presented in Figure 4.4B demonstrated the antagonistic effect of ADM22-
52 on the ability of ADM to affect cell numbers in OD-21 cells. When the cells were 
treated with ADM alone cell numbers increased statistically significantly by 35%. 
Whilst this increase in cell number was decreased by the addition of 10
-12
M and 10
-
10
M ADM22-52 these reductions in cell number were not shown to be statistically 
significant. Similar to the data obtained for MDPC-23 cells, 10
-8
M ADM22-52 was the 
lowest concentration used which reduced cell number by a statistically significant 
amount (19%). The highest concentration of ADM22-52 used, 10
-6
M, reduced cell 
numbers by 54% compared to 10
-11
M ADM stimulation alone, resulting in a 
statistically significant 20% reduction compared to the control.  
In 3T3 cells, treatment with 10
-7
M ADM alone increased cell numbers by 51% 
in this cell line and the relatively low concentrations of the antagonist, 10
-12
M and 10
-
10
M ADM22-52, resulted in minimal inhibition (Figure 4.4C). Whilst the addition of 
10
-8
M ADM22-52 reduced cell numbers by 19% compared to 10
-7
M ADM exposure 
alone, this result was not found to be statistically significant. Treatment with 10
-6
M 
ADM22-52 did however elicit a statistically significant reduction in 3T3 cell numbers 
by ~60% compared to 10
-7
M ADM exposure alone. 
In each cell line the lower concentrations of ADM22-52 failed to have an affect 
on cells exposed to 10
-7
M ADM, but at higher concentrations of ADM22-52 exposure, 
cell numbers are significantly reduced. This data is not surprising as ADM22-52 acts as 
a low infinity competitive inhibitor to ADM (Eguchi et al, 1994; Hay et al, 2003). 
The fact that the higher concentrations of ADM22-52 lowers cell numbers below that of 
the control could perhaps be explained by blocking the effect endogenous ADM, 
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however, this is unlikely as exposure to ADM22-52 alone (Section 4.4) did not elicit 
such an effect. To fully elucidate why this reduction occurs, further pharmacological 
studies would be required.  
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4.6 Effect of DMP exposure on MDPC-23, OD-21 and 3T3 cell numbers 
Previous studies have demonstrated that amongst the growth factors sequestered in 
EDTA extracted DMPs (E-DMPs), ADM is present at relatively high concentrations 
(approximately 2.61pg/mg), especially when compared to other growth factors such 
as TGF-β1 (MacLachlan et al, 2002; Graham, 2004; Tomson et al, 2007). In addition 
it has also been demonstrated that DMPs extracted using this method stimulate 
MDPC-23 and OD-21 cell growth (Graham, 2004).  
In this study, MDPC-23, OD-21 and 3T3 cells were treated with a range of 
concentrations of DMPs using the same protocol as that described previously for 
ADM exposure (see Section 4.3). Cell numbers were subsequently compared to those 
obtained using ADM exposure alone to determine if there is a possibility that the 
proliferative effect previously found with DMPs might correlate with the 
concentration of its‟ ADM component. However, there are other growth factors, such 
as TGF-β1, also released from E-DMPs and therefore, without antagonistic studies 
demonstrating a reduction in ADM induced cell number, this data should be viewed 
solely as an indication of ADM‟s potential involvement. Notably, no previous 
comparisons have been made between the effects of E-DMPs on cell number and the 
effects of it‟s constituent growth factors on cell number, providing interesting avenues 
for future study. 
According to data obtained by Graham, (2004), there is ~2.61pg ADM 
contained within 1mg E-DMP. Therefore, the concentrations of DMPs utilised in this 
study were selected to enable relative comparative analysis with single ADM 
exposure as presented in Table 4.1. 
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E-DMP 
concentration 
(mg/ml) 
ADM present in 
E-DMP (pg) 
Concentration of 
ADM in E-DMP 
(M) 
Concentration of 
ADM used in 
Section 4.2 (M) 
0.00001 0.0000026 4.4 x 10
-16
 1 x 10
-15
 
0.001 0.00026 4.4 x 10
-14
 1 x10
-13
 
0.1 0.026 4.4 x 10
-12
 1 x 10
-11
 
10 2.6 4.4 x 10
-10
 1 x 10
-9
 
1000 261 4.4 x 10
-8
 1 x 10
-7
 
Table 4.1: Table showing concentrations of ADM sequestered from E-DMPs and 
those examined in Section 4.2.  
 
Following cellular exposure to E-DMPs, viable cell number counts were 
determined and compared to that of the control (see Section 2.2.2). Statistical 
significance was determined using one-way ANOVA tests (P<0.05) (see Section 2.9). 
Cell viability data not presented as non-viable cell number was not affected by E-
DMP exposure (non viable cells < 1% for all concentrations studied). 
 
4.6.1 Cell number characterisation following exposure of MDPC-23, OD-21 and 
3T3 cells to DMPs and comparable concentrations of ADM  
The data on the effect of E-DMPs on the cell number of MDPC-23 cells, with 
previous ADM data, are illustrated in Figure 4.5A. The graph indicates that the lower 
three concentrations of DMPs used (0.00001mg/ml, 0.001mg/ml and 0.1mg/ml) 
increased cell numbers in comparison to ADM. Exposure of MDPC-23 cells to 
0.001mg/ml of DMPs increased numbers by 33%, while the nearest concentration of 
ADM (10
-13
M) increased cell number by 24%. The optimal increase in cell number 
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occurred at 0.1mg/ml DMP and 10
-11
M ADM, which cell numbers increased by 54% 
and 35%, respectively, all of which were statistically significant increases compared 
to the unstimulated control. 
At the higher two concentrations of DMPs examined (10mg/ml and 
1000mg/ml), cell numbers decreased to below that of the control. Indeed 10mg/ml 
DMP decreased cell numbers to 68% whilst 1000mg/ml decreased numbers to 18% of 
the control. The higher concentrations of ADM (10
-9
M and 10
-7
M) produced non-
significant increases in cell number compared to the control. The decreases in cell 
number seen with the higher DMP treatments (10mg/ml and 1000mg/ml) were 
statistically significant compared to the unstimulated control. 
The effects of E-DMP and ADM treatment on the number of OD-21 cells 
were also studied (Figure 4.5B). In this cell line, increases in cell numbers were 
observed following exposure to 0.00001mg/ml DMP and 10
-15
M ADM of 10% and 
7%, respectively. Notably, cells exposed to 0.001mg/ml DMP exhibited a 19% 
increase in cell numbers whilst exposure to the nearest ADM concentration (10
-13
M) 
increased cell numbers by 32%. Both increases were statistically significant compared 
to the control. Statistically significant increased cell numbers, above those of control, 
were also observed following 0.1mg/ml DMP and 10
-11
M ADM exposure, which 
increased numbers by 41% and 32%, respectively. 
Similar to the pattern observed for MDPC-23 cells, the higher two 
concentrations of DMP studied (10mg/ml and 1000mg/ml) statistically significantly 
decreased cell number by 18% and 80%, respectively. Conversely, the number of 
cells following treatment with the higher concentrations of ADM (10
-9
M and 10
-7
M) 
slightly increased cell number, although not statistically significantly, compared to the 
control; 9% with 10
-9
M and 8% with 10
-7
M.  
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 Analysis of the effects of exposure to E-DMPs and the results obtained 
following ADM exposure to 3T3 cell numbers is presented in Figure 4.5C. Cell 
numbers increased with 3T3 cells exposed to 0.00001mg/ml DMP and the lowest 
ADM concentration. Neither of these increases were, however, statistically significant 
compared to the unstimulated control cultures. Cell numbers notably increased as the 
concentration of DMP used increased to 0.001mg/ml and 0.1mg/ml, with cell number 
increases of 24% and 51% above control, respectively. The nearest comparative ADM 
concentrations had differing effects with 10
-13
M slightly decreasing cell number and 
10
-11
M increasing cell number by 23%. When the cells were subjected to relatively 
high concentrations of DMPs, cell numbers decreased, as seen previously for the two 
cell lines used. DMPs at concentrations of 10mg/ml and 100mg/ml decreased cell 
numbers by 12% and 45%, respectively, which were statistically significant compared 
to the unstimulated control. The higher concentrations of ADM used (10
-9
M and 10
-
7
M) continued to produce statistically significant increases in cell numbers, 24% and 
51%, respectively. 
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4.7 Effect of Dexamethasone exposure on MDPC-23, OD-21 and 3T3 cell 
numbers 
The ability of Dexamethasone (DEX) to increase cell numbers in MDPC-23, OD-21 
and 3T3 cell lines was investigated. DEX has been shown to regulate expression of 
ADM and/or its receptors in several cell lines, including myocytes, smooth muscle 
cells, retinal pigment epithelial cells and osteoblasts (Nishimori et al, 1997; Hattori et 
al, 1999; Frayon et al, 2000; Udono-Fujimori et al, 2004 and Uzan et al, 2004), 
furthermore, the regulatory sequences of ADM and it‟s receptor CRLR contain a 
glucocorticoid receptor element (Nikitenko et al, 2003; Zudaire et al, 2005) indicating 
the potential for a component of dexamethasone‟s cellular effects to be mediated via 
regulation of an ADM autocrine signalling mechanism.  
The range of concentrations used in this study were similar to that previously 
described by Uzan et al (2004) when studying ADM‟s effect on ADM receptor 
expression in osteoblasts. The effect of DEX on cell number was assessed by 
determining viable cell number (see Section 2.2.2). Statistical significance was 
measured using one-way ANOVA test (P<0.05) (see Section 2.9). Cell viability data 
not presented as non-viable cell number was not affected by DEX exposure (non 
viable cells < 1% for all concentrations studied). 
The effect of DEX on MDPC-23 cell numbers is presented in Figure 4.6A. In 
this study, 10
-11
M DEX increased MDPC-23 cell numbers after 48 hrs of growth by 
9%. As the concentration increased to 10
-10
M, cell numbers peaked with an increase 
of 25%. 10
-9
M DEX also resulted in an increased cell number of 15%. 10
-8
M and 10
-
7
M DEX reduced cell numbers by 10% and 15%, respectively. The increase in cell 
number seen as a result of exposure to 10
-10
M DEX was the only one found to be 
statistically significant. 
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Figure 4.6B illustrates the effect of DEX on numbers of OD-21 cells following 
48 hours of exposure. OD-21 cells that were exposed to 10
-11
M DEX showed an 
increase in number of 8%, which was not found to be statistically significant. Both 10
-
10
M and 10
-9
M DEX increased cell numbers by statistically significant amounts, 20% 
and 21%, respectively. Cells exposed to 10
-8
M DEX had an increase in cell number of 
7%, whilst treatment with 10
-7
M DEX had no effect of the number of OD-21 cells 
when compared to that of the control. 
The effect of DEX exposure on 3T3 cell number is presented in Figure 4.6C. 
In this study none of the concentrations of DEX used altered cell number by a 
statistically significant amount. Minor reductions (~6%) in cell number were observed 
at both 10
-11
M and 10
-10
M DEX exposure and 10
-9
M, 10
-8
M and 10
-7
M DEX also 
slightly reduced cell numbers. 
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4.8 Effect of Dexamethasone exposure on ADM expression in MDPC-23 and OD-
21 cells 
As dexamethasone demonstrably affected dental cell numbers (Section 4.7) and as it 
has been previously reported to regulate ADM related transcripts in osteoblasts (Uzan 
et al, 2004), the effects of dexamethasone exposure on ADM gene expression was 
assessed in MDPC-23 and OD-21 cells. A preliminary study was also performed on 
RAMP-2 expression in MDPC-23 cells following exposure to dexamethasone. For 
these analyses, MDPC-23 and OD-21 cells were exposed to a range of concentrations 
of dexamethasone for 24 hours prior to cells being lysed and the RNA extracted for 
RT-PCR analysis.  
In MDPC-23 cells, DEX appeared to induce a dose-dependant decrease in 
ADM expression (Figures 4.7A & B), with each concentration of DEX statistically 
significantly reducing the densitometric value of the ADM amplified product. 
Exposure to 10
-10
M DEX reduced ADM expression by 22%, while both 10
-9
M and 10
-
8
M DEX reduced ADM expression by 33% compared to the unstimulated control. 
The largest reduction in ADM expression in MDPC-23 cells was following 24 hour 
exposure to 10
-7
M DEX, which reduced the densitometric value by 47%. This data 
suggests the possible negative feedback of ADM by DEX, particularly at higher 
concentrations.  
The preliminary study regarding the effect of DEX exposure on RAMP-2 
expression in MDPC-23 cells indicates that DEX may cause a dose-dependant 
increase in RAMP-2 levels following 24-hour exposure (Figures 4.7C & D). The 
densitometrically derived values increased with the increasing concentrations of DEX 
used. DEX concentrations of 10
-10
M, 10
-9
M, 10
-8
M and 10
-7
M increased RAMP-2 
levels by 22%, 38%, 40% and 50%, respectively. 
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 ADM transcript levels in OD-21 cells were reduced following 24 hour 
exposure to DEX (Figures 4.7E & F). 10
-10
M DEX reduced ADM levels by 10% 
densitometrically, although this was not a statistically significant reduction. 10
-9
M, 
10
-8
M and 10
-7
M DEX did, however, reduce ADM levels by statistically significant 
amounts, reducing the densitometric-derived values by 43%, 38% and 26%, 
respectively. Similar to the effect seen in MDPC-21 cells, this data suggest that DEX 
is acting to suppress ADM expression in a negative feedback system. 
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5. Results Chapter 3 
 
5.1 Effect of ADM on mineral deposition in dental cells in vitro 
Previous studies have demonstrated that in vitro, ADM can stimulate osteoblast 
proliferation (Cornish et al, 1997; Cornish et al, 2002) whilst in vivo, ADM 
supplementation can promote mineralised bone area, bone volume and strength 
(Cornish et al, 1997; Cornish et al, 2001). As the previous results (Chapters 3 and 4) 
indicated significant levels of ADM in odontoblast cells during tooth development 
and that ADM can stimulate increases of dental cell numbers in vitro, work was 
undertaken to determine whether ADM can also promote mineral deposition, 
indicative of mineralisation, from developmentally relevant dental tissue cell lines.  
Subsequently, ADM was used as a substitute for the known mineralised tissue 
promoting agent dexamethasone, as well as in conjunction with it, to determine 
whether ADM can induce mineral deposition that is indicative of mineralisation in a 
similar manner to dexamethasone, or whether it can enhance mineral deposition in 
combination with it. For these analyses cells were exposed to two control media:  
i) medium containing 50mg/ml Ascorbic Acid (A.A) and 10mM β-
glycerophosphate (β-G) and, 
ii) standard mineralising medium containing 50mg/ml A.A, 10mM β-G and 
10
-8
M DEX.  
A range of concentrations of ADM (10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and 10
-7
M, as in 
Chapter 4) were used in conjunction with both these control media. As in Chapter 4, 
the odontoblast-like MDPC-23 cells and pulp-like OD-21 cells were used for analysis 
together with the 3T3 skin fibroblast cell line, which was used as a negative control.  
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5.2 Effect of ADM exposure on the MDPC-23 cell mineral deposition 
The mineralising effect of ADM in vitro was determined using von Kossa staining 
(Section 2.4). Briefly, cells were exposed to a range of conditions, as stated in Section 
5.1, for 3, 7, 11, 14 and 21 days, following which, the medium was removed and the 
cells fixed. To visualise mineral deposition, cultures were exposed to the von Kossa 
stain and, following digital image capture, the area of mineral deposition was 
determined using ImageJ software analysis (see Sections 2.2.5 and 2.4). Statistical 
significance was measured using one-way ANOVA test (P<0.05) (see Section 2.9). 
 Following 3 days of exposure under the conditions shown (Figure 5.1), only 
the MDPC-23 culture supplemented with ascorbic acid (A.A), β-Glycerophosphate 
(β-G) and 10-7M ADM exhibited detectable mineral deposition. The area of mineral 
deposition detected was 1.6% of the culture area. However, there was no statistically 
significant difference in mineral deposition with this treatment, or any other, after 3 
days of culture compared to the control, therefore any mineral deposition seen is more 
likely to be mere artefact (Figure 5.1). 
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Following 7 days exposure of MDPC-23 cultures, greater areas of mineral deposition 
were detected (Figure 5.2). Notably, exposure to the mineralisation control medium 
resulted in a mineral deposition area of 5.7% being detected (Figure 5.2A). Similar 
results using the conditions of A.A, β-G and 10-13M ADM; A.A, β-G and 10-9M 
ADM; A.A, β-G and 10-7M ADM were also obtained. The conditions of A.A, β-G and 
10
-15M ADM and A.A, β-G and 10-11M resulted in the detection of a mineral 
deposition area of 3.5%, A.A and β-G supplementation alone resulted in production of 
a relatively low detectable area of mineral deposition, 1.5%. ADM supplementation in 
addition to the mineralised control medium appeared to produce an increase in 
detectable mineral deposition in MDPC-23 cells when compared to the mineralised 
control medium alone (Figure 5.2C). Including 10
-13
M, 10
-11
M, 10
-9
M ADM or 10
-
7
M ADM within the mineralised control medium increased the area of mineral 
deposition observed to 10.2%, 9.3%, 8.1% and 9.2%, respectively. Seven day 
exposure of MDPC-23 cells to 10
-13
M, 10
-11
M and 10
-7
M ADM in addition to the 
mineralisation control medium produced a statistically significant difference when 
compared to A.A and β-G medium exposure alone. 
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The effects on in vitro mineral deposition following 11 days exposure of the 
differently supplemented media are presented in Figure 5.3. Exposure to all 
conditions resulted in a statistically significant increase in the mineral deposition area 
detected when compared to the control A.A and β-G supplemented medium alone. 
When ADM was used in addition to the A.A and β-G medium, the area of mineral 
deposition detected for the range of ADM concentrations used was between 6.9% and 
7.5%. The area of mineral deposition detected following treatment with the standard 
mineralisation control medium was marginally higher at 8.2%. Supplementation with 
ADM in addition to the standard mineralisation control medium resulted in a 
statistically significant increase in detectable mineral deposition. Data presented in 
Figure 5.3C indicate that there is minimal variation in the area of mineral deposition 
detected between each concentration of ADM used which ranged from 11.5% for 10
-
15
M ADM to 12.2% for the 10
-9
M ADM exposures.  
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Following 14 days of culture, all test conditions analysed produced a 
statistically significant increase in the area of mineral deposition detected compared to 
A.A and β-G exposure alone (Figure 5.4). Medium containing A.A and β-G alone 
resulted in a minimal detectable area of mineral deposition, 3.5%. The addition of 10
-
15
M, 10
-13
M, 10
-11
M, 10
-9
M and 10
-7
M ADM increased the area of mineral deposition 
to 10.9%, 9.6%, 10.5%, 10.8% and 10.7%, respectively. Notably, none of these 
detectable areas were statistically significantly different from the mineralisation 
control medium samples. When the range of concentrations of ADM were 
supplemented into the mineralisation control medium, no statistically significant 
difference, compared to the mineralisation control medium alone, was observed 
although the area of mineral deposition detected was incrementally larger with each 
concentration of ADM used. Notably, the 10
-15
M ADM concentration generated an 
area of mineral deposition of 14.2% and the higher concentration of ADM (10
-7
M) 
resulted in a detectable area of mineral deposition of 15.7%.  
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Twenty-one days of exposure of MDPC-23 cultures to ADM resulted in greater areas 
of mineral deposition being observed (Figure 5.5). The data presented indicate that 
when treated with A.A and β-G alone, MDPC-23 cells produced an area of mineral 
deposition of 4.9%. When the cells were exposed to A.A, β-G and a range of 
concentrations of ADM there was a statistically significant increase in the area of 
mineral deposition compared to A.A and β-G alone. 10-15M and 10-9M ADM both 
produced a detectable area of mineral deposition of 22.2%, 10
-13
M ADM yielded an 
area of 22.4% and 10
-11
M ADM promoted an area of mineral deposition of 21.3%. 
The largest increase in mineral deposition resulted from exposure to 10
-7
M ADM (+ 
A.A, β-G), which produced an area of 23.6%. This value, however, was marginally 
less than the mineralisation control medium, which produced an area of detectable 
mineral deposition of 25.2%. The effect of treatment with the mineralisation control 
and a range of concentrations of ADM were also analysed (Figure 5.5C & D). Data 
demonstrated (Figure 5.5C) that there were minimal differences between samples 
treated with the mineralisation control medium alone and those treated with the 
mineralisation control medium supplemented with the range of concentrations of 
ADM. Inclusion of 10
-15
M, 10
-13
M and10
-7
M ADM gave detectable areas of mineral 
deposition of 24.1%, 24.4% and 24.7%, respectively, whereas inclusion of 10
-13
M 
(25.3%) and 10
-9
M (26.5%) ADM produced marginal increases in the area of mineral 
deposition compared to the mineralisation control medium. These values represented 
statistically significant increases in area compared to the A.A and β-G medium used, 
but not to the standard mineralisation control medium (A.A, β-G & 10-8M Dex). 
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To provide a summary of the results presented thus far (Figures 5.1 – 5.5), a 
graph is presented in Figure 5.6 demonstrating the changes in MDPC-23 cell mineral 
deposition over the period of 3, 7, 11, 14 and 21 days, following exposure to each pre-
described treatment. 
When looking at the results in full it appears that when MDPC-23 cells were 
exposed to A.A, β-G and differing concentrations of ADM (10-15M, 10-13M, 10-11M, 
10
-9
M and10
-7
M), there is a uniform increase in mineral deposition from 7 days 
exposure through to 21 days exposure, when compared to A.A and β-G medium alone 
(Figure 5.6A). The exceptions to this are following exposure to 10
-15
M and10
-7
M 
ADM after 7 days, which produced an increase in mineral deposition compared to 
A.A and β-G exposure that did not prove to be statistically significant (Figure 5.6A). 
When MDPC-23 ECM secretion with these treatments [A.A, β-G and 
differing concentrations of ADM (10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and10
-7
M)] are 
compared to MDPC-23 cells exposed to the standard mineralising medium (A.A, β-G 
& 10
-8
M Dex), it is clear that at 7 and 11 days there is generally very little difference 
in levels of mineral deposition, however, following 14 and 21 days exposure the 
standard mineralising medium increases mineral deposition to a higher level than all 
other treatments (Figure 5.6A). This suggests that ADM is capable of inducing a 
mineral deposition, indicative of mineralisation, at a similar rate to dexamethasone in 
MDPC-23 cells up to 11 days exposure, after which the rate of deposition slows 
compared to the standard mineralising medium. 
MDPC-23 cells exposed to the standard mineralising medium plus a range of 
concentrations of ADM (10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and10
-7
M) appeared to 
produce a higher amount of mineral deposition compared to the standard mineralising 
medium following 7, 11 and 14 days exposure. However, this increase in mineral 
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deposition was only found to be statistically significant at 11 days exposure (Figure 
5.6B). Following 21 days exposure, this increased rate of mineral deposition appears 
to be negated, with the standard mineralising medium marginally increasing the 
amount of mineral deposition compared to the standard mineralising medium plus a 
range of concentrations of ADM (10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and10
-7
M). This 
suggests that when used in coordination with Dex, ADM at all concentrations is 
capable of producing higher levels of mineral deposition compared to Dex alone 
during the early stages of mineralisation, while this effect is lost later in the 
mineralisation process. In Section 4.6 Dex demonstrated an ability to reduce levels of 
ADM expression, particularly at 10
-8
M. The loss of increased mineral deposition 
following exposure to ADM over the longer time points could relate to this. It would 
be interesting to look at time points over 21 days to determine whether this trend 
continues. It may be that any increases in mineral deposition following exposure to 
ADM were due to increased cell numbers, as described in Section 4.2, however, as 
the increased mineral deposition is roughly uniform for each concentration studied, 
while cell number increases were found to be biphasic, makes this unlikely. 
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5.3 Effect of ADM exposure on OD-21 cell mineral deposition 
The mineralising effect of ADM on the OD-21 pulp-like cell line cultured in vitro was 
determined using the von Kossa staining approach previously described, with cultures 
exposed to a range of conditions for 3, 7, 11, 14 and 21 days, following which, the 
medium was removed and the cells fixed. Analysis was performed as described 
previously in Section 5.2. 
 
Figure 5.7 provides data demonstrating the effects of the supplementation of 
the control medium (A.A and B-G) and standard mineralising medium (A.A, B-G and 
DEX) with ADM on detection of mineral deposition in OD-21 cells following 3 days 
culture. No significant mineral deposition was detected after 3 days exposure to each 
of the conditions.  
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The effect of ADM on mineral deposition in OD-21 cells after 7 days of 
culture was subsequently analysed (Figure 5.8). A.A and β-G treatment alone 
produced a minimal detectable area of mineral deposition (0.7%), as did medium 
containing A.A, β-G and 10-9M ADM. Increases were evident following treatment 
with the mineralisation control medium, and with A.A, β-G and 10-11M ADM 
medium. Other cell exposures to these supplements also generated minimally 
increased detectable areas of mineral deposition including A.A, β-G and 10-13M ADM 
(1.7%), A.A, β-G and 10-15M (2%) and A.A, β-G and 10-7M (2%). Cells exposed to 
the standard mineralisation control medium supplemented with a range of 
concentrations of ADM also generated increased levels of mineral deposition. The 
addition of 10
-15
M and 10
-13
M ADM produced a 2.3% detectable area of mineral 
deposition, 10
-11
M gave 1.7% and the additions of 10
-9
M and 10
-7
M ADM both 
resulted in detectable areas of mineral deposition of 2.7% for these treatments. None 
of these results however were statistically significantly different compared to the 
control medium. 
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Following 11 days treatment (Figure 5.9), A.A and β-G exposure resulted in a 
0.47% detectable area of mineral deposition in OD-21 cell cultures. The data 
presented (Figure 5.8A) demonstrate that treatment with A.A, β-G and each 
concentration of ADM elicited a statistically significant increase in the area of mineral 
deposition compared to A.A and β-G containing media alone. The inclusion of ADM 
at all concentrations within this medium resulted in >4% increases in mineral 
deposition. Each of these exposures resulted in more mineral deposition than cells 
treated with the standard mineralisation control medium alone, which gave a 
detectable area of mineral deposition of 3.7%. However, none of these differences 
were statistically significant. Cells exposed to the mineralising medium control 
containing a range of concentrations of ADM also produced more mineral deposition 
than the standard mineralisation control medium alone. OD-21 cells exposed to the 
mineralisation control medium containing 10
-15
M ADM, produced the greatest levels 
of mineral deposition after 11 days of exposure, exhibiting an area of 6.27%. The 
addition of 10
-13
M ADM to the mineralisation medium control gave a detectable area 
of mineral deposition of 5.8%. Inclusion of 10
-11
M, 10
-9
M and 10
-7
M ADM in the 
mineralisation control medium resulted in detectable areas of mineral deposition of 
4.7 - 4.9% for the OD-21 cultures. Each treatment with ADM and the mineralisation 
control media gave a statistically significant difference in area of mineral deposition 
compared to A.A and β-G alone, however, there were no statistically significant 
differences when these values were compared with the standard mineralisation control 
medium (A.A, B-G & 10
-8
M Dex) alone. 
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Figure 5.10A provides data demonstrating the effect of media containing A.A, 
β-G plus the range of concentrations of ADM on OD-21 cell mineral deposition 
following 14 days culture, compared to A.A and β-G medium use alone along with 
the standard mineralisation control medium. A.A and β-G alone induced a detectable 
area of mineral deposition of 3.9%, whilst exposure to A.A, β-G plus the range of 
ADM concentrations produced statistically significant increases in the areas of 
mineral deposition detected. 10
-13
M ADM elicited the greatest increase in conjunction 
with A.A and β-G, stimulating a detectable area of mineral deposition of 6.37%. 
Inclusion of 10
-15
M, 10
-11
M, 10
-9
M and 10
-7
M ADM promoted detectable areas of 
mineral deposition of 5.7%, 6.3%, 5.2% and 6.3%, respectively. These percentage 
areas were lower than the cells treated with the mineralisation control medium, which 
stimulated an area of mineral deposition of 7.1%. This value was statistically 
significant when compared to A.A and β-G alone and A.A, β-G and 10-9M ADM. 
When ADM was used in conjunction with the standard mineralisation control medium 
(Figure 5.10C), each concentration stimulated a greater area of mineral deposition 
compared to the mineralisation control medium except 10
-9
M ADM, which resulted in 
an area of 7.0% of detectable mineral deposition. Cells exposed to the standard 
mineralisation control medium supplemented with 10
-15
M ADM produced the greatest 
detectable mineral deposition with an area of 8.6%. Inclusion of 10
-13
M, 10
-11
M and 
10
-7
M ADM induced a detectable area of mineral deposition of ~7.5% in all cases. 
Each of these areas of mineral deposition was shown to represent a statistically 
significant increase compared to A.A and β-G alone. 
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Data indicating the effect of ADM on the OD-21 mineral deposition after 21 
days culture are provided (Figure 5.11). Results presented (Figure 5.11A) 
demonstrate the effect of A.A, β-G and the range of concentrations of ADM on the 
OD-21 cell-line mineral deposition compared to A.A and β-G containing medium 
alone together with the standard mineralisation control medium (A.A., B-G & 10
-8 
M 
Dex). A.A and β-G medium exposure alone resulted in an area of mineral deposition 
of 4.9% detected whilst the standard mineralisation medium control induced an area 
of mineral deposition of 15.2%. The cells exposed to the A.A and β-G medium 
supplemented with the range of concentrations of ADM all gave results that were 
statistically significantly lower than the standard mineralisation control medium, 
whilst being significantly higher than the control A.A and β-G medium alone. The 
addition of 10
-15
M, 10
-13
M, 10
-11
M, 10
-9 M ADM to A.A and β-G resulted in 
promotion of mineral deposition in the ranges of 7.9 - 8.9%. The concentration of 
ADM that produced the greatest detectable mineral deposition in conjunction with 
A.A and β-G medium was 10-7M, which stimulated a detectable area of mineral 
deposition of 10.2%. Cells exposed to ADM in conjunction with the standard 
mineralised control medium also gave a statistically significant increase in mineral 
deposition compared to A.A and β-G alone (Figure 5.11C). Minimal variation in 
detectable mineral deposition induction was evident between the range of 
concentrations of ADM studied, the smallest area of detectable mineral deposition 
was 13.5% for 10
-13
M ADM with the highest area of mineral deposition detected 
being 14.1% following treatment with 10
-7
M ADM. 10
-15
M, 10
-11
M and 10
-9
M each 
produced detectable areas of mineral deposition of 13.8%, 13.7% and 13.9%, 
respectively. Each ADM treatment produced an area of mineral deposition that was 
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smaller than that observed with the standard mineralisation control medium alone, 
however, the differences were not statistically significant.  
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A graph is presented in Figure 5.12 demonstrating the changes in OD-21 cell 
mineral deposition over the period of 3, 7, 11, 14 and 21 days, following exposure to 
each pre-described treatment, to provide a summary of the OD-21 cell results 
presented thus far (Figures 5.7 – 5.11). 
OD-21 cells exposed to A.A, β-G and a range of concentrations of ADM (10-
15
M, 10
-13
M, 10
-11
M, 10
-9
M and10
-7
M) generally appeared to produce statistically 
significant increased mineral deposition compared to A.A and β-G exposure alone, 
from day 11 onwards (Figure 5.12A), suggesting that ADM is capable of inducing 
mineral deposition, indicative of mineralisation, in OD-21 cells. This increase is later 
than the increases seen in MDPC-23 cells, which increased mineral deposition from 
day 7 onwards (Figure 5.6A).  These treatments [A.A, β-G and a range of 
concentrations of ADM (10
-15
M, 10
-13
M, 10
-11
M, 10
-9
M and10
-7
M)] generally 
increased mineral deposition in OD-21 cells to similar amounts as the standard 
mineralising medium (A.A, β-G & 10-8M Dex) up to 14 days exposure, whilst at 21 
days exposure there was a significantly larger amount of mineral deposition following 
treatment with the standard mineralising medium compared to the other treatments 
[A.A, β-G and a range of concentrations of ADM (10-15M, 10-13M, 10-11M, 10-9M 
and10
-7
M)] (Figure 5.12A). This is similar to the pattern of mineralisation observed 
in MDPC-23 cells (Figure 5.6A) suggesting that ADM is capable of inducing a 
mineral deposition, indicative of mineralisation, at a similar rate to dexamethasone in 
MDPC-23 cells during the early stages of mineralisation. 
In a similar pattern to that observed in MDPC-23 cells, OD-21 cells exposed 
to the standard mineralising medium plus a range of concentrations of ADM (10
-15
M, 
10
-13
M, 10
-11
M, 10
-9
M and10
-7
M) appeared to produce higher amounts of mineral 
deposition compared to the standard mineralising medium following 7 and 11 days 
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exposure. Although statistically significant increases were limited to 10
-15
M and 10
-
13
M ADM after 11 days exposure (Figure 5.12B). Following 14 days exposure, 
treatments supplemented with ADM marginally increased levels of mineral 
deposition, while at 21 days the standard mineralising medium marginally increased 
mineral deposition compared to all other treatments (Figure 5.21B). Once again, this 
suggests that when used in coordination with Dex, ADM is capable of producing 
marginally higher levels of mineral deposition compared to Dex alone during the 
early stages of mineralisation, an effect that is lost later in the mineralisation process. 
This could relate to the potential negative feedback effect Dex has on ADM, as 
discussed in Section 4.6 and the results surrounding Figure 5.12. 
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5.4 Analysis of mineral deposition in 3T3 fibroblast cultures exposed to ADM  
The potential effect of ADM on mineral deposition in 3T3 cultures in vitro was 
determined with von Kossa staining as previously described. Cultures were exposed 
to a range of conditions for 3, 7, 11, 14 and 21 days, following which, the medium 
was removed and the cells fixed. Analysis was performed as described previously in 
Section 5.2. 
 
The data for detectable 3T3 culture mineral deposition in response to exposure 
to the range of treatments described for 3, 7, 11, 14 and 21 days are shown in Figures 
5.13 and 5.14. The representative images presented in Figure 5.13 demonstrate that 
there was very little discernable mineral deposition detected in 3T3 cells following 
exposure to any treatment. As these cells are derived from a non-mineralising tissue, 
i.e. skin, it is perhaps not surprising that only minimal amounts of mineral deposition 
were detected, as compared to the dental cell line cultures. 
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6.0 Results Chapter 4 
 
6.1 Systemic administration of ADM to adult male Swiss mice 
Previous results indicate that ADM i) is present in the cells responsible for tooth 
mineralisation (Chapter 3), ii) increases developmentally derived dental cell number 
in vitro (Chapter 4) and, iii) can promote mineralisation in vitro in these dental cell 
lines (Chapter 5). In vivo, ADM administration has been demonstrated to increase 
murine tibia bone length and to increase bone strength (Cornish et al, 2001). The 
following work was therefore performed with the aim of determining whether ADM 
affects dental and cranio-facial mineralised tissue biology in vivo. 
To study the in vivo effects of ADM on dental and cranio-facial tissues, mice 
were kindly donated by Professor Cornish from the Bone Research Group at the 
University of Auckland, New Zealand. Animals had been systemically exposed to 
ADM with 20 injections of either ADM or saline (sham-treated, controls) over a 4-
week experimental period (Cornish et al, 1997). Data obtained from these animals had 
previously demonstrated that ADM increase tibia bone length and strength (Cornish et 
al, 2001). To determine whether ADM affected the hard tissue volume of the teeth 
and study any changes in cranio-facial bone growth, tooth hard tissue volume was 
determined using micro-computed Tomography (µCT) analysis (Section 2.6) and key 
mandibular measurements were determined using digital image analysis (Section 
2.7), respectively. Briefly, 600 X-ray images were generated from sample murine 
skulls (see Figure 6.1A - E for example images) at 0.6º intervals, to provide full 360º 
coverage of the region of interest. Images were then converted into 2D bitmap images 
using CT Reconstruction (CTRecon) computer software (Skyscan, Belgium) (Figure 
6.1F - J), provided with the µCT equipment (Skyscan, Belgium). From the 2D bitmap 
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images, the teeth hard tissue volume was determined by segmented isolation of the 
tooth hard tissue area on each cross sectional image (Figures 6.2A - D), 
approximately 120 per molar and 215 per incisor. Subsequently, CT analysis (CTan) 
software (Skyscan, Belgium) was used to calculate the overall tooth volume. 
Mandible hard tissue volume was measured in a similar manner to tooth hard tissue 
volume described above, with mandible hard tissue outline isolated in each cross 
sectional image (Figures 6.2E & F), approximately 750 per mandible, and CTan 
software (Skyscan, Belgium) used to calculate overall mandibular volume. It is also 
possible to create 3D reconstructions of the mandible using CTRecon (Skyscan, 
Belgium) (Figure 6.1K – O). This is useful for determining morphological changes 
that may occur as a result of treatment, but lacks accuracy when precise 
measurements are required. 
Measurements of cranio-facial bone length were also determined from 
macroscopically derived digital images using ImageJ software (downloaded from 
http://rsbweb.nih.gov/ij) analysis for key mandibular parameters, as proposed by 
Atchley et al, (1984), in control and test specimens (see Sections 2.5 and 2.7 for 
detailed procedure). The approach used here was comparable to that applied by 
Cornish et al, (1997; 2001) which demonstrated ADM administration enhanced 
murine tibia bone growth parameters. 
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6.2 Effect of systemic ADM administration on murine molar and lower incisor 
tooth hard tissue volume 
The effect of ADM on tooth hard tissue volume was assessed by determining the 
volumes of hard tissue in the upper and lower molars and lower incisors of treated and 
untreated mice, n = 8. Mandible volume was also assessed to study the effect of ADM 
on cranio-facial bone volume, n = 3. 
 
6.2.1 Effect of systemic ADM administration on murine molar hard tissue 
volume 
Mice exposed to ADM exhibited marginally more hard tissue in their 1
st
 molars than 
those of mice injected with saline solution (Figure 6.3A). The average volume of the 
ADM treated 1
st
 molars was 13.6µm
3
 whereas the average of the control 1
st
 molars 
was 12.55µm
3
. This difference, however, was not found to be statistically significant 
(P<0.05).  
Analysis of the 2
nd
 molars of ADM treated and control mice indicated there 
was little difference in hard tissue volumes of these teeth. The sham treated and ADM 
exposed animals exhibited no significant (P<0.05) difference in their hard tissue 
volume with averages of 6.92µm
3 
and 6.9µm
3,
 respectively (Figure 6.3B). There was 
a negligible difference in the hard tissue volume of 3
rd
 molars in ADM treated mice 
compared with those injected with saline solution (Figure 6.3C). ADM exposed mice 
had an average 3
rd
 molar hard tissue volume of 2.39µm
3
 with control mice having a 
comparable average volume of 2.38µm
3
. 
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6.2.2 Effect of systemic administration of ADM on murine lower incisor hard 
tissue volume 
No significant differences were observed between the incisor hard tissue volumes of 
mice that had been exposed to saline solution compared to those exposed to ADM 
(Figure 6.4A). ADM exposed mice had a slightly lower mean incisor hard tissue 
volume of 46.2µm
3
, whilst the mean lower incisor hard tissue volume of the saline 
treated mice was 46.3µm
3
. This difference, however, was not found to be statistically 
significant (P<0.05). 
 
6.2.3 Effect of systemic administration of ADM on total dentition hard tissue 
volume in mice 
The mean hard tissue volume of all the teeth in the mice exposed to ADM was 
slightly higher than in the mice exposed to saline solution (Figure 6.4B). The ADM 
treated dentition hard tissue volume mean was 7.63µm
3
 compared to 7.29µm
3
 in the 
sham treated samples. This difference was also not found to be statistically significant 
(P<0.05). 
 
6.3 Effect of systemic administration of ADM on murine mandible hard tissue 
volume 
The mean mandible hard tissue volume of mice exposed to ADM was lower 
than that of sham control mice (Figure 6.4C). ADM treated mandibles exhibited a 
hard tissue volume of 219.27µm
3
 compared to sham treated mandibles measuring 
221.1µm
3
. This difference was not found to be significant (P<0.05). 
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6.4 Effect of systemic administration of ADM on key murine mandibular 
measurements 
The effect of systemic administration of ADM on murine mandible growth was 
assessed as previously described (see Sections 2.5, 2.6 and 6.1). Examples of digital 
images used for analysis are shown in Figures 6.5A and 6.6A. 
 
6.4.1 Effect of systemic administration of ADM on mandibular corpus 
measurements 
For measurement 1 (denoted by arrow 1 in Figure 6.5A) ADM treated mice did not 
show statistically significantly differences (P<0.05) in length compared to those of the 
sham control mice, averaging 1.25cm and 1.26cm, respectively (Figure 6.5C).  
The length of measurement 2 (denoted by arrow 2 in Figure 6.5A) was 
marginally lower following systemic treatment with ADM compared to the control 
samples (Figure 6.5D). This measurement in ADM exposed mice averaged 0.96cm 
compared to the control mice averaging 0.97cm. The difference was also not found to 
be statistically significant (P<0.05). 
 
6.4.2 Effect of systemic administration of ADM on mandibular ramus and 
alveolar process measurements 
Mice that were systemically treated with ADM had an average alveolar process length 
(denoted by arrow 3 in Figure 6.5A) of 325mm, which was not statistically 
significantly different (P<0.05) from that found in sham treated samples which had an 
average alveolar process length of 323mm (Figure 6.5E).  
The average length of measurement 4 (as denoted by arrow 4 in Figure 6.5A) 
from the samples systemically treated with ADM was marginally higher than the 
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average length of those treated with a saline solution, averaging 0.9 and 0.88cm, 
respectively (Figure 6.5F). This difference was also not statistically significant 
(P<0.05). 
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6.4.3 Effect of systemic administration of ADM on mandibular ramus and 
condylar measurements 
Mice that had been systemically treated with ADM for four weeks had an mean ramus 
length (as denoted by arrow 1 in Figure 6.6A) of 0.58cm. This value was not 
statistically significantly different (P<0.05) from the mean length determined for the 
sham mice (Figure 6.6C).  
The differences in measurement 2 (as denoted by arrow 2 in Figure 6.6A) 
between mice systemically treated with ADM and those treated with a saline solution, 
was found to be negligible. Values for ADM treated mice were not statistically 
significantly different (P<0.05) from those for control mice with this measurement, 
averaging 270mm compared to 260mm in sham treated animals (Figure 6.6D).  
 The average length of measurement 3 (as denoted by arrow 3 in Figure 6.6A) 
for mice systemically treated with ADM was statistically significantly higher than for 
those treated with saline solution (P<0.05). Values for ADM treated mice measured 
432.5mm compared to 400mm measured in saline treated samples (Figure 6.6E). 
 Mice that were systemically exposed to ADM had a marginally higher average 
for measurement 4 (as denoted by arrow 4 in Figure 6.6A) than sham mice (Figure 
6.6F). The mean length for this measurement in ADM exposed animals was 580mm 
compared to 550mm in the sham control group. This was not a statistically significant 
difference (P<0.05). 
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7. Discussion 
 
Recently, preliminary data has indicated the presence of ADM in the odontoblasts of a 
mouse developing tooth bud at E13 (Monuenga et al, 1997) and an 
immunohistochemical study has demonstrated similar temporo-spatial patterns of 
expression between ADM and TGF-β1, a growth factor known to play a key role in 
tooth development, in the heart, lungs, kidney, skeletal forming tissues and neural 
system during mouse embryogenesis (Montuenga et al, 1998). Furthermore, in 
osteoblasts, cells which share many structural and functional similarities to 
odontoblasts, data demonstrates that ADM increases proliferation in vitro (Cornish et 
al, 1997; Cornish et al, 2001) and can promote mineralised bone volume and strength 
in vivo (Cornish et al, 1997; Cornish et al, 2001). This has lead to the hypothesis that 
ADM may play a key role in tooth development. 
 In this study, immunohistochemical analysis created novel data highlighting 
the expression of ADM in the developing tooth bud of rats over three developmental 
ages (E16, E18 and E20), during which key stages of tooth development occur. 
Particularly interesting was the expression of ADM in the cells responsible for 
signalling odontoblast differentiation and subsequently in secretory odontoblasts. This 
novel data goes some way to explaining the presence of ADM in dentine matrix 
proteins as it is expressed by secretory odontoblasts and subsequently it is likely to be 
deposited into the dentine matrix during dentinogenesis. Furthermore, this study 
demonstrated that TGF-β1 was expressed in the odontoblasts of developing rat teeth 
at the E20 embryonic stage of development, the same temporo-spatial expression as 
ADM.  
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In vitro analysis demonstrated the expression of calcitonin receptor-like 
receptor (CRLR) and receptor activity modifying protein-2 (RAMP-2), which as a 
dimer forms an ADM receptor, in the developmentally derived dental cell lines, 
MDPC-23 and OD-21. In these cells ADM stimulated a biphasic response in dental 
cell growth with peak stimulation at 10
-11
M, with a similar biphasic response in dental 
cell growth observed following exposure to DMPs and dexamethasone. Furthermore, 
ADM demonstrated an ability to promote mineral deposition that is indicative of 
mineralisation in dental cells at levels comparable to that of the known mineralising 
agent dexamethasone. However, analysis of tooth hard tissue volume and key 
mandibular measurements in Swiss mice systemically treated with ADM using 
techniques including micro-Computer Tomography did not identify significant 
differences in craniofacial mineralised tissue structures compared to sham treated 
controls. 
 
Histological analysis of ADM and TGF-β1 in developing rat dentition 
Initially, a histological study was undertaken to determine the key stages of tooth 
development present in the Wistar rats used in the study. Given the difficulty 
distinguishing between these stages, which are present as a continuum, due to the 
often overlapping histological features, all developmental stages stated in this study 
were used as a guide.   
The results from the histological observations and the measurement studies 
undertaken (Section 3.2) indicate that the Wistar rats developing 1
st
 molars used in 
this study were approximately at the bud stage at age E16 (Figure 3.1A & B), cap 
stage by age E18 (Figures 3.2D – I) and subsequently demonstrated histological 
features of both cap and bell stages by age E20 (Figure 3.3D – F). In contrast the 
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developing incisors of the Wistar rats used in this study were at the cap stage at age 
E16 (Figure 3.1C), appeared to be in transition from cap to bell stages at E18 (Figure 
3.2A – C) and almost entirely at the bell stage by E20 (Figure 3.3A – C). These data 
correspond with histological evidence previously published (Thesleff et al, 2003; 
Tucker and Sharpe, 2004) and suggest that key stages of tooth development, i.e. pre- 
and post-odontoblast differentiation, have been successfully identified for the 
immunohistochemical studies undertaken to more specifically describe the temporo-
spatial expression of ADM during rat dentition development. 
 The positive control staining observed for ADM in rat heart tissue 
demonstrated that the ADM antibody utilised in this study was binding the correct 
epitope and therefore would provide reliable data in the rodent dentition analysis 
(Figure 3.4A) (Jougasaki et al, 1995). The reduction in positive staining observed 
following the pre-incubation of an ADM peptide with the ADM antibody (ADM 
blocking control) and a TGF-β1 peptide with the TGF-β1 antibody (TGF-β1 blocking 
control) (Figure 3.4B, 3.6C 3.7B & 3.7D) also supported that fact that the positive 
staining observed was due to specific antigen binding. The absence of apparent 
immunoreactivity following incubation with the pre-bleed rabbit serum and in the 
absence of antibodies (negative sections) further supports the validity of the data 
obtained, as no significant background staining was observed. 
Analysis of the developing rat dentition indicated immunoreactivity for ADM 
was initially isolated to the epithelial cells of the developing incisor in Wistar rats, 
which is perhaps unsurprising given that ADM expression has been demonstrated in a 
number of epithelial tissues, including bronchioles, skin and oral epithelium (Huttner 
and Bevins, 1999; Kapas et al, 2001; Kapas et al, 2001). ADM‟s prominent 
expression in epithelial cells is thought to be related to ADM‟s inflammatory 
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regulation properties (Elsasser and Kahl, 2002). Notably, immunoreactivity was 
observed in the internal dental epithelial cells during cap and early bell stage (ages 
E16 & E18) (Figures 3.5 & 3.6) and the cells of the external dental epithelium and 
oral epithelium were also positively stained for the presence of ADM during the cap 
stage of development (E16) (Figure 3.5). At the developmentally later bell stage of 
development (E20) the cells responsible for hard tissue formation (secretory 
odontoblasts and ameloblasts) were clearly visible and both exhibited positive 
staining for ADM (Figure 3.7). Notably these cells were also immunopositive to the 
TGF-β1 antibody (Figure 3.7C), data which is consistent with that previously 
published (Vaahtokari et al, 1991; Begue-Kirn et al, 1994). This result demonstrates 
the presence of TGF-β1 in the same developmental regions of the tooth as ADM at 
this key developmental stage when dentine and enamel is deposited. Furthermore, in 
vitro studies have demonstrated that TGF-β1 and ADM can act to suppress each 
others expression (Huang et al, 2006), while in vivo studies in TGF-β1 null mutant 
mice demonstrated a reduction in embryonic ADM expression in a number of 
developing tissues, including heart, lung, liver, kidney and chondrocytes (Bodegas et 
al, 2004). This previously published data indicates the existence of an inter-
relationship between the two molecules and the possibility that there may be 
functional redundancy in the roles that these growth factors play. The novel data 
presented in this study showing the co-expression of ADM and TGF-β1 in secretory 
odontoblasts explains their subsequent presence in dentine matrix proteins (Tomson et 
al, 2007; Graham, 2007). 
The potential to initiate development of the tooth bud resides in the cells of the 
first arch epithelium prior to E12-13 in mice (Koller and Fisher, 1980; Mina and 
Koller, 1987; Lumsden, 1988), after which point the potential is assumed by the 
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ectomesenchyme (Koller and Fisher, 1980; Mina and Koller, 1987; Lumsden, 1988). 
ADM expression appears limited to epithelial cells post-E16 in Wistar rats (Section 
3.3). As potential to initiate tooth development would likely reside in the 
mesenchymal cells at this time point (Koller and Fisher, 1980; Mina and Koller, 1987; 
Lumsden, 1988) this suggests that ADM may not be involved in the initiation of tooth 
development. However, a further immunohistochemical study into the expression of 
ADM in the developing rat jaw from E10 – E15 would be required to determine 
whether ADM likely plays a role in the initiation of tooth development. While an 
immunohistochemical study of both ADM and TGF-β1 in developing teeth over a 
greater range of embryonic ages would better characterise ADM‟s potential inter-
relationship with TGF-β1. 
Initiation of odontoblast differentiation is controlled by the inner dental 
epithelium and occurs in a well-defined temporo-spatial pattern (Lesot et al, 1994; 
Ruch et al, 1995; Smith and Lesot, 2001). ADM is demonstrably present in these cells 
during the approximate time of odontoblast differentiation (transition from cap to bell 
stage) (Figure 3.6) and in mature odontoblasts secreting dentine (Figure 3.7). This 
study has to some degree provided further supporting data indicating that TGF-β1 
shares the same spatial expression pattern as ADM at age E20 in the developing rat 
dentition (Figure 3.7C) as previous studies have also demonstrated TGF-β1 is present 
in the inner dental epithelium at the onset of odontoblast differentiation (Vaahtokari et 
al, 1991; Heikinheimo et al, 1993; Begue-Kirn et al, 1994) the same time-point at 
which ADM is also expressed. Given that ADM has well characterized pleiotropic 
properties, demonstrating both pro- and anti-inflammatory properties (Elsasser and 
Kahl, 2002), being both antiapoptotic and proapoptotic depending on cell type 
(Filippatos et al, 2001), has demonstrated an ability to dose dependently enhance 
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astrocyte migration (Xia et al, 2004), is upregulated in carious teeth (McLachlan et al, 
2002), can induce osteoblastic activity (Cornish et al, 1997) and appears to share 
potentially similar temporo-spatial patterns of expression to TGF-β1, which is able to 
stimulate odontoblast differentiation and secretion of dentine extracellular matrix 
(Begue-Kirn et al, 1992; Ruch et al, 1995), it is reasonable to propose that ADM 
could be involved in signalling similar dentinogenic events both developmentally and 
potentially post-natally. There are a several lines of possible study that could be 
applied to aid elucidation of ADM‟s role(s) in development of the dentition and 
craniofacial structures. In vivo experimentation could be carried using genetically 
modified ADM mutant mice. While ADM
-/-
 mice are embryonically lethal, ADM
+/-
 
mice are fertile and viable (Ando and Fujita, 2003). A simple histological examination 
comparing the developing dentition in ADM
+/-
 mice and the developing dentition of 
control mice would highlight whether a deficiency of ADM resulted in developmental 
deformities. Similar approaches have been utilised to study members of the TGF-β 
family (D‟Souza and Litz, 1995; Letterio and Roberts, 1996; Atti et al, 2002), BMPs 
(Bandyopadhyay et al, 2006; Retting et al, 2009) and FGFs (Naganawa et al, 2008),  
and may provide information as to whether ADM is involved in key stages of tooth 
development. Furthermore, immunohistochemical analysis or in situ hybridisation 
comparing the developing dentition of ADM
+/-
 mice and control mice could also be 
performed to determine whether a deficiency of ADM affects the presence and 
expression levels of other key growth and transcription factors known to play a role in 
tooth development. Such data would increase our knowledge of the interactions ADM 
may be involved in during this process.  
Other in vivo studies that would aid further elucidation of ADM‟s role in the 
development of the tooth could include the preparation of type V cavities in rodent 
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teeth (as discussed in Section 1.10.1) followed by localised administration of ADM. 
Similar studies have been performed using bone sialoprotein and BMP-7 which have 
shown their regenerative potential (Goldberg et al, 2001).  
The ability of ADM to stimulate extracellular secretion could also be 
determined using an ex vivo organ culture model examining tooth slices. A similar 
approach to that previously utilised to demonstrate the ability of TGF-β1 and -3 
isoforms and BMP-7 to induce predentine extracellular secretion in rat incisors could 
conceivably be applied (Sloan and Smith, 1999; Sloan et al, 2000). In vitro analyses 
to study ADMs role in dental tissue development could involve the use of primary 
dental pulp cells or even dental pulp stem cells. A significant number of studies have 
utilised such approaches to study the ability of growth factors and dentine matrix 
extract administration on the ability of these cells to differentiate into odontoblasts 
and produce mineralised ECM (Iohara et al, 2004; Huojia et al, 2005; Liu et al, 2005; 
Almushayt et al, 2006; He et al, 2008), this indicates the potential utility of similar 
experimental approaches to characterize ADM activity. 
Whilst these approaches are primarily methods for characterizing the post-
natal effects of growth factors, such knowledge using these models would be 
extremely valuable as they may signify the likelihood of ADM‟s role in development, 
as the process of stem cell recruitment, odontoblast differentiation and the induction 
of dentine secretion from the new generation odontoblasts are thought to closely 
mimic those of tooth development (Smith and Lesot, 2001). 
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ADM related transcript expression in dental cell lines 
To begin to understand ADMs mechanisms of action in dental tissues it was important 
to determine which cells were expressing it and/or may be exposed to it during 
development. For in vitro analysis it was also important to determine whether cells 
were likely able to respond to ADM via expression of relevant receptor complexes. 
ADM is part of the calcitonin superfamily of regulatory peptides (Kitamura et al, 
1993) and exerts its effect upon cells via interactions with CRLR/RAMP-2 (AM-1) 
and CRLR/RAMP-3 (AM-2) receptor complexes (McLatchie et al, 1998). In the 
developmentally derived murine odontoblast-like and dental pulp-like cells, MDPC-
23 and OD-21 cells, respectively, both CRLR and RAMP-2 transcripts were present 
(Figures 4.1A & C) indicating the potential of these cells to respond to ADM. 
Furthermore, their expression appeared to be potentially regulated following exposure 
to ADM (Figures 4.1B & D) possibly indicating a negative feedback response 
mechanism. However, as this experiment was only performed in duplicate, further 
repetitions of this experiment would be required to determine whether these findings 
were statistically significant and confirm this observation. The 3T3 skin fibroblast 
cells were used as control in these experiments due to a significant volume of data 
already analysing the effects of ADM on these cells (Withers et al, 1996; Isumi et al, 
1998). Notably these cells were also found to express both CRLR and RAMP-2 
(Figure 4.1E) as has been previously described (Withers et al, 1996; McLatchie et al, 
1998). These data provided here therefore validated the experimental approach used, 
provided novel data on the receptor complexes present in these cells and initially 
supported the likelihood of the foetal derived dental cell lines, MDPC-23 and OD-21, 
ability to respond to ADM. 
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 The expression of PCNA, a characterized surrogate marker for cell 
proliferation due to its increased expression in the nuclei of cells during DNA 
synthesis (Leonardi et al, 1992), appeared to increase following exposure of the cell 
lines to ADM. In MDPC-23 and OD-21 cells the peak increase in PCNA expression 
occurred following exposure to 10
-11
M ADM (Figures 4.1B & D). These data 
therefore initially suggested that ADM may promote cell proliferation in these cell 
lines. In 3T3 cells there appeared a dose-dependent increase in PCNA expression 
following exposure to ADM (Figure 4.1F), which is in keeping with previously 
published data which demonstrated a dose-dependant increase in cell number 
following exposure of 3T3 cells to ADM (Isumi et al, 1998). However, further 
repetitions of this work are required to determine if the increases observed in the 
expression of PCNA in these cell lines was robust and represented statistically 
significant changes. 
 
Effects of ADM on dental cell cultures  
ADM reportedly stimulates proliferation in several cells types, including osteoblasts 
(Cornish et al, 2002), which share many structural and functional similarities to 
odontoblasts, with both responsible for the production and deposition of highly 
mineralised compounds. The increase in PCNA expression seen in the odontoblast- 
and pulp-like MDPC-23 and OD-21 cultures following exposure to ADM (Figure 
4.1A - D), respectively, also suggested that ADM may induce a proliferative effect on 
these cell lines. Therefore, the effect of ADM on MDPC-23 and OD-21 cell number 
was determined and the 3T3 cell line was used as control due to it previously having 
been shown to increase in proliferation following ADM exposure (Isumi et al, 1998). 
A biphasic response in terms of cell number was observed in MDPC-23 and OD-21 
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cells following exposure to a range of concentrations of ADM (Figure 4.2A & B), 
with 10
-11
M ADM producing the greatest increase in cell number in both cell lines. 
These biphasic responses may indicate varying, concentration dependent actions 
induced by ADM, for example ADM stimulates an increase in cell numbers at 10
-11
M, 
but at higher concentrations, i.e. 10
-7
M, ADM does not significantly affect cell 
number in culture. Whilst these results in dental cells are novel, they are comparable 
to those observed in osteoblasts (Cornish et al, 2002) and in agreement with the 
increases in PCNA transcript levels observed (Section 4.2). In 3T3 cells there was a 
dose-dependant increase in cell number following exposure to ADM, in agreement 
with both previously published data (Isumi et al, 1998) and the PCNA results 
observed (Section 4.2). The difference observed between cell numbers of MDPC-23, 
OD-21 and 3T3 cells exposed to ADM is perhaps not unsurprising given the cells are 
derived from diverse tissues, with MDPC-23 cells being odontoblast-like in nature, 
OD-21 cells being mesenchymal pulp-like cells in nature and 3T3 cells being derived 
from skin fibroblasts (Todaro and Green, 1963; Hanks et al, 1998) and the data 
presented here may indicate that in vivo dental cells, as compared to skin fibroblasts, 
may be more sensitive to local or systemic ADM levels. 
Combined with the IHC data reported here, results suggest that in vivo ADM 
may increase specific dental cell proliferation during tooth development. The similar 
proliferative effects observed in odontoblast-like cells and osteoblasts following 
exposure of to ADM also suggests this molecule may promote mineralisation in 
dental cells and tissues in vivo comparable to that observed during bone development 
(Cornish et al, 1998; 2001). A relative simple in vitro approach which could be used 
to determine this would be to expose odontoblast-like cells to ADM and subsequent 
detection of mineral deposition, indicative of mineralisation, as has been performed in 
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this study (Chapter 5, subsequently discussed later in this chapter). However, to fully 
characterise ADMs ability to promote mineral deposition, further in vivo and ex vivo 
studies would be required which involve the use of the cavity preparation and organ-
culture models previously described. 
 Similar biphasic patterns in cell number were observed following exposure of 
MDPC-23 and OD-21 cells to ADM and DMP concentrations (Figure 4.5A & B). 
DMP preparations are known to contain ADM, which, along with other key growth 
factors, are released following dentine dissolution via plaque bacterial acids or dental 
cavity etchants (Graham, thesis; Graham et al, 2006; Tomson et al, 2007). However, 
both the lower three of E-DMPs and ADM alone increased cell numbers, however the 
increases seen following exposure to the lower three concentrations of E-DMPs were 
higher than those seen with the lower three concentrations of ADM alone. While the 
two higher concentrations of E-DMPs significantly lowered cell number compared to 
the control. These findings suggest that there are other factors influencing cell number 
following E-DMP exposure to MDPC-23 and OD-21 cells, other than any ADM 
sequestered. Indeed, without including an ADM antagonist it is difficult to state 
ADM‟s role in these results. However, this data is the first to compare results and 
provides interesting avenues for future study such as analysing the effects on cell 
numbers of ADM in co-ordination with other growth factors and the inclusion of an 
ADM antagonist with E-DMP stimulation of cell number. In vivo, histological 
analysis and dentine-bridge measurements of cavities introduced to ferret teeth, 
subsequently exposed to DMPs etchants, have demonstrated their ability of to 
increase tertiary dentinogenesis and this is thought to be due to the release of the 
cocktail of growth factors sequestered within (Smith et al, 1990; Smith et al, 1994). 
As ADM constitutes one of these growth factors it is reasonable to suggest that once it 
 225 
is released, ADM may be important in regulating tertiary dentine secretion either on 
its own or in synergy with other molecules present. Given ADMs pleiotropic actions it 
is also likely that it could be important in regulating several cellular aspects in 
response to dental trauma, such as caries. Notably, ADM displays antibacterial 
properties (Allaker and Kapas, 2003; Gröschl et al, 2009) and regulates inflammatory 
responses (Elsasser and Kahl, 2002), both of which would be important factors in the 
tooth‟s response during dental caries. In addition ADM may also act as a chemotactic 
agent for cells involved in the immune and regenerative response (Zudaire et al, 2006) 
and/or may also be important in signalling angiogenesis to faciltate repair (Ribatti et 
al, 2007). Clearly several of these processes may also be activated by ADM during 
tooth development. Potential studies which may elucidate ADM‟s ability to stimulate 
tertiary dentinogenesis could utilize the in vivo local administration of ADM to 
exposed pulp following cavity preparations, as previously discussed, or use of an ex 
vivo organ-culture model, whereby incisor tooth slices are exposed to agarose beads 
soaked in ADM (see Sloan et al, 1998; Sloan and Smith, 1999). In vitro exposure of 
cells to DMPs in the presence of an ADM antagonist, such as ADM22-52, would 
increase our knowledge of ADMs role within the cocktail of growth factors. Induction 
of tertiary dentine formation may subsequently also support ADMs role in tooth 
development due to the overlap between the molecules and processes involved.  
 ADM22-52 is a well characterized competitive antagonist of ADM activity in 
vitro (Eguchi et al, 1994; Hay et al, 2004). The data presented here demonstrate that 
at higher concentrations, ADM22-52 debilitated ADMs capacity to increase cell number 
in MDPC-23 and OD-21 cells (Figures 4.4A & B) in a similar manner to that 
observed in other experiments (Hay et al, 2004). These results indicated that the 
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increases in cell numbers previously described were due to specific ADM interactions 
with the receptor components previously discussed. 
 A biphasic response in cell number, similar to that observed following 
exposure to ADM, was also detected in MDPC-23 and OD-21 cultures following 
dexamethasone exposure (Figure 4.6A & B). Significantly dexamethasone is well 
characterized in vitro with regards to its mineralising induction action (Cheng et al, 
1996; Hildebrandt et al, 2009). In addition, in vitro dexamethasone is also known to 
induce the differentiation of bone marrow stromal cells into osteoblasts (Cheng et al, 
1994) and has been reported to be able to regulate expression of ADM and/or its 
receptors (Nishimori et al, 1997; Hattori et al, 1999; Udono-Fujimori et al, 2004 and 
Uzan et al, 2004). Notably, a glucocorticoid receptor element has recently been 
identified in the regulatory sequences of ADM and the ADM receptor component, 
calcitonin receptor like receptor (CRLR) (Nikitenko et al, 2003; Zudaire et al, 2005). 
Suggesting the potential for ADM to regulate mineralisation in a similar manner to 
dexamethasone and/or even substitute for it in in vitro in cellular and biochemical 
assays. It is also conceivable that due to potential activity redundancy and regulatory 
control ADM may function downstream of dexamethasone signalling in these 
processes. These observations were also further supported by data indicating that 
dexamethasone was able to dose dependently reduce ADM expression in MDPC-23 
and OD-21 cells (Figure 4.7B & F), indicating a potential negative feedback 
regulatory relationship. There was no significant response in 3T3 cells following 
exposure to the mineralising agent dexamethasone, data which is unsurprising given 
that these cells are derived from a non-mineralising organ, i.e. skin, and therefore are 
not predicted to respond in a similar manner as cells derived from mineralised tissues.  
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Effects of ADM on mineral deposition in vitro 
Following the observation of comparable effects of ADM on cell growth in 
odontoblasts and osteoblasts, combined with the similar effects observed for ADM 
and the known mineralisation agent dexamethasone on dental cells, the ability of 
ADM to stimulate mineral deposition was analysed. In odontoblast-like MDPC-23 
cultures, ADM appeared capable of acting as a substitute for dexamethasone in 
standard mineralising medium (Section 5.2). During the earlier stages of analysis 
(after 7 and 11 days exposure), when ADM was used in conjunction with 
dexamethasone, ADM appeared to increase mineral deposition compared to 
dexamethasone alone (Section 5.2). However, by the end of the study period (21 days 
exposure) there were negligible differences in the areas of mineral deposition detected 
following exposure to all concentrations of ADM or dexamethasone. This result could 
be explicable due to dexamethasone‟s ability to dose-dependently reduce ADM 
expression in MDPC-23 cells (Figure 4.7B), thereby inducing a negative feedback 
mechanism. It is reasonable to suggest that as ADM can increase cell numbers in 
MDPC-23 cultures, the increase in mineral deposition observed here was due to an 
increase in cells present in culture after this time period. However, increased mineral 
deposition was observed following exposure to all concentrations of ADM, while only 
10
-13
M and 10
-11
M ADM produced significant increases in cell number (Figure 4.2). 
These data suggest that the increased areas of mineral deposits were not likely linked 
to increasing cell number. Overall, it seems reasonable to conclude that ADM can 
stimulate increases in mineral deposition that is indicative of mineralisation in 
odontoblast-like cells at comparable levels to the known mineralising agent 
dexamethasone, especially during the earlier stages of mineralisation. 
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 In dental pulp-like OD-21 cells, the areas of mineral deposition detected were 
decreased compared to those determined in odontoblast-like MDPC-23 cells. These 
data are perhaps not unsurprising given that these cells are not characterized for their 
ability to secrete mineralised deposits, although they are reportedly capable of 
differentiating into odontoblast progenitor cells (Goldberg et al, 2008). When these 
cells were exposed to concentrations of ADM in the absence of dexamethasone they 
produced areas of mineral deposition that were significantly greater than those 
obtained following ascorbic acid and β-glycerophosphate exposure alone, whilst 
being significantly less than cells exposed to the standard mineralisation media 
containing dexamethasone. When concentrations of ADM were used in conjunction 
with dexamethasone there was minimal variation in the areas of mineral deposition 
detected. The fact that ADM increased mineral deposition compared to ascorbic acid 
and β-glycerophosphate exposure alone suggests that ADM is capable of inducing 
mineral deposition in pulp-like cells. Notably, however, dexamethasone significantly 
increased detectable mineral deposition in OD-21 cells compared to all concentrations 
of ADM after 21 days exposure (Figure 5.12A). These data indicate that 
dexamethasone is still the most potent inducer of mineral deposition in OD-21 cells. 
No discernable mineralised deposits were detected in 3T3 cells following exposure to 
any of the treatments. This result was therefore as predicted due to the skin fibroblast 
origin of 3T3 cells (Todaro and Green, 1963). 
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Effect of systemic ADM administration on dental and craniofacial mineralised 
tissue 
As ADM had demonstrable ability to promote mineralisation in dental cells in vitro 
(Chapter 5) and in vivo can increase mouse long bone length and strength (Cornish et 
al, 1998) it was reasonable to hypothesize that systemic ADM administration may 
also positively affect dental and craniofacial mineralised tissues. Such an opportunity 
to study this potential effect was provided via collaboration with Professor Cornish 
(Bone Research Group, University of Auckland, New Zealand). 
 Micro-computed tomography (µCT) analysis of adult Swiss mice systemically 
treated with either ADM or saline solution over a period of four weeks revealed that 
there was no significant difference in the hard tissue volume in either sample group 
(Section 6.2 & 6.3). Furthermore, little variation in the key mandibular measurements 
obtained from digital images in either treatment group was observed (Section 6.4). 
The exception to this was that the condylar measurements, where the group 
systemically treated with ADM exhibited a significantly increased mean length 
compared to the saline control group (Figure 6.4E). 
 The lack of variation in dental hard tissue volume following systemic 
administration of ADM could be explicable due to several reasons. Firstly, the Swiss 
mice analysed were adults at the onset of the experiment; therefore, the entire 
dentition would be fully developed, no ameloblasts would be present and the 
odontoblasts would be fully mature, resulting in the odontoblasts having undergone a 
series of morphological changes that are associated with a pronounced down-
regulation in dentine production. In this state the odontoblasts produce relatively low 
amounts of dentine whilst staying viable throughout the tooth‟s life (Begue-Kirn et al, 
1994; Linde & Goldberg, 1993; Ten Cate, 1998). Secondly, the mice were injected at 
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the base of the tail. Under normal physiological conditions ADM is bound to an 
accessory binding protein in blood which can modulate its physiological role and 
potentially increase its blood borne stability (Pio et al, 2001). Following external, 
systemic administration of unbound ADM it is unclear as to neither its stability nor, 
therefore, the concentration subsequently localized to the dentine-pulp complex. To 
potentially overcome the problems described a better experimental design could be 
applied, whereby mice were subjected to localised injections directly into the 
craniofacial tissues preferably at an age where the teeth are still undergoing hard 
tissue formation, i.e immediately post-natally. Another possible study modification 
could involve the use of cavity preparation in rodent teeth (as has been previously 
discussed in Section 1.10.2). These studies could provide further information into the 
in vivo effects of ADM on dental tissue biology. 
 Similarly in craniofacial tissue measurements minimal variation was observed 
between the different treatment groups. This could also be due to the localisation of 
the injections and the resulting concentration of ADM subsequently present in the 
mandibular region. A further consideration is the fact that the long bones studied by 
Cornish et al, 2001 and the bones of the cranio-facial region, such as the mandible 
studied here, are formed from developmentally different processes (Netter, 1987). 
Long bones are formed by a process known as endochondral ossification. 
Endochondral formed bone begins as cartilage, however, as it begins to develop a 
layer of osteoblasts form around the cartilage and deposit a thin layer of bone, 
ultimately resulting in the cell death of the cartilage forming chondrocytes. 
Subsequently, the cartilage begins to calcify and further bone is deposited, eventually 
forming the trabeculae of the long bones (Netter, 1987). Intramebranous ossification 
is responsible for the formation of so-called flat bones generally associated with the 
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craniofacial regions (Netter, 1987). In this model of bone development mesenchymal 
progenitor cells differentiate into osteoblast cells. These osteoblasts subsequently 
deposit non-mineralised osteoid, which mineralises to form the trabeculae of spongy 
bone (Netter, 1987). Potentially, such differences in developmental processes may 
account for why minimal changes were observed in ADM treated mandibles 
compared to sham treated animals. This data suggests that ADM could play a role in 
endochonral bone growth, but not intramembranous bone growth, however as ADM 
has demonstratably increased the indexes of bone formation and mineralized bone 
area of mouse calvaria in vivo (Cornish et al, 1997), an area that is formed by 
intramembranous ossification, this is unlikely. The significant increase observed in 
the key condylar measurement (Figure 6.4E) could be related to the fact that this 
region of the mandible is a major site of on-going growth (Enlow and Hans, 1996). To 
better determine whether ADM administration in vivo has potential for mandibular 
regeneration, a similar experimental design as that proposed above for the dental 
tissues could be applied, whereby localised or topical delivery mechanisms could be 
utilised, as in the study of mouse calvaria mineralization following local ADM 
delivery (Cornish et al, 1997). 
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Conclusion 
Novel data presented here has demonstrated the expression of ADM in key temporo-
spatial patterns in the developing tooth bud, specifically in the cells responsible for 
inducing odontoblast differentiation and in secretory odontoblasts. The presence of 
ADM in secretory odontoblasts is identical to the expression of a key growth factor in 
odontoblast differentiation and dentine secretion, TGF-β1. This expression pattern 
could denote a key role for ADM in tooth development, potentially in odontoblast 
differentiation and dentine secretion.  
In vitro, novel data was produced demonstrating that ADM increases dental 
tissue cell numbers and can promote mineral deposition that is indicative of 
mineralisation, whilst in vivo, it‟s effects on murine adult dental and craniofacial 
mineralised tissue biology appear minimal but require further characterisation.  
Data presented here suggests it is plausible that ADM may play an important 
role in tooth development, a hypothesis supported by ADM‟s temporo-spatial 
expression pattern in developing teeth and the fact ADM can regulate mechanisms 
such as increasing cell number and extracellular matrix secretion in several cell types 
derived from developing foetal dentition. This study therefore provides a number 
novel discoveries indicating that further study of ADM in dental tissue biological 
processes is required, as its better understanding may aid development of novel 
biomimetic dental tissue regenerative procedures. 
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